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Preface to ”Asymmetric and Selective Biocatalysis”
The synthesis of compounds or chiral building blocks with the desired configuration is one of the
greatest challenges of chemistry, and is of the great interest in fields such as analytical chemistry and
especially in fine and pharmaceutical chemistry. For this, different biocatalysts (i.e., cells, enzymes,
catalytic antibodies, or ribozymes) have been used to catalyze different processes used, even on
an industrial scale. Biocatalysts have a high activity under very mild conditions, such as ambient
temperature, neutral pH, and atmospheric pressure. They are also able to catalyze highly selective
and specific modifications in different substrates with high complexity, allowing the synthesis of
enantiomerically pure compounds either by resolution processes or by asymmetric synthesis from
prochiral substrates or regioselective modifications in complex molecules. This avoids side reactions
as well as costly purification processes.
In addition to the pure biocatalysts that are traditionally used, in recent years, different
hybrid catalysts have been developed that combine the good catalytic properties of traditional
biocatalysts with the properties of organometallic catalysts. In this way, different mixed catalysts have
been developed as artificial metalloenzymes combining enzymatic and metallic catalytic activities,
expanding the applicability to different systems, such as cascade processes.
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The synthesis of compounds or chiral building-blocks with the desired configuration is one of the
greatest challenges of chemistry and is of great interest in different fields such as analytical chemistry
and especially in fine and pharmaceutical chemistry. Different biocatalysts (cells, enzymes, catalytic
antibodies, or ribozymes) have been used to catalyze different processes, even on an industrial scale.
Biocatalysts have high activity under very mild conditions such as ambient temperature, neutral pH,
and atmospheric pressure. They are also able to catalyze highly selective and specific modifications in
different substrates with high complexity, allowing the synthesis of enantiomerically pure compounds
either by resolution processes or by asymmetric synthesis from prochiral substrates or regioselective
modifications in complex molecules. This avoids side reactions as well as costly purification processes.
In recent years, in addition to the pure biocatalysts traditionally used, different hybrid catalysts
have been developed, which combine the good catalytic properties of traditional biocatalysts with
the properties of organometallic catalysts. In this way, different mixed catalysts have been developed
as artificial metalloenzymes combining enzymatic and metallic catalytic activities, expanding the
applicability to different systems such as cascade processes.
This issue contains one communication, six articles, and two reviews.
The communication from Paola Vitale et al. [1] represents a work where whole-cells were used
as biocatalysts for the reduction of optically active chloroalkyl arylketones, followed by a chemical
cyclization to give the desired heterocycles. Among the various whole cells screened (baker’s yeast,
Kluyveromyces marxianus CBS 6556, Saccharomyces cerevisiae CBS 7336, Lactobacillus reuteri DSM 20016),
baker’s yeast provided the best yields and the highest enantiomeric ratios (95:5) in the bioreduction
of the above ketones. In this respect, valuable, chiral non-racemic functionalized oxygen-containing
heterocycles (e.g., (S)-styrene oxide, (S)-2-phenyloxetane, (S)-2-phenyltetrahydrofuran), amenable to
be further elaborated on, can be smoothly and successfully generated from their prochiral precursors.
Research regarding pure biocatalysts utilizing mechanistic studies, their application in different
reactions and new immobilization methods for improving stability featured in five different articles.
The article by Su-Yan Wang et al. [2] describes the cloning, expression, purification, and
characterization of an N-acetylglucosamine 2-epimerase from Pedobacter heparinus (PhGn2E). For this
research, several N-acylated glucosamine derivatives were chemically synthesized and used to
test the substrate specificity of the enzyme. The mechanism of the enzyme was studied by
hydrogen/deuterium NMR. The study of the anomeric hydroxyl group and C-2 position of the
substrate in the reaction mixture confirmed the epimerization reaction via ring-opening/enolate
formation. Site-directed mutagenesis was also used to confirm the proposed mechanism of this
interesting enzyme.
The article by Forest H. Andrews et al. [3] studies two enzymes benzoylformate decarboxylase
(BFDC) and pyruvate decarboxylase (PDC) that catalyze the non-oxidative decarboxylation of 2-keto
acids with different specificity. BFDC from P. putida exhibited very limited activity with pyruvate,
whereas the PDCs from S. cerevisiae or from Z. mobilis showed virtually no activity with benzoylformate
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(phenylglyoxylate). After research using saturation, mutagenesis BFDC T377L/A460Y variant was
obtained, with a 10,000-fold increase in pyruvate/benzoylformate. The change was attributed to
an improvement in the Km value for pyruvate and a decrease in the kcat value for benzoylformate.
The characterization of the new catalyst was performed providing context for the observed changes in
the specificity.
The article by Xin Wang et al. [4] compares two types of biocatalysts to produce D-lysine L-lysine
in a cascade process catalyzed by two enzymes: racemase from microorganisms that racemize L-lysine
to give D,L-lysine and decarboxylase that can be in cells, permeabilized cells, and the isolated enzyme.
The comparison between the different forms demonstrated that the isolated enzyme showed greater
decarboxylase activity. Under optimal conditions, 750.7 mmol/L D-lysine was finally obtained from
1710 mmol/L L-lysine after 1 h of racemization reaction and 0.5 h of decarboxylation reaction. D-lysine
yield could reach 48.8% with enantiomeric excess (ee) of 99%.
In the article of Rivero and Palomo [5], lipase from Candida rugosa (CRL) was highly stabilized at
alkaline pH in the presence of PEG, which permits its immobilization for the first time by multipoint
covalent attachment on different aldehyde-activated matrices. Different covalent immobilized
preparation of the enzyme was successfully obtained. The thermal and solvent stability was highly
increased by this treatment and the novel catalysts showed high regioselectivity in the deprotection of
per-O-acetylated nucleosides.
The article by Robson Carlos Alnoch et al. [6] describes the protocol and use of a new generation
of tailor-made bifunctional supports activated with alkyl groups that allow the immobilization of
proteins through the most hydrophobic region of the protein surface and aldehyde groups that allow
the covalent immobilization of the previously adsorbed proteins. These supports were especially used
in the case of lipase immobilization. The immobilization of a new metagenomic lipase (LipC12) yielded
a biocatalyst 3.5-fold more active and 5000-fold more stable than the soluble enzyme. The PEGylated
immobilized lipase showed high regioselectivity, producing high yields of the C-3 monodeacetylated
product at pH 5.0 and 4 ◦C.
The hybrid catalysts composed by an enzyme and metallic complex is also covered in this
Special Issue.
The article by Christian Herrero et al. [7] describes the development of the Mn(TpCPP)-Xln10
A artificial metalloenzyme, obtained by non-covalent insertion of Mn(III)-meso-tetrakis(p-
carboxyphenyl)porphyrin [Mn(TpCPP), 1-Mn] into xylanase 10 A from Streptomyces lividans (Xln10
A). The complex was found to be able to catalyze the selective photo-induced oxidation of organic
substrates in the presence of [RuII(bpy)3]2+ as a photosensitizer and [CoIII(NH3)5Cl]2+ as a sacrificial
electron acceptor, using water as an oxygen atom source.
The two published reviews describe different subjects of interest to the fields of biocatalysis and
mix metallic-biocatalysis respectively.
The review by Anika Scholtissek et al. [8] describes the state-of-the-art of ene-reductases from
the old yellow enzyme family (OYEs) to catalyze the asymmetric hydrogenation of activated alkenes
to produce chiral products with industrial interest. The dependence of OYEs on pyridine nucleotide
coenzyme can be avoided by using nicotinamide coenzyme mimetics. In the review, three main types
of OYEs classification are described and characterized.
The review by Yajie Wang and Huimin Zhao [9] highlights some of the recent examples in the past
three years that combined transition metal catalysis with enzymatic catalysis. With recent advances in
protein engineering, catalyst synthesis, artificial metalloenzymes, and supramolecular assembly, there
is great potential to develop more sophisticated tandem chemoenzymatic processes for the synthesis
of structurally complex chemicals.
In conclusion, these nine publications give an overview of the possibilities of different catalysts,
both traditional biocatalysts and hybrids with metals or organometallic complexes, to be used in
different processes, in particular in synthetic reactions at very mild reaction conditions.
Author Contributions: Both authors contributed in writing the manuscript.
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Abstract: A two-step stereoselective chemoenzymatic synthesis of optically active α-aryl-substituted
oxygen heterocycles was developed, exploiting a whole-cell mediated asymmetric reduction of α-,
β-, and γ-chloroalkyl arylketones followed by a stereospecific cyclization of the corresponding
chlorohydrins into the target heterocycles. Among the various whole cells screened (baker’s
yeast, Kluyveromyces marxianus CBS 6556, Saccharomyces cerevisiae CBS 7336, Lactobacillus reuteri
DSM 20016), baker’s yeast was the one providing the best yields and the highest enantiomeric
ratios (up to 95:5 er) in the bioreduction of the above ketones. The obtained optically active
chlorohydrins could be almost quantitatively cyclized in a basic medium into the corresponding
α-aryl-substituted cyclic ethers without any erosion of their enantiomeric integrity. In this respect,
valuable, chiral non-racemic functionalized oxygen containing heterocycles (e.g., (S)-styrene oxide,
(S)-2-phenyloxetane, (S)-2-phenyltetrahydrofuran), amenable to be further elaborated on, can be
smoothly and successfully generated from their prochiral precursors.
Keywords: whole cell biocatalyst; baker’s yeast; enantioselective bioreduction; oxiranes; oxetanes;
tetrahydrofurans; halohydrins; chloroketones; oxygen-containing heterocycles; chemoenzymatic synthesis
1. Introduction
Oxygen-containing heterocycles are ubiquitous in natural products and biologically active
compounds, and are also very common in many blockbuster pharmaceuticals [1,2]. The chemistry
of saturated oxygen heterocycles is a topic of growing interest, and several papers dealing with
more efficient methodologies for their preparation and their synthetic utility have been increasingly
published. Epoxides, in particular, have been widely used in preparative chemistry [3,4] and in
the asymmetric synthesis of fine chemicals and drugs (e.g., sertraline, nifenalol, Figure 1) [5–8]
because of their versatility related to the ring strain. The oxetane skeleton is present in several
Catalysts 2017, 7, 37; doi:10.3390/catal7020037 www.mdpi.com/journal/catalysts4
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natural organic products (e.g., oxetanocin, taxol, mitrophorone), and represents a versatile building
block for the construction of biologically active compounds (e.g., EDO, Figure 1), or other valuable
heterocyclic compounds [9–11]. It is also of interest in medicinal chemistry for the isosteric replacement
of both the carbonyl and the gem-dimethyl group [12–15]. Asymmetric syntheses of optically active
tetrahydrofurans have also been extensively investigated in the last few decades [16] because of
their presence in many natural products and biologically active compounds (e.g., Goniothalesdiol,
Figure 1). The preparation of chiral tetrahydrofurans has been efficiently performed by asymmetric
cycloetherifications of hydroxy olefins in the presence of organocatalysts [17] or transition metals [18],
or by the catalytic asymmetric hydrogenation of substituted furans [19].
Figure 1. Drugs derived from optically active oxygen-containing heterocycles.
Optically active halohydrins have been successfully employed for the preparation of several chiral
non-racemic oxygenated heterocycles (e.g., epoxides, oxetanes, tetrahydrofurans, pyrans).
Some general examples of stereoselective syntheses of halohydrins, as precursors of optically
active cyclic ethers, are (a) the reduction of halogen-substituted ketones by means of hydrides
complexed with chiral ligands (e.g., CBS-catalyst) [20,21]; (b) stereoselective hydrogenation processes
run in the presence of Rh/Ru catalysts [22–24]; (c) microbial [25–28] or isolated enzymes-mediated [29]
stereoselective reductions of α-halo-acetophenones; and (d) the kinetic resolution of racemic
mixtures using dehalogenases (e.g., HheC from Agrobacterium radiobacter AD1) [30,31]. Our group
recently focused on the development of new bio-catalyzed whole-cell biotransformations for the
enantioselective preparation of chiral secondary alcohols, which are valuable precursor compounds
for active pharmaceutic ingredients (APIs) [32–35].
Biocatalytic methodologies have received a great deal of attention for the asymmetric synthesis of
biologically active molecules (also in industrial production) because of their high chemo-, regio-, and
stereoselective performance under mild reaction conditions [36–38]. Building on these findings, herein
we describe a chemoenzymatic synthetic strategy to prepare optically active epoxides, oxetanes, and
tetrahydrofurans, which is based on the enantioselective bioreduction of α-, β-, and γ-haloketones
in the presence of whole cell biocatalysts, followed by stereospecific cyclization of the corresponding
enantio-enriched halohydrins (Scheme 1).
Scheme 1. A chemoenzymatic approach for the synthesis of optically active epoxides, oxetanes, and
tetrahydrofurans via enantioselective bioreduction of halo-ketones with whole-cell biocatalysts.
5
Catalysts 2017, 7, 37
2. Results
2.1. Screening of Biocatalysts for the Stereoselective Reduction of 3-Chloro-1-Arylpropanones
Various microorganisms are known to express different alcohol dehydrogenases (ADHs), each
one exhibiting a specific stereo-preference according to the species, the metabolic growth conditions
and phase, and the substrate specificity. To date, different yeasts have proven to be effective for
the synthesis of functionalized styrene oxides with high stereoselectivity [39], whereas whole-cell
biocatalysts with different stereo-preferences (e.g., Kluyveromyces marxianus, Lactobacillus reuteri) have
been successfully employed for the preparation of enantio-enriched secondary alcohols [32–35].
With the aim of identifying the best whole-cell biocatalyst able to reduce different chloroketones with
high enantioselectivity, we started our study by screening various biocatalysts for the stereoselective
reduction of 3-chloro-1-arylpropanones (Table 1).
In the presence of 0.1 g/L resting cells (RC) of baker’s yeast, chlorohydrin (S)-2a could be
isolated with a 42% yield and in up to a 94:6 enantiomeric ratio (er) (Table 1, entry 1) starting from
3-chloro-1-phenylpropanone (1a), whereas the reduction in the presence of Saccharomyces cerevisiae
CBS 7336 (GC) furnished (S)-2a with a 48% chemical yield and lower er (75:25) (Table 1, entry 2). In the
presence of growing cells (GC) of Kluyveromyces marxianus CBS 6556, a mixture of products was detected
in the reaction crude after 24 h incubation at 30 ◦C, and (S)-2a was isolated with only a 31% yield and
almost in a racemic form (58:42 er) (Table 1, entry 3). The same biotransformation run in the presence
of Lactobacillus reuteri DSM 20016 (RC) whole cells did not afford the desired chlorohydrin, with the
main reaction being instead the dehydroalogenation of the starting haloketone and the formation of
other minor products (see Supporting Information), as observed for other biocatalysts [40].
Table 1. Screening of biocatalysts for the stereoselective reduction of 3-chloro-1-aryl-propanones a.
Ar






30 or 37°C, 24 h








1 Baker’s yeast (RC) C6H5 1a 2a (42) 50 94:6 S
2 Saccharomyces cerevisiae (GC) e C6H5 1a 2a (48) 55 75:25 S
3 Kluyveromyces marxianus (GC) f C6H5 1a 2a (31) g 70 58:42 S
4 Baker’s yeast (RC) 4-FC6H4 1b 2b (13) 15 63:37 S
5 Baker’s yeast (RC) 4-BrC6H4 1c 2c (5) h 85 95:5 S
6 Baker’s yeast (RC) 4-MeOC6H4 1d 2d (–) 12 ND i ND i
a Typical reaction conditions: orbital incubator (200 rpm); temperature: 30 ◦C; (GC): inoculum after 24 h growth in
a sterile medium containing glucose (1%), peptone (0.5%), yeast extract (0.3%), and malt extract (0.3%) in sterile
water; (RC): 0.1 g/L of cell wet mass in 0.1 M KH2PO4 buffer (pH = 7.4) enriched with 1% glucose, halo-ketone
(2 mM final concentration); b Isolated yield after column chromatography; c Enantiomeric ratio (er) determined
by HPLC analysis; d Absolute configuration (abs. conf.) of halohydrins (2a–d) determined by comparing optical
rotation sign and retention time (HPLC analysis) with known data; e CBS 7536; f CBS 6556; g Propiophenone (35%)
and 1-phenylpropan-1-ol (33%) have been detected by 1H NMR analysis of the reaction crude. h Propiophenone
(75%) was isolated as the main product, together with 4-bromophenyloxetane (9%, er = 96:4); i ND means not
determined because of the trace content.
Electronic effects of substituents present on the aromatic ring were also investigated.
Upon reduction of 3-chloro-1-(4-fluorophenyl)-1-propanone (1b) with baker’s yeast (RC), the
corresponding alcohol (S)-2b was formed with a 13% yield and 63:37 er only (Table 1, entry 4),
whereas Lactobacillus reuteri DSM 20016 (RC) was ineffective (see Table S1, Supporting Information).
1-(4-Bromophenyl)-3-chloro-1-propanone (1c) mainly underwent a dechlorination reaction with baker’s
yeast (RC), furnishing the corresponding propiophenone as the main product (75% yield) together
with a small amount of 4-bromophenyloxetane (9% yield), though highly enantio-enriched (96:4 er).
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The expected chlorohydrin (S)-2c formed with a 5% yield only but with 95:5 er (Table 1, entry 5).
Finally, the action of baker’s yeast (RC) on 1-(4-methoxyphenyl)-3-chloro-1-propanone (1d) produced
the corresponding propiophenone (5%) as the result of a dehalogenation reaction of the starting ketone.
Of note, such a dehalogenation reaction took place at 37 ◦C also in the absence of yeast. Thus, the
elimination reaction was found to be independent from the biocatalyst [41,42], different from the
behavior of the other microorganisms [43].
2.2. Screening of Biocatalysts for the Stereoselective Reduction of 4-Chloro-1-Aryl-1-Butanones
Several 4-chloro-1-aryl-1-butanones 1e–h were also incubated and screened with various
whole-cell biocatalysts. Baker’s yeast (RC) mediated bioreduction of 1e took place with moderate yield
(44%), affording the chlorohydrin (S)-2e with an excellent 95:5 er (Table 2, entry 1).
Table 2. Screening of biocatalysts for the stereoselective reduction of 4-chloro-1-aryl-1-butanones a.





er c Abs. Conf. d
1 Baker’s yeast (RC) C6H5 1e 2e (44) 49 95:5 S
2 S. cerevisiae (GC) e C6H5 1e 2e (65) 70 49:51 S
3 K. marxianus (GC) f C6H5 1e 2e (4) 7 42:58 S
4 Baker’s yeast (RC) 4-FC6H4 1f 2f (–) g 40 ND h ND h
5 Baker’s yeast (RC) 4-BrC6H4 1g 2g i – i ND h ND h
6 Baker’s yeast (RC) 4-CH3OC6H4 1h 2h (–) j 5 ND h ND h
a Typical reaction conditions: orbital incubator (200 rpm); temperature: 30 ◦C; (GC): inoculum after 24 h cell growth
in a sterile medium containing glucose (1%), peptone (0.5%), yeast extract (0.3%), and malt extract (0.3%) in sterile
water; (RC): 0.1 g/L of cell wet mass in 0.1 M KH2PO4 buffer (pH = 7.4) enriched with 1% glucose, haloketone
(2 mM final concentration); b Isolated yield after column chromatography; c Enantiomeric ratio (er) determined by
HPLC analysis; d Absolute configuration (abs. conf.) of halohydrins (2e–h) determined both by comparing optical
rotation sign and retention time (HPLC analysis) with known data; e CBS 7336; f CBS 6556; g The corresponding
butyrophenone (37%) has been detected by 1H NMR analysis of the reaction crude; h ND means not determined
because of the trace content; i No reaction. j Chlorohydrin 2h (5%) has been detected by GC-MS analysis of the
reaction crude.
The yields increased up to 65% working with Saccharomyces cerevisiae CBS 7336 (GC), even if the
corresponding halohydrin was isolated as a racemic mixture (49:51 er) (Table 2, entry 2). Kluyveromyces
marxianus CBS 6556 (GC) reduced the halo-ketone 1e both in low yield and enantioselectivity
(Table 2, entry 3), whereas Lactobacillus reuteri DSM 20016 (RC) promoted the formation of
4-hydroxy-1-phenylbutanone as the only product, by the halogen substitution with a water molecule
(Table S2, Supporting Information) [44]. As in the case of 1-arylpropanones, the baker’s yeast
performance was the best in terms of chemo- and stereo-selectivity. However, the reduction of different
aryl-substituted γ-chloro-butyrophenones 1f–h bearing electron-withdrawing and electron-donating
groups proceeded sluggishly in water, presumably because of the poor solubility of the substrates in
the used reaction medium or because of the lower intrinsic ketone reactivity, the main products being
dehalogenated or hydroxy-substituted derivatives (Table 2 entries 4–6). Thus, the lower bioreduction
reaction rates, corresponded to increasingly competitive dehalogenation reactions.
2.3. Screening of Biocatalysts for the Stereoselective Reduction of 2-Chloro-1-Acetophenones
The enantioselective reduction of functionalized α-haloacetophenones by baker’s yeast is
well-known [45], as well as the synthesis of optically active styrene oxides from haloketones by
using isolated alcohol dehydrogenases (e.g., LkDHs from Lactobacillus kefir) [46]. Wild-type whole-cell
biocatalysts are often preferred as biocatalysts over isolated and purified enzymes because they are
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cheaper than isolated and purified enzymes, easy to handle, and have a continuous source of enzymes
and efficient internal cofactor (e.g., NAD(P)H) regeneration systems [39,47]. Building on our recent
studies on the anti-Prelog stereo-preference of Lactobacillus reuteri DSM 20016 in the bioreduction
of acetophenones [32], we investigated the possibility of preparing both the enantiomers of chiral
aryl-epoxides 3i,j (Table 4) carrying out the biotransformations in the presence of either baker’s
yeast or Lactobacillus reuteri DSM 20016 whole cells, followed by cyclization in a basic medium of the
corresponding halohydrins 2i,2j (Table 3).
Table 3. Screening of biocatalysts for the stereoselective reduction of 2-chloro-1-arylethanones.





Er b Abs. Conf. c
1 Baker’s yeast d C6H5 1i 2i (53) 55 90:10 R
2 Baker’s yeast 4-ClC6H4 1j 2j (64) 70 63:37 R
3 L. reuteri (RC) e 4-ClC6H4 1j 2j (28) 30 96:4 S
a Isolated yield after column chromatography; b Enantiomeric ratio (er) determined by HPLC analysis; c Absolute
configuration (abs. conf.) of halohydrins determined by comparing optical rotation sign with known data; d Typical
reaction conditions: orbital incubator: 200 rpm; temperature: 30 ◦C; haloketone (2 mM final concentration) was
added to a 0.1 g/L of cell wet mass suspended in tap water (RC); e Typical reaction conditions: cells were suspended
in PBS at pH 7.4 supplemented with 1% glucose; then, ketone was added at the final concentration of 1 g/L (50 mL
total volume), anaerobiosis; temperature: 37 ◦C; orbital incubator: 200 rpm; e DSM 20016.
Baker’s yeast successfully reduced α-chloroacetophenone 1i and α-chloro-p-chloroacetophenone
1j providing the expected chlorohydrins (R)-2i and (R)-2j with 53% and 64% yields, respectively,
and with up to 90:10 er after 24 h incubation at 30 ◦C (Table 3, entries 1, 2). On the other hand, the
anti-Prelog stereo-preference of Lactobacillus reuteri DSM 20016 [10,32] furnished (S)-2j with a 28%
yield but with a higher stereoselectivity (96:4 er) in comparison with baker’s yeast (Table 3, entry 3).
Thus, baker’s yeast and Lactobacillus reuteri DSM 20016 behave as two complementary whole cell
biocatalysts for the synthesis of optically active 2-chloro-1-arylethanols because of their ADHs opposite
stereo-preference, though with their own substrate specificity (Table 3, entries 2, 3).
2.4. Synthesis of Optically Active 2-Aryloxetanes, 2-Phenyltetrahydrofurans, 2-Arylepoxides
Stereospecific cyclization in basic conditions (t-BuOK/THF or NaOH/iPrOH, room temperature)
of enantio-enriched chlorohydrins 2a, 2c, 2e, 2i, and 2j obtained from baker’s yeast (vide supra)
took place smoothly, providing almost quantitatively the corresponding (S)-2-aryloxetanes 3a,c,
(S)-2-phenyltetrahydrofuran (3e), and (S)-styrene oxide (3i) with high er (up to 96:4) (Table 4, entries
1–4). On the other hand, (R)-p-chlorostyrene oxide 3j was isolated with a 97% yield and with er = 96:4
further to the bioreduction of 1j with L. reuteri DSM 20016 (Table 4, entry 5). Thus, two terminal
enantiomeric arylepoxides could be synthesized exploiting the opposite stereo-preference of two cheap
and complementary biocatalysts.
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Table 4. Synthesis of optically active 2-aryloxygenated heterocycles 3 from halohydrins 2 a.
Entry Ar Chlorohydrin 2 (er) n Product 3 (Yield %) b er c Abs. Conf. d
1 C6H5 (S)-2a (94:6) 2 3a (98) 95:5 S
2 4-BrC6H4 (S)-2c (95:5) 2 3c (98) 96:4 S
3 C6H5 (S)-2e (95:5) 3 3e (98) 95:5 S
4 C6H5 (R)-2i (90:10) 1 e 3i (95) 90:10 R
5 4-ClC6H4 (S)-2j (96:4) 1 e 3j (97) 96:4 S
a Typical reaction conditions: chlorohydrin 2 (1 mmol), t-BuOK (3 mmol), THF (5 mL), 25 ◦C, 4 h; b Isolated yield
after column chromatography; c Enantiomeric ratio (er) determined by GC analysis; d Absolute configuration (abs.
conf.) of cyclic ethers 3 determined by comparing optical rotation sign with known data; e NaOH (3 mL, 1 N) as the
base and i-PrOH (2 mL) as the solvent were used instead of t-BuOK and THF.
3. Materials and Method
3.1. General Methods
1H NMR and 13C NMR spectra were recorded on a Bruker Avance 600 MHz (Bruker, Milan,
Italy) or Varian Inova 400 MHz spectrometer (Agilent Technologies, Santa Clara, CA, USA) and
chemical shifts are reported in parts per million (δ).19F NMR spectra were recorded by using CFCl3
as an internal standard. Absolute values of the coupling constants are reported. FT-IR spectra were
recorded on a Perkin-Elmer 681 spectrometer (Perkin Elmer, Waltham, MA, USA). GC analyses were
performed on a HP 6890 model Series II (Agilent Technologies, Santa Clara, CA, USA) by using a HP1
column (methyl siloxane; 30 m × 0.32 mm × 0.25 μm film thickness). Thin-layer chromatography
(TLC) was carried out on pre-coated 0.25 mm thick plates of Kieselgel 60 F254; visualisation was
accomplished by UV light (254 nm) or by spraying a solution of 5% (w/v) ammonium molybdate
and 0.2% (w/v) cerium(III) sulfate in 100 mL 17.6% (w/v) aq. sulfuric acid and heating to 200 ◦C
until blue spots appeared. Column chromatography was conducted by using silica gel 60 with a
particle size distribution of 40–63 μm and 230–400 ASTM. Petroleum ether refers to the 40–60 ◦C
boiling fraction. GC-MS analyses were performed on a HP 5995C model (Agilent Technologies,
Santa Clara, CA, USA) and elemental analyses on an Elemental Analyzer 1106-Carlo Erba-instrument
(Carlo-Erba, Milan, Italy). MS-ESI analyses were performed on an Agilent 1100 LC/MSD trap system
VL (Agilent Technologies, Santa Clara, CA, USA). Optical rotation values were measured at 25 ◦C using
a Perkin Elmer 341 polarimeter (Perkin Elmer, Waltham, MA, USA) with a cell of 1 dm path length; the
concentration (c) is expressed in g/100 mL. The enantiomeric ratios were determined by HPLC analysis
using an Agilent 1100 chromatograph (Agilent Technologies, Waldbronn, Germany), equipped with
a DAD detector, and Phenomenex LUX Cellulose-1 [Cellulose tris(3,5-dimethylphenylcarbamate)],
LUX Cellulose-2 [Cellulose 2 tris(3-chloro-4-methylphenylcarbamate)], and LUX Cellulose-4 [Cellulose
tris(4-chloro-3-methylphenylcarbamate)] columns (250 × 4.6 mm), or by GC-analyses performed
on a Hewlett–Packard 6890 Series II chromatograph (Agilent Technologies, Inc., Wilmington, DE,
USA) equipped with a Chirasil-DEX CB (250 × 0.25 μm) capillary column, column head pressure
= 18 psi, He flow 2 mL/min, split ratio 100/1, T (oven) from 90 to 120 ◦C. All the chemicals and
9
Catalysts 2017, 7, 37
solvents were of commercial grade and were further purified by distillation or crystallization prior
to use. All optically active halohydrins 2a–j and oxygen-containing heterocycles 3a–j obtained by
bioreductions of halo-ketones had analytical and spectroscopic data identical to those previously
reported or to the commercially available compounds. Racemic mixtures (for HPLC references)
were synthesized by NaBH4 reduction in EtOH with 87%–96% yields according to the reported
procedures [32–35].
3.2. Microorganism and Cultures
Saccharomyces cerevisiae CBS 7336 and Kluyveromyces marxianus CBS 6556 were obtained from public
type culture collections (CBS, DSM, Delft, The Netherlands) under aerobic conditions in a medium
containing 0.3% yeast extract, 0.3% malt extract, 0.5% peptone, and 1% glucose. Agar-agar (2%) was
added to the same medium for cell preservation on agar slants.
Lactobacillus reuteri DSM 20016 was obtained from a DSMZ culture collection (Braunschweig,
Germany) [48]. Cells were maintained at –80 ◦C in culture broth supplemented with 25% (w/v)
glycerol. Pre-cultures and cultures were carried out in a classical MRS medium [49] (Oxoid) containing
20 g/L glucose, 10 g/L peptone, 8 g/L meat extract, 4 g/L yeast extract, 1 g/L Tween 80, 2 g/L
di-potassium hydrogen phosphate, 5 g/L sodium acetate·3H2O, 2 g/L tri-ammonium citrate, 0.2 g/L
of magnesium sulfate·7H2O, and 0.05 g/L manganese sulfate·2H2O. Cells were incubated at 37 ◦C for
24 h, statically. Cell density was monitored using optical density at 620 nm (OD620) with a Genesys
TM 20 spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA).
3.3. Blank Experiments
A 1 L flask containing 400 mL of the culture medium was stirred at 30 ◦C on an orbital shaker at
200 rpm. Halo-ketones 1a–j (50 mg) were added. The reaction was monitored by TLC and stopped after
24 h. The content of the flask was extracted with Et2O and analyzed by GC-MS or 1H NMR analysis.
3.4. Bioreduction of Haloketones 1a,e by Yeasts Growing Cells: General Procedure
Cells preserved on agar slants at 4 ◦C were used to inoculate 250 mL flasks containing 100 mL of
the culture medium. The flasks were incubated aerobically at 30 ◦C on an orbital shaker and stirred at
250 rpm. Flasks (250 mL) containing 100 mL of the culture medium were then inoculated with 5 mL of
the 24-h-old suspension and incubated in the same conditions for 24 h. Flasks (1 L) containing 400 mL
of the culture medium were then inoculated with 5 mL of the latter suspension and incubated for 24 h.
The optical density was checked at 620 nm for all cultures before adding halo-ketones 1a,e (100 mg)
previously dissolved in 1 mL of EtOH. The progress of the reactions was monitored by TLC and/or
GC and stopped after 24 h, as indicated in Tables 1 and 2. The content of the flask was then centrifuged
and the supernatant extracted with EtOAc. All the reactions were repeated at least twice without any
detectable bias in the results. Silica gel column chromatography of the reaction crude, using hexane
and EtOAc (90:10 or 80:20) as the eluents yielded the desired halohydrins (2a,e) (Tables 1 and 2).
3.5. Baker’s Yeast Bioreductions General Procedure
Baker’s yeast (15 g) was dispersed to give a smooth paste in tap water (250 mL). The substrate
(100 mg) was added and stirred at 30 ◦C in an orbital shaker (200 rpm). The reaction progress was
monitored by TLC. After 24 h (Tables 1–3), the reaction was stopped by centrifugation, decantation, and
extraction by EtOAc or CH2Cl2. The extracts were dried over anhydrous Na2SO4 and the solvent was
evaporated under reduced pressure. The residue was purified by silica gel column chromatography
using hexane and EtOAc (10:1 or 8:2) as the eluents to yield the desired halohydrins (2a–j) (Tables 1–3).
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3.6. Characterization Data of Compounds 2a-c,e,i,j and 3a,c,e,i,j
(S)-3-Chloro-1-phenylpropan-1-ol (2a) [50]. 42% Yield (from baker’s yeast), Rf 0.50 (2:8 ethyl
acetate:hexane); [α]D20 = –16.9 (c 1, CHCl3), er [S]:[R] = 94:6 determined by HPLC [LUX Cellulose-1
column (hexane:2-propanol = 90:10), 0.8 mL/min], tR [major (S)-enantiomer] = 11.9 min; tR [minor
(R)-enantiomer] = 12.8 min. 1H NMR (CDCl3, 600 MHz, 25 ◦C, δ): 7.38–7.25 (m, 5 H, aromatic protons),
4.97–4.95 (m, 1 H, CHOH), 3.77–3.73 (m, 1 H, CHHCl), 3.59–3.55 (m, 1 H, CHHCl), 2.28–2.22 (m, 1 H,
CHH), 2.13–2.08 (m, 1 H, CHH), 1.97–1.89 (bs, 1 H, OH, exchanges with D2O). 13C NMR (150 MHz,
CDCl3, 25 ◦C; δ): 143.7, 128.7, 127.9, 125.8, 71.3, 41.7, 41.4. GC-MS (70 eV) m/z (rel.int.): 172 [(M + 2)+, 1],
170 (M+, 3), 117(2), 115(2), 108(8), 107(100), 105(9), 79(49), 77(28), 31(8).
(S)-3-Chloro-1-(4′-fluorophenyl)propan-1-ol (2b) [51,52]. 13% Yield (from baker’s yeast), Rf 0.40 (1:15
ethyl acetate:hexane); [α]D20 = –8.13◦ (c 0.75, CHCl3), er [S]:[R] = 63:37, determined by HPLC [LUX
Cellulose-1 column (hexane:2-propanol 90:10), 0.8 mL/min], tR [major (S)-enantiomer] = 9.8 min; tR
[minor (R)-enantiomer] = 10.5 min. 1H NMR (CDCl3, 400 MHz, 25 ◦C, δ): 7.36–7.33 (m, 2 H, aromatic
protons), 7.07–7.03 (m, 2 H, aromatic protons), 4.96–4.93 (m, 1 H, CHOH), 3.77–3.70 (m, 1 H, CHHCl),
3.57–3.52 (m, 1 H, CHHCl), 2.25–2.19 (m, 1 H, CHH), 2.10–2.03 (m, 1 H, CHH), 1.99–1.85 (bs, 1 H, OH,
exchanges with D2O). 13C NMR (CDCl3, 125 MHz, 25 ◦C, δ): 41.5, 41.6, 70.7, 115.5 (d, 2JC–F = 21.0 Hz,
127.4 (d, 3JC–F = 8.0 Hz), 139.4, 162.3 (d, 1JC–F = 246.0 Hz).19F NMR (376 MHz, CDCl3, δ): –114.53, (m).
GC-MS (70 eV) m/z (rel.int.): 188 (M+, 3), 126(8), 125(100), 123(11), 97(46), 96(7), 95(15), 77(14).
(S)-3-Chloro-1-(4′-bromophenyl)propan-1-ol (2c) [53,54]. 5% Yield (from baker’s yeast), Rf 0.3 (1:10
ethyl acetate:hexane); [α]D20 = −4.95◦ (c 0.75, CHCl3), er [S]:[R] = 95:5, determined by GC with isotherm
at 170 ◦C, tR [minor (R)-enantiomer] = 43.0 min; tR [major (S)-enantiomer] = 44.3 min. 1H NMR (CDCl3,
400 MHz, 25 ◦C, δ): 7.49–7.45 (m, 2 H, aromatic protons), 7.25–7.22 (m, 2 H, aromatic protons), 4.14–4.08
(m, 1 H, CHOH), 3.77–3.70 (m, 1 H, CHHCl), 3.57–3.52 (m, 1 H, CHHCl), 2.22–2.15 (m, 1 H, CHH),
2.05–2.00 (m, 1 H, CHH), 2.00–1.85 (bs, 1 H, OH, exchanges with D2O). 13C NMR (CDCl3, 150 MHz,
25 ◦C, δ): 142.7, 131.8, 131.7, 127.5, 121.7, 70.6, 41.5. GC-MS (70 eV) m/z (rel.int.): [(M + 4)+, 2]; [(M+2)+, 8];
(M+, 6), 188 (7), 187 (91), 185 (100), 183 (5), 159 (13), 157 (17), 155 (5), 78 (21), 76 (5), 75 (5), 51 (8), 50 (5).
(S)-4-Chloro-1-phenylbutan-1-ol (2e) [55]: 44% Yield (from baker’s yeast), Rf 0.3 (1:10 ethyl acetate:
hexane); [α]D20 = –26◦ (c 1, CHCl3), er [S]:[R] = 95:5, determined by HPLC [LUX Cellulose-1
coloumn (hexane:2-propanol = 90:10), 0.5 mL/min], tR [minor (R)-enantiomer] = 24.2 min; tR [major
(R)-enantiomer] = 25.7 min. 1H NMR (CDCl3, 400 MHz, 25 ◦C, δ): 7.40–7.27 (m, 5 H, aromatic protons),
4.74–4.71 (m, 1 H, CHOH), 3.60–3.53 (m, 2 H), 1.97–1.78 (m, 4 H), 1.85–1.80 (bs, 1 H, OH, exchanges
with D2O). 13C NMR (CDCl3, 100 MHz, 25 ◦C, δ): δ 29.1, 36.4, 45.2, 74.0, 125.9, 128.0, 128.7, 144.5.
GC-MS (70 eV) m/z (rel.int.): 186 [(M+2)+, 0.4], 184 (M+, 3), 126 (8), 108 (6), 107 (100), 105 (17), 91 (4), 79
(42), 78 (6), 77 (28).
(R)-2-Chloro-1-phenylethanol (2i): 53% yield, Rf 0.4 (1:10 ethyl acetate:hexane); [α]D20 = −40◦
(c 0.50, CHCl3) from baker’s yeast, er [S]:[R] = 90:10, determined by HPLC [LUX Cellulose-1
coloumn (hexane:2-propanol 90:10), 0.8 mL/min], tR [minor (S)-enantiomer] = 13.7 min; tR [major
(R)-enantiomer] = 15.4 min. 1H NMR (CDCl3, 600 MHz, 25 ◦C, δ): 7.41–7.38 (m, 5 H, aromatic protons),
4.92–4.91 (m, 1 H, CHOH), 3.77–3.75 (m, 1 H, CHHCl), 3.68–3.65 (m, 1 H, CHHCl), 2.20 (bs, 1 H, OH,
exchanges with D2O).
(S)-2-Chloro-1-(4′-chlorophenyl)ethanol (2j): 28% Yield, Rf 0.4 (2:8 ethyl acetate:hexane); [α]D20 = +29◦
(c 0.3, CHCl3) from Lactobacillus reuteri. er [S]:[R] = 96:4, determined by HPLC tR [minor (R)-enantiomer]
= 17.4 min; tR [major (S)-enantiomer] = 17.8 min. 1H NMR (CDCl3, 600 MHz, 25 ◦C, δ): 7.36–7.32 (m,
2 H), 7.20–7.16 (m, 2 H), 4.89–4.87 (m, 1 H, CHOH), 3.72–3.70 (m, 1 H, CHHCl), 3.62–3.59 (m, 1 H,
CHHCl), 3.30–2.60 (bs, 1 H, OH, exchanges with D2O). GC-MS (70 eV) m/z (rel.int.): 192[(M + 2)+, 3],
190 (M+, 5), 143 (32), 142 (8), 141 (100), 113 (14), 78 (6), 77 (55); 51 (8), 50 (5), 49 (3).
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(S)-2-Phenyloxetane (3a) [56–58]: 98% Yield, [α]D20 = −4.3◦ (c 1, CHCl3), er [S]:[R] = 95:5 determined by
GC with isotherm at 90 ◦C, tR [major (S)-enantiomer] = 38.3 min; tR [minor (R)-enantiomer] = 40.8 min.
1H NMR (CDCl3, 400 MHz, 25 ◦C, δ): 7.48–7.27 (m, 5 H, aromatic protons), 5.69–5.65 (m, 1 H), 4.86–4.81
(m, 1 H), 4.69–4.50 (m, 1 H, CHH), 3.07–2.98 (m, 1 H, CHH), 2.72–2.63 (m, 1 H, CHH).
(S)-2-(4-Bromophenyl)oxetane (3c) [59]: 9% yield, er [S]:[R] = 96:4, determined by GC with isotherm at
150 ◦C, tR [minor (R)-enantiomer] = 22.5 min; tR [major (S)-enantiomer] = 23.1 min. 1H NMR (CDCl3,
600 MHz, 25 ◦C, δ): 7.47–7.45 (m, 2 H, aromatic protons), 7.21–7.10 (m, 2 H, aromatic protons), 5.69–5.59
(m, 1 H), 4.83–4.78 (m, 1 H), 4.69–4.63 (m, 1 H), 2.93–2.50 (m, 2 H.
(S)-2-Phenyltetrahydrofuran (3e) [60]: 98% yield, [α]D20 = –1.6◦ (c 0.50, CHCl3), er [S]:[R] = 95:5
determined by GC with isotherm at 110 ◦C, tR [major (S)-enantiomer] = 21.8 min; tR [minor
(R)-enantiomer] = 22.9 min. 1H NMR (CDCl3, 400 MHz, 25 ◦C, δ): 7.38–7.26 (m, 5 H, aromatic
protons), 4.74–4.71 (m, 1 H), 4.60–3.53 (m, 2 H), 1.98–1.79 (m, 4 H).13C NMR (CDCl3, 150 MHz, 25 ◦C,
δ): 144.3, 128.6, 127.8, 125.8, 73.9, 44.9, 36.2, 28.9.
(R)-Styrene oxide (3i) [61]: 95% yield, [α]D20 = –25◦ (c 1, CHCl3), er [R]:[S] = 90:10, determined by GC
with isotherm at 100 ◦C, tR [major (R)-enantiomer] = 11.7 min; tR [minor (S)-enantiomer] = 12.3 min.
1H NMR (CDCl3, 600 MHz, 25 ◦C, δ): 7.31–7.22 (m, 5 H, aromatic protons), 3.83–81 (m, 1 H), 3.13–3.10
(m, 1 H); 2.91–2.87 (m, 1 H). 13C NMR (CDCl3, 150 MHz, 25 ◦C, δ): 51.0, 52.2, 125.4, 128.1, 128.4, 137.5.
(S)-4-Chlorostyrene oxide (3j) [62]: 97% yield, [α]D20 = +23◦ (c 1, CHCl3), er [R]:[S] = 4:96 determined by
GC with isotherm at 100 ◦C, tR [minor (R)-enantiomer] = 37.5 min; tR [major (S)-enantiomer] = 39.2 min.
1H NMR (CDCl3, 600 MHz, 25 ◦C, δ): 7.30–7.27 (m, 2 H, aromatic protons), 7.19–7.17 (m, 2 H, aromatic
protons), 3.81–3.79 (m, 1 H), 3.12–3.10 (m, 1 H), 2.73–2.71 (m, 1 H). 13C NMR (CDCl3, 150 MHz, 25 ◦C,
δ): 51.3, 51.8, 126.8, 128.7, 133:9, 136.2.
4. Conclusions
In summary, stereo-defined aryl-substituted oxygen-containing heterocycles have been, for the
first time, synthesized via a new chemoenzymatic approach based on the stereoselective whole-cell
bioreduction of α-, β-, and γ-chloroalkyl arylketones into the corresponding chlorohydrins, followed
by a final stereospecific cyclization. Among the different microorganisms screened (baker’s yeast,
Kluyveromyces marxianus CBS 6556, Saccharomyces cerevisiae CBS 7336, Lactobacillus reuteri DSM 20016)
baker’s yeast was the most efficient in providing chlorohydrins with the best isolated yields ranging
from 42% to 64% and the highest er up to 95:5. 3-Chloropropiophenone, 4-chlorobutyrophenone,
4-chloro-4′-bromopropiophenone, and 2-chloroacetophenone have been reduced with good to
moderate enantioselectivities by baker’s yeast, whereas Lactobacillus reuteri DSM 20016 proved
to be the best microorganism in performing the bioreduction of 2-chloro-4′-chloroacetophenone
with an (S) absolute configuration and er up to 96:4. All the optically active chlorohydrins were
subsequently stereo-specifically and almost quantitatively converted into optically active S-configured
2-aryloxetanes, 2-phenyltetrahydrofuran, and 2-arylepoxides without any erosion of the starting
er. (R)-p-Chlorostyrene oxide could be prepared with the opposite configuration and in up to
96:4 er compared to baker’s yeast, by subjecting to cyclization the α-chlorohydrin obtained from
Lactobacillus reuteri DSM 20016. Since the wild-type whole-cell biocatalysts selected (baker’s yeast and
Lactobacillus reuteri DSM 20016) are cheap and commercially available, this methodology is auspicious
for setting up industrially relevant and cost-effective biotransformations for a large-scale production
of oxygen-containing heterocycles, and thus for the stereo-selective preparation of chiral drugs [18].
It is noteworthy that the tested substrates were slightly soluble in the aqueous solvents used in the
above-mentioned biotransformations. Hence it is very likely that the yield can be further increased
by simple process engineering approaches such as the fed-batch supply of the substrate or the use of
bioreactors with carefully controlled operational conditions.
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biocatalysts for the stereoselective reduction of 4-chloro-1-aryl-1-butanones.
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Abstract: Immobilized and stabilized lipases are important biocatalytic tools. In this paper, different
tailor-made bifunctional supports were prepared for the immobilization of a new metagenomic lipase
(LipC12). The new supports contained hydrophobic groups (different alkyl groups) to promote
interfacial adsorption of the lipase and aldehyde groups to react covalently with the amino groups
of side chains of the adsorbed lipase. The best catalyst was 3.5-fold more active and 5000-fold
more stable than the soluble enzyme. It was successfully used in the regioselective deacetylation of
peracetylated D-glucal. The PEGylated immobilized lipase showed high regioselectivity, producing
high yields of the C-3 monodeacetylated product at pH 5.0 and 4 ◦C.
Keywords: regioselective hydrolysis; biocatalysis; lipase; interfacial activation; covalent immobilization;
tailor-made supports; enzyme stabilization
1. Introduction
Lipases (EC 3.1.1.3) normally catalyze the hydrolysis of carboxylic esters in aqueous media,
but they can also be used to synthesize carboxylic esters in water-restricted media, exhibiting high
regio-, chemo-, and enantioselectivity. Due to these properties, lipases have been used in different
reactions, standing out among the most widely used enzymes in biotechnology [1,2].
Recently, a new lipase, LipC12, was identified in a metagenomic library constructed from soil
samples contaminated with fat [3]. LipC12 had a specific activity against long-chain triglycerides
(e.g., olive oil 1722 U·mg−1) that is comparable to the specific activities of several well-known commercial
lipases [3,4]. Furthermore, LipC12 was stable at moderate temperatures and in the presence of
co-solvents such as methanol, propanol, or acetone [3]. These features suggest that LipC12 might be
suitable for use in biocatalysis.
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Typically, industrial biocatalytic processes require that the lipases be immobilized since that
immobilization facilitates reutilization of the enzyme, reducing process costs [5]. The immobilization of
different lipases has been performed using different immobilization methods such as covalent linkage
with different reactive groups, electrostatic or hydrophobic adsorptions, entrapment, encapsulation, or
cross-linked enzyme aggregates (CLEAs); and using different materials such as nanomagnetic particles,
microspheres, organic or inorganic materials, porous and/or macroporous gel beads, graphene oxides,
exfoliated bentonite, and many others [6–19]. The different immobilization methods have enabled the
procurement of lipase catalysts with different properties in terms of activity, stability, and selectivity [5].
The most successful strategy used for lipase immobilization is adsorption on hydrophobic
supports [5,20]. This strategy has permitted the purification and immobilization of various lipases in a
single step [9,11,21,22]. These protocols are based on the special characteristics and mechanisms of
lipases. In aqueous media, lipases are in equilibrium between closed and open forms. In the closed
form, the lid, which is formed by a short alpha helix, secludes the catalytic site from the medium,
making it inaccessible to the substrate, such that the lipase is in an inactive state. In the open and active
form, the internal side of the lid and the surroundings of the active site form a hydrophobic pocket that
is exposed to the medium. The open form is stabilized upon contact of the lipase with a hydrophobic
surface, as occurs at the oil-water interface when lipases are used to hydrolyze triacylglycerides in
oil-in-water emulsions [9,11]. The adsorption of lipases in the open form at this interface leads to
high activity in a phenomenon that is called interfacial activation. Immobilization by adsorption
on hydrophobic surfaces takes advantage of this phenomenon by fixing the lipase predominantly
in its open conformation. This gives this method a significant advantage over other methods that
immobilize the lipase by other regions and which therefore allow the immobilized lipase to equilibrate
between the open and closed conformations. This method is specific and yields more active and
selective catalysts [23,24], this being especially important for the catalysis of complex reactions, such as
regioselective deprotection reactions with carbohydrates [25]. However, physical adsorption also has a
significant disadvantage: the association between the protein and the support is reversible, meaning
that the lipase can leach from the solid support, especially in the presence of low concentrations of
detergents or solvents [9].
One strategy for preventing the leaching of lipases from hydrophobic supports would be to create
covalent bonds between the adsorbed enzyme and the support. In fact, covalent immobilization of
enzymes using aldehyde-activated supports is a widely used technique [26]. However, a heterofunctional
support that combines hydrophobic and aldehyde groups in the same matrix has not previously
been described.
In the present work, novel tailor-made alkyl-aldehyde supports were prepared (Scheme 1).
The novel supports contain: (i) a very dense layer of different hydrophobic moieties (different alkyl
groups) that are able to absorb lipases at neutral pH; and (ii) a high concentration of aldehyde groups
that are able to react covalently with the enzyme, especially at alkaline pH. The presence of different
groups with different functions on the surface of the support should permit better control of the
immobilization, which occurs through a two-step mechanism: first the enzyme adsorbs onto the
hydrophobic groups and then the aldehyde groups react with it, immobilizing it covalently.
These novel functionalized supports were used to immobilize the novel lipase LipC12,
and the stability, activity, and regioselectivity of the new heterogeneous biocatalyst were tested.
The best heterogeneous biocatalyst that was obtained was used in the regioselective hydrolysis of
per-O-acetylated D-glucal, an interesting building block for the synthesis of various tailor-made
di- and trisaccharides.
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Scheme 1. (A) Preparation of new tailor-made alkyl-aldehyde supports; (B) Mechanism of
immobilization-stabilization of lipases in the open form on new alkyl-aldehyde supports. n = C8
(1-octanethiol); C12 (1-dodecanethiol) and C18 (1-octadecanethiol).
2. Results and Discussion
2.1. Preparation of New Alkyl-Aldehyde Supports
Agarose beads were utilized as the base matrix for the construction of different bifunctional
supports. The surface of the support, which is rich in primary hydroxyl groups, was activated in
alkaline conditions, with epiclorohydrin, forming epoxy groups and diol groups (Scheme 1A). The total
amount of activated primary hydroxyl groups was around 65 μmol·g−1, with epoxy groups accounting for
23 μmol·g−1 and diol groups accounting for 42 μmol·g−1 (Table 1). The epoxy groups were functionalized
with different bifunctional hydrophobic agents (octane-, dodecane-, and octadecane-thiol) in order to
have supports containing groups with different degrees of hydrophobicity for interfacial adsorption
of the lipase (Scheme 1A). The diol groups were then oxidized with sodium periodate, producing
aldehyde groups. These aldehyde groups are capable of reacting covalently with different amine
groups of the protein. Immobilization of the lipase on this support occurs in two steps: first, the enzyme
adsorbs hydrophobically in an orientation that favors the open form; second, the aldehyde groups
react covalently with the side chains of lysine that are exposed at the surface of the enzyme, fixing it
covalently o the support (Scheme 1B).
Table 1. Quantification of groups on the new alkyl-aldehyde supports.
Support Ligands (μmol·g−1) Diol Groups (μmol·g−1)
Agarose-Epoxy 23 ± 0.4 43 ± 0.4
C8-aldehyde 23 ± 1 43 ± 1
C12-aldehyde 21 ± 1.6 41 ± 1.6
C18-aldehyde 19 ± 1.1 38 ± 1.1
The number of epoxy/ligands groups was calculated from the difference in periodate consumption
between the hydrolyzed support and the initial epoxy support as described in the methods section. Results
are expressed as the average of triplicate assays ± the standard error of the mean.
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2.2. Immobilization of LipC12 on New Alkyl-Aldehyde Supports
Figure 1 shows the immobilization of LipC12 by adsorption onto the new alkyl-aldehyde supports.
LipC12 was quite rapidly immobilized at pH 7.0 on all bifunctionalized supports, with complete
immobilization (i.e., >95% removal of activity from the supernatant) occurring in less than 2 h.
Figure 1. Immobilization courses of LipC12 on new alkyl-aldehyde supports. () C8-aldehyde;
() C12-aldehyde; () C18-aldehyde. () Control. Symbols: Black (suspension); Hollow (supernatant).
Results are expressed as the average of triplicate assays ± the standard error of the mean.
LipC12 was activated by adsorption onto the support, with the activities measured for the
suspension being significantly higher than that of the original supernatant (Figure 1). The highest
value of recovered activity, 380%, was obtained with the preparation C12-aldehyde/LipC12.
The preparations C8-aldehyde/LipC12 and C18-aldehyde/LipC12 also showed high values of
recovered activity (>200%), showing the hyperactivation of lipase LipC12 immobilized these supports
(Table 2). The results show that these new tailor-made supports allowed the immobilization of this
lipase in its open conformation via interfacial activation [9,11].
Table 2. Principal parameters for immobilization of the lipase LipC12 on new alkyl-aldehyde supports.
Support Immobilization Efficiency (%) a Recovered Activity b (%) Recovered Activity after Reduction c
C8-aldehyde >95 357 346
C12-aldehyde >95 380 370
C18-aldehyde >95 252 256
a Calculated as the difference between the initial and final activities in the supernatant after 2 h of immobilization;
b Recovered activity (%), measured as the ratio between the real activity (U·g−1 support) of immobilized LipC12
and theoretical activity of the immobilized LipC12 (U·g−1 support); c Recovered activity (%) after incubation at
pH 10 for 1 h and reduction with NaBH4.
In order to fix LipC12 covalently to the support, the immobilized preparations were incubated at
different pH values (7.0, 8.5, and 10) for 1 h. After the incubation, the imine bonds formed between
the enzyme and the support were then reduced by adding sodium borohydride. This reduction did
not affect the activity of the immobilized enzyme (Table 2). No leaching of lipase was found after
incubation in surfactants.
2.3. Thermal Inactivation of Different Immobilized LipC12 Preparations
The various immobilized LipC12 preparations previously incubated at different pH values were
incubated in phosphate buffer 25 mM at 55 ◦C. In all cases, the thermal stability of the derivatives
incubated at pH 10 was higher than that incubated at pH 8.5 and 7.0 or the only adsorbed preparations
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(Figure S1). At pH 7.0, the reactivity of the amino groups of the enzymes was not high enough to
produce a covalent attachment with the aldehyde groups; at pH 10, the increase in the reactivity of the
amine groups of side chains close to the lid that promote the rigidification on this region resulting in
a high stabilization. At 55 ◦C, C8-aldehyde/LipC12, C12-aldehyde/LipC12, C18-aldehyde/LipC12
conserved more than 80% of their activity after 24 h (Figure 2A) while the half-life of the soluble
enzyme was 37 min.
(A) (B)
Figure 2. Thermal inactivation of LipC12 immobilized on different alkyl-aldehyde supports.
(A) Inactivation was performed at pH 7.0, 55 ◦C after incubation at pH 10 for 1 h; (B) Inactivation
was performed at pH 7.0, 80 ◦C after incubation at pH 10 for 1 h. () C12-aldehyde/LipC12;
( ) C8-aldehyde/LipC12; () C18-aldehyde/LipC12 and () Soluble enzyme. Results are expressed as
the average of triplicate assays ± the standard error of the mean.
After 24 h incubation at 80 ◦C, C8-aldehyde/LipC12 and C12-aldehyde/LipC12 still had residual
activities above 50%, while the residual activity of C18-aldehyde/LipC12 was only 20% (Figure 2B).
Intermediary spacer arms (C8 and C12) supports produced a slight increment in the stability effect
achieved when compared with C18. The half-lives were 22 h for C8-aldehyde/LipC12 and 21 h for
C12-aldehyde/LipC12, while the soluble lipase lost 50% of the activity after only 15 s. This means
that the alkyl-aldehyde-lipase preparations were from 2000- to 5000-fold more stable than the soluble
enzyme (Table 3). Considering the retention of activity (Table 2) and stability, the C12-aldehyde/LipC12
preparation was chosen for the remaining studies.
Table 3. Half-lives (in hours) of the different immobilized preparations at 80 ◦C.
Preparations a Half-Life (t 12 ) at 80
◦C Stability Factor




a Preparations were incubated at 80 ◦C. Aliquots were withdrawn periodically for quantification of residual
enzymatic activity to estimate the half-life according to Henley and Sadana [27].
2.4. Effect of Temperature and pH on Activity of Free and Immobilized LipC12
The optimum temperatures for the activity of free and immobilized LipC12 were determined over
the temperature range of 20–90 ◦C. The maximum activity of the free enzyme was obtained at 30 ◦C
while the optimal temperature for C12-aldehyde/LipC12 was 70 ◦C (Figure 3).
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Figure 3. Effect of temperature on free and C12-aldehyde/LipC12 activity. ( ) Soluble LipC12;
() C12-aldehyde/LipC12. The activity was determined using p-nitrophenyl proprionate (pNPP)
as the substrate, at pH 7.0. Results are expressed as the average of triplicate assays ± the standard error
of the mean.
This shift in the optimal temperature was related to the improvement of the stability of the
obtained preparation. The high improvement after adsorption and covalent linkage is important
because it permits the transformation of a mesophilic enzyme into an enzyme with properties that
are similar to, or even better than, those of enzymes from thermophile organisms, such as Bacillus
thermocatenolatus lipase (BTL) and Thermus thermophilus lipase (TTL) [28,29].
In relation to the effects of pH on activity, the maximum activity was obtained at around pH 7.0
for both free LipC12 and C12-aldehyde/LipC12 (Figure 4).
Figure 4. Effect of pH on free and C12-aldehyde/LipC12 activity. ( ) Soluble LipC12;
() C12-aldehyde/LipC12. The activity was determined using p-nitrophenyl proprionate (pNPP) as the
substrate. Results are expressed as the average of triplicate assays ± the standard error of the mean.
2.5. Regioselective Hydrolysis of 3,4,6-tri-O-acetyl-D-glucal by Immobilized LipC12
C12-aldehyde/LipC12 was used to catalyze the hydrolytic deacetylation of per-O-acetylated-D-glucal
(1). The yield of this reaction depends strongly on the reaction conditions. The principal variables
assayed were the pH and temperature. Additionally, the recovering of the optimal catalyst with PEG
was performed. This treatment has demonstrated that it is able to improve the activity and stability [30].
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The activity of the soluble enzyme was also assayed. However, at 25 ◦C, its activity was extremely low,
so no attempt was made to assay it at 4 ◦C (data not shown).
At 25 ◦C, low regioselectivity was C12-aldehyde/LipC12 at both pH 7.0 and pH 5.0, producing
only around 10% yield of monodeacetylated products at 100% conversion (Table 4). The PEGylated
preparation, C12-aldehyde/LipC12-PEG, had a slightly improved regioselectivity at pH 5.0 and 25 ◦C,
although the yield of 3-OH product (2) was only 22%.


































/LipC12 7.0 4 18 96 77 52 1 7 17
C12-aldehyde
/LipC12 5.0 4 4 96 34 26 1 1 6
C12-aldehyde
/LipC12-PEG 5.0 4 15 96 81 69 0 3 9
C12-aldehyde
/LipC12 7.0 25 140 24 100 5 4 0 91
C12-aldehyde
/LipC12 5.0 25 140 24 100 11 0 0 89
C12-aldehyde
/LipC12-PEG 5.0 25 110 24 100 22 2 2 74
(1)- 3,4,6-tri-O-acetyl-D-glucal; (2)- 4,6-di-O-acetyl-D-glucal; (3)- 3,4-di-O-acetyl-D-glucal; and (4)- 3,6-di-O-acetyl-
D-glucal; * ×10−3; a Total conversion of substrate (1) with different products; b D-glucal and dideacetylated products.
The regioselectivity was higher at 4 ◦C than at 25 ◦C (Table 4). At pH 7.0, 52% of C-3-OH product
(2) was obtained at 77% conversion, with slight conversion into 4-OH product (4) (7%) and 6-OH
product (3) (1%), reducing the undesired product in 17% (Table 4). The PGEylation of this catalyst
(C12-aldehyde/LipC12-PEG) allowed an improvement of the regioselectivity. This catalyst produced
69% of 3-OH product (2) at 81% conversion, and only 3% of 4-OH product (4) (Table 4).
The PEGylated catalyst was reused in three reaction cycles at 4 ◦C and similar reaction yields were
obtained, demonstrating its reusability (Figure S2). However, the recycle of the catalysts in this reaction
are not reported, these data are similar to others obtained by different authors for the hydrolysis of
esters as reported by Macario et al. [31], where the catalyst (lipase of Rhizomucor miehei immobilized on
zeolites) was used in the hydrolysis of methyl myristate for four cycles or Cao et al. [12] that recycled
the catalyst (nanohybrids of Yarrawia lipolytica lipase) for 12 reaction cycles using pNPP as substrate.
3. Materials and Methods
3.1. Materials
The strains E. coli TOP10 (Invitrogen, Carlsbad, CA, USA) and BL21(DE3) (Novagen, Madison,
MI, USA) and the vector pET-28a(+) (Novagen, Madison, MI, USA) were used as the recombinant
protein expression system. Agarose 4 BCL was purchased from Agarose Bead Technologies (Madrid,
Spain). Epichlorhydrine, iminodiacetic acid, triethylamine, sodium borohydride, sodium periodate,
1-octanothiol, 1-dodecanothiol, 1-octadecanethiol, tri-O-acetyl-D-glucal, polyethylene glycol (1.500),
nickel(II) chloride hexahydrate, and high molecular weight protein (Sigma Marker™) were purchased
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from Sigma (Sigma-Aldrich, St. Louis, MO, USA). The substrate p-nitrophenyl proprionate (pNPP)
was synthesized according to Ghosh et al. [32]. All other chemicals used were of analytical grade.
3.2. Overexpression of Recombinant LipC12
E. coli BL21(DE3) cells carrying the pET28a(+)/lipC12 plasmid were grown in 500 mL of LB medium at
37 ◦C until an OD600 of 0.5 and induced by the addition of Iso-propyl β-D thiogalactopyranoside (IPTG)
to a final concentration of 0.5 mM. The induced culture was incubated for a further 16 h at 20 ◦C before
harvesting the cells by centrifugation (10,000 rpm for 5 min) at 4 ◦C. The cell pellet was re-suspended
in 30 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 10 mM β-mercaptoethanol, 1% (v/v)
Triton X-100 and 10% (v/v) glycerol) and disrupted by ultrasonication in an ice bath (15 cycles of
20-s pulses, 90 W, with 30-s intervals), using a SONICATOR® XL 2020 (Heat Systems-Ultrasonics Inc.,
New Highway, Farmingdale, NY, USA). The crude extract was then centrifuged at 15,000 rpm 30 min
at 4 ◦C to pellet the cell debris.
3.3. Protein Content Determination and Electrophoresis Analysis
Protein content was determined by the Bradford method [33] using a Coomassie Protein Assay Kit
(Pierce Biotechnology, Rockford, IL, USA) with bovine serum albumin as the standard. Electrophoresis
of protein samples was done with 12% (w/v) SDS-PAGE [34] and the gel was stained with Coomassie
Brilliant Blue R-250 and destained with methanol/acetic-acid/water (5/1/4 v/v/v). A mixture
of high molecular weight proteins (Sigma Marker™, Sigma-Aldrich®) was used as the molecular
weight standard.
3.4. Lipase Activity Assay
Lipase activity was determined using p-nitrophenyl proprionate (p-NPP) as the substrate. Free or
immobilized enzyme was added to the reaction mixture (0.4 mM pNPP, mM NaH2PO4 pH 7.0) and the
increase of absorbance was monitored at 348 nm (at pH 7, ε348 nm = 5150 M−1·cm−1) [35]. One unit
of activity (U) was defined as the production of 1 μmoL of p-nitrophenol per minute, under the
assay conditions.
3.5. Preparation of Supports
3.5.1. Epoxy-Agarose
The epoxy-agarose support was prepared according to Mateo et al. [26]. Briefly, 10 g of agarose
BLC (cross-linked 4% agarose beads) was mixed with 44 mL of distilled water, 3.2 g of NaOH, 200 mg
of NaBH4, 16 mL of acetone, and 11 mL of epichlorohydrin. The suspension was stirred for 16 h at 25 ◦C.
The epoxy-agarose was washed with an excess of water, filtered through a glass filter, and stored at 4 ◦C.
3.5.2. Epoxy-Agarose-IDA-Ni2+
The epoxy-agarose support was treated with 0.5 M iminodiacetic acid in solution at pH 11 for different
durations (1, 3, 5, and 24 h), 25 ◦C. The support was then chelated with a NiCl2 solution (30 mg·mL−1)
for 1 h. Finally, the support was washed, filtered under using a glass filter, and stored at 4 ◦C.
3.5.3. Alkyl-Agarose-Aldehyde
The epoxy-agarose support was treated with 100 mM of different alkyl thiols (1-octanothiol;
1-dodecanothiol and 1-octadecanethiol) in a 25 mM NaHCO3 solution at pH 10 for 24 h, 25 ◦C. For the
treatment with 1-octadecanethiol, 50% (v/v) acetone was used as a co-solvent. The reagent was
solubilized using a 50:50 (v/v) mixture of acetone and NaHCO3 solution. After that, the supports were
oxidized with NaIO4 (100 mM), washed, filtered through a glass filter, and stored at 4 ◦C.
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The number of epoxy/ligand groups was calculated from the difference in periodate consumption
between the hydrolyzed support and the initial epoxy support. Periodate consumption was quantified
using potassium iodide, as previously described [36].
3.6. Purification of Recombinant LipC12
The purification was performed using the IDA-Ni2+ supports prepared from agarose gel beads
and activated with different amounts of metal chelate groups [37]. The optimal support was that
obtained after 3 h of activation with IDA (data not shown). For the purification, 4 mL of crude
extract (3.2 mg·mL−1) was offered for 1 g of support and the residual activity of the supernatant was
monitored over time. After that, the support was washed three times with 25 mM NaH2PO4 pH 7.0
and resuspended in the same buffer at increasing concentrations of imidazole. Figure S3 shows the
protein band corresponding to the molecular mass of LipC12 (32 kDa) after SDS-PAGE of the eluate
from IDA-Ni2+ support at 50 mM of imidazole. Table S1 summarizes the results of the purification
step, showing an activity yield of 58%. The specific hydrolytic activity against pNPP was 6.2 U·mg−1.
This preparation was used in further experiments of immobilization.
3.7. Enzyme Immobilization
A standard protocol was established for the immobilization of LipC12 on all supports. One gram
of support was suspended in 4 mL of enzyme solution (containing 0.6 mg of protein) in 25 mM
NaH2PO4 at pH 7, 25 ◦C and left under mild stirring. The time course of immobilization was evaluated
by determining the activity (Section 3.4) in aliquots of the supernatant and suspension removed over
time. After the immobilization, the preparations were washed with 25 mM NaH2PO4 pH 7.0 and
incubated in 4 mL of 25 mM NaHCO3 at different pH values (7.0, 8.5, 10) at 25 ◦C for 1 h. Finally,
the preparations were reduced by adding NaBH4 (1 mg·mL−1) at pH 10 and leaving the mixture under
stirring for 30 min.
The immobilization efficiency (IE, %) was calculated as:
EI =
Ai − A f
Ai
× 100% (1)
where Ai is the hydrolytic activity (U) of the enzyme solution before immobilization and Af is the
hydrolytic activity (U) remaining in the supernatant at the end of the immobilization procedure.





where A0 is the observed hydrolytic activity the immobilized preparation (U·g−1 of support) and AT
is the theoretical activity of the immobilized preparation (U·g−1 of support), calculated based on the
amount of activity removed from the supernatant during the immobilization procedure.
In some assays, immobilized preparations were treated after reduction with PEG (polyethylene
glycol). PEG was used as an additive due to its protective effect on the enzymes described in the
literature [30,38]. To assay, 1 g of immobilized preparation was added to 10 mL phosphate buffer
pH 7.0 25 mM containing 40% PEG1500 (w/v). The suspension was stirred for 2 h at 25 ◦C. After that,
the preparation was washed, filtered under using a glass filter, and stored at 4 ◦C.
3.8. Thermal Stability
The thermal stabilities of free and immobilized LipC12 were assessed by incubation in sodium
phosphate buffer (25 mM, pH 7.0) in a water bath at 55 and 80 ◦C. Inactivation was modeled based
on the deactivation theory proposed by Henley and Sadana [19]. Inactivation parameters were
determined from the best-fit model of the experimental data which was the one based on a two-stage
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series inactivation mechanism with residual activity. Half-life was used to compare the stability of the
different preparations, being determined by interpolation from the respective models described in [39].
3.9. Effect of pH and Temperature on the Activity of Free and Immobilized LipC12
The optimum temperature for the activity of free and immobilized LipC12 was determined over
the temperature range of 20–90 ◦C. The effect of pH on the activity was determined over a range of
pH 4.0–8.0, at 25 ◦C, using citrate (pH 4.0–6.0) and phosphate (pH 6.0–8.0) buffers at 25 mM. The activity
was determined using p-nitrophenyl proprionate (pNPP) as substrate (Section 3.4). The activities were
calculated in relation to controls that were treated identically, but without enzyme to control of
spontaneous hydrolysis of the substrate.
3.10. Hydrolysis of 3,4,6-tri-O-acetyl-D-glucal
For the hydrolysis of peracetylated 3,4,6-tri-O-acetyl-D-glucal, 200 mg of immobilized Lipc12 was
added to a solution (1.5 mL) of substrate-1 (1 mM) in 25 mM of phosphate (pH 7.0) or acetate (pH 5.0)
buffer. The reaction was carried out at 25 or 4◦C, 50 rpm. Samples were removed and analyzed by
reverse phase HPLC (Spectra Physic SP 100, Thermo Fisher-Scientific, Waltham, MA, USA) using
a Kromasil C18 column (25 cm × 0.4 cm, 5 μm·Ø) and a UV detector (Spectra Physic SP 8450, Thermo
Fisher-Scientific, Waltham, MA, USA) set at 220 nm. The mobile phase utilized was acetonitrile (20%)
in milli-Q water. The products were characterized and identified as previously described in [24].
Retention times were: 3,4,6-tri-O-acetyl-D-glucal 1-24.6 min, C-3 monodeacetylated 2-6.3 min, C-6
monodeacetylated 3-6.6 min and C-4 monodeacetylated 4-8.1 min. One unit of activity (U) was defined
as the hydrolysis of 1 μmol of substrate per hour. Activities were expressed as specific activities
(U per mg of immobilized protein). The reutilization of immobilized preparations was studied using
the same reaction conditions as described above.
4. Conclusions
Bifunctional supports with aldehyde and different hydrophobic groups have been synthesized.
The main advantage of the immobilization protocol developed in the current work is the ease with
which the amounts of aldehyde and hydrophobic groups on the surface of the support can be
controlled. This enables modulation of immobilization conditions which may be adapted to the
immobilization/stabilization of proteins which may be limited in commercial supports. This versatile
strategy could also be applied to synthesize supports with other hydrophobic groups to immobilize
different lipases, producing catalysts with different properties. These modulated lipase biocatalysts
could be used to produce products that are difficult synthesize by traditional methods.
The use of different supports allowed us to obtain immobilized preparations of LipC12 with
different activities and stabilities. The best catalyst was 3.5-fold more active and 5000-fold more stable
than the soluble enzyme. Thus, the immobilization procedure converted a mesophilic enzyme into
an enzyme that can operate at high temperature, with a maximal activity obtained at 70 ◦C.
The optimal catalyst was used for the regioselective hydrolysis of peracetylated-D-Glucal.
The highest yield of the C-3 monodeacetylated product was 69% with a conversion of 81%, at pH 5
and 4 ◦C using the PEGylated preparation.
Supplementary Materials: The following are available online at www.mdpi.com/2073-4344/6/12/191/s1,
Figure S1: SDS-PAGE analyses of the LipC12 purification; Figure S2: Thermal stability of different preparations of
LipC12; Figure S3: Hydrolysis of 3,4,6-tri-O-acetyl-D-glucal during successive reaction cycles; Table S1: Summary
of the purification of LipC12.
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Abstract: Lipase from Candida rugosa (CRL) was stabilized at alkaline pH to overcome the inactivation
problem and was immobilized for the first time by multipoint covalent attachment on different
aldehyde-activated matrices. PEG was used as a stabilizing agent on the activity of CRL. At these
conditions, CRL maintained 50% activity at pH 10 after 17 h incubation in the presence of 40% (w/v)
of PEG, whereas the enzyme without additive was instantaneously inactive after incubation at pH
10. Thus, this enzyme was covalently immobilized at alkaline pH on three aldehyde-activated
supports: aldehyde-activated Sepharose, aldehyde-activated Lewatit105 and heterofunctional
aldehyde-activated EDA-Sepharose in high overall yields. Heterogeneous stable CRL catalysts
at high temperature and solvent were obtained. The aldehyde-activated Sepharose-CRL preparation
maintained 70% activity at 50 ˝C or 30% (v/v) acetonitrile after 22 h and exhibited high regioselectivity
in the deprotection process of per-O-acetylated thymidine, producing the 31-OH-51-OAc-thymidine
in 91% yield at pH 5.
Keywords: Candida rugosa lipase; stabilization; covalent immobilization; PEG; alkaline pH;
regioselectivity; nucleosides
1. Introduction
Enzymes are natural catalysts working at mild conditions with high specificity by substrate and
excellent selectivity which could constitute a green solution for the industry. However, enzymes
are unstable out of their natural environments, and parameters such as pH and temperature (T) are
relevant to their stability. Therefore, the stabilization mechanism represents an important issue in
enzyme development for possible industrial implementation. Low enzyme stability has been overcome
using several strategies: genetic engineering [1], chemical modifications [2], the addition of stabilizing
agents [3–6], or the use of different immobilization mechanisms [7,8].
Particularly, multipoint covalent attachment on macroporous supports has been described as a
very interesting approach to stabilize enzymes [9–11].
The functionalization of the support materials by molecules as short spacer arms assures the
attachment of an enzyme molecule to the matrix through various covalent linkages. The amino-acidic
residues of the protein involved in the covalent immobilization should be rigid, conserving the relative
positions against changes in the protein conformation, e.g., with the effect of distorting agents, such as
heat and organic solvents [12–14].
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In this way the use of supports functionalized by aldehyde groups under alkaline conditions
promotes enzyme immobilization by a specific orientation, through the richest area containing the
highest number of lysines, generating a multipoint covalent interaction [15]. The advantages of the
aldehyde groups are: (i) they are reactive toward unprotonated primary amines; (ii) they are stable
under alkaline conditions; (iii) they do not exhibit steric hindrances for intramolecular reactions [16].
In fact, several industrial enzymes have been stabilized by multipoint covalent attachment on these
aldehyde-activated supports [15].
However, enzymes sensitive to alkaline pH are not able to be immobilized through this
methodology. Candida rugosa lipase (CRL), a very useful enzyme in biotransformations [17–19],
is one of these enzymes with very limited conditions for proper use, especially in regards to pH [20].
The immobilization methods for the covalent attachment of this lipase described in the literature
use the application of functionalized supports, e.g., with glutaraldehyde or cyanogen bromide
groups, for covalent immobilization at neutral pH, which mainly correspond to the reaction to the
terminal amino group, with a low, intense covalent immobilization [20,21]. Also, the adsorption
on hydrophobic supports at neutral pH has been used for improving its stability, although this is a
reversible immobilization and the enzyme can be leached from the support in the presence of some
concentration of solvent or detergent [20]. Therefore, the multipoint covalent immobilization of this
enzyme on aldehyde supports would be an excellent strategy, considering the advantages described,
for obtaining an irreversible, immobilized biocatalyst with high stability.
Improvements of the enzyme’s stability with the presence of some additives such as polyols,
solvents or sugars have been reported [22,23].
The use of these additives has the advantage of providing enzyme activity at high temperatures
and alkaline pH [24]. A study of the protective effect of PEG, trehalose and glycerol revealed an
increase with the reagent concentration and length of the carbon chain [25,26]. These compounds are
known to have a more or less pronounced effect on water activity and on the degree of water molecule
association [25]. On the other hand, aqueous solutions of polyols, polymers and sugars, as additives,
were used to study the thermostabilization of enzymes [27].
Herein, we propose a methodology to stabilize Candida rugosa lipase (CRL) at alkaline pH using
PEG as an additive, permitting for the first time its immobilization by multipoint covalent attachment
on aldehyde-activated (Ald) derivative supports. Two different covalent immobilization strategies
involving different orientations of the protein (Figure 1) in the immobilization were used (Scheme 1).
These new immobilized CRL biocatalysts were used to catalyze the regioselective monodeprotection
of per-O-acetylated thymidine, an interesting intermediate in the synthesis of different fungicidal,
antitumor, and especially antiviral agents [28].
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Figure 1. Structure of mature CRL. (A) Lid side. Oligopeptide lid (green), Lys (blue); (B) Lid opposite
side marked lysines; (C) Lid opposite side marked lysines and aspartic and alutamic acids (orange).
The structure of CRL was obtained from the Protein Data Bank (pdb code: CRL) and the picture was
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Scheme 1. Covalent immobilization of CRL by different methodologies.
2. Results and Discussions
2.1. Stabilization of CRL at Alkaline pH
The stability of soluble pure CRL by incubation at different pHs was first studied (Figure 2). This
lipase has been described to be a very sensitive enzyme [20]. After purification, the enzyme incubated
at pH 7 maintained around 92% activity during 25 h at 4 ˝C. When the pH was increased up to 9,
60% activity was found after 25 h. However, the activity of the enzyme was totally lost immediately
after incubation at pH 10, exhibiting the extremely low stability at alkaline pH, which is mandatory to
perform the multipoint covalent immobilization on an aldehyde-activated support.
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Figure 2. Stability of purified CRL at 25 ˝C and different pHs: pH 7 (rhombus), pH 9 (circles), pH 10
(squares); 0.27 mg purified free lipase was used in each experiment.
Thus, different additives—at 20% (w/v) concentration—were added to the enzyme solution to
study their effect on the enzyme stability (Figure 3). The best result was achieved when PEG was
previously added to the lipase alkaline solution (pH 10), where the enzyme retained 40% activity after
incubation for 4.5 h, whereas the soluble enzyme without additives maintained only 20% activity.



















Figure 3. Stabilization of CRL in the presence of different additives. The additives were added at
20% (w/v) concentration and the experiments were performed at pH 10 and 4 ˝C. Without additive
(squares), PEG (rhombus), glycerol (circles), dextran (triangles), threalose (ˆ).
PEG was selected as a stabilizing agent and the effect of the additive concentration and the
molecular size on the lipase stability was studied (Figure 4). PEG1500 stabilized the enzyme slightly
better than PEG6000 at a 15% concentration (w/v), although the best results were found using 40%
(w/v) PEG1500, where CRL conserved 50% activity after 17 h incubation (Figure 4).
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Figure 4. Effect of PEG concentration on the stability of CRL at 4 ˝C and pH 10. Without additive (ˆ),
PEG-1500 15% (squares), PEG-6000 15% (circles), PEG-1500 20% (rhombus), PEG-1500 40% (triangles).
The possible mechanism for the high stabilization of lipase achieved by the addition of PEG
could be explained by two different effects. The first is (1) a strong physical adsorption of the PEG
molecules to the hydrophobic area of the protein, as previously has been reported [29]. Especially
here, in lipases the most hydrophobic area is concentrated on the lid and the surrounding active site;
therefore, the PEG could generate protection of the active site, significantly improving the stability
in an extreme condition such as alkaline pHs. The second effect is (2) due to the fact that the use of
higher PEG concentrations causes a high viscosity which also may prevent undesired changes in the
enzyme structure promoted by the alkaline pH [30].
2.2. Multipoint Covalent Immobilization of CRL
The enzyme was immobilized at optimal conditions (with 40% PEG in solution) using two different
strategies to get multipoint covalent immobilization of the lipase throughout different orientations
(Scheme 1). CRL was immobilized on Ald-Sepharose at 89% yield (loading of 4.9 mg lipase/g
support) at pH 10.2 over 24 h retaining 53% initial activity, whereas a 69% yield of lipase immobilized
maintaining 39% of initial activity was obtained using Ald-Lew105 (Table 1).
Table 1. Covalent immobilization of Candida rugosa lipase on different supports at 4 ˝C.




a Immobilization for 24 h; 5.5 mg pure lipase was offered per gram of support.
The immobilization on heterofunctional Ald-EDA-Sepharose was performed at pH 8 and around
90% yield was achieved after 3 h incubation. After that, the immobilized preparation was incubated at
pH 10 for 24 h to promote a possible multipoint covalent attachment. The immobilized preparation
retained 37% overall initial activity (Table 1).
2.3. Stability of Different Covalent Immobilized Preparations of CRL
To evaluate the effect of the immobilization method on the stabilization of the enzyme, inactivation
experiments at different conditions were studied (Figures 5 and 6).
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Figure 5. Thermal inactivation course of different CRL immobilized preparations. Experiments




















Figure 6. Inactivation profile of different CRL immobilized preparations in the presence of co-solvent.
Experiments were carried out at 25 ˝C, pH 5 and 30% (v/v) acetonitrile. Free CRL (ˆ), Ald-EDA-CRL
(rhombus), Ald-CRL (squares), Ald-Lew105-CRL (circles).
At 50 ˝C, the best stabilization of CRL was achieved after immobilization on Ald-Sepharose. The
Ald-CRL, Ald-lew105-CRL and Ald-EDA-CRL immobilized preparations conserved more than 50%
activity after 9 h incubation at 50 ˝C, whereas the free lipase only retained 6% activity (Figure 5).
Indeed, the Ald-CRL preparation still conserved 70% of the initial activity after 22 h at 50 ˝C whereas
the Ald-Lew105-CRL preparation only maintained 38% activity at this time. This demonstrates the
effect of the matrix on the lipase stabilization.
Also, of the differently oriented catalysts, Ald-EDA-CRL showed good activity, maintaining
around 60% activity after 22 h incubation (Figure 5).
When the CRL preparations were incubated at 30% (v/v) acetonitrile at 25 ˝C, the effect was
even clearer (Figure 6). The Ald-CRL preparation was the most stable catalyst also in the presence
of a co-solvent, retaining 70% activity after 25 h incubation, conditions where the soluble enzyme
was completely inactive. The enzyme immobilized on the Ald-EDA support conserved 55% activity
whereas the Ald-Lew105-CRL preparation was again less stable than the Sepharose one (Figure 6).
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2.4. Regioselective Deprotection of Per-O-acetylated Thymidine by Immobilized CRL Biocatalysts
The different covalent immobilized preparations of CRL were used as catalysts in the hydrolytic
deacetylation of per-O-acetylated thymidine (1) at different pHs (Table 2).
Table 2. Regioselective deprotection of 3,5-O-diacetylated thymidine 1 with different

































2 (%) 3 (%) Thymidine
free CRL 5.0 0.08 104 99 81 9 10
Ald-CRL 5.0 0.24 71 100 91 3 6
Ald-EDA-CRL 5.0 0.09 144 100 70 10 20
Lew105-CRL 5.0 0.06 144 100 17 15 67
free CRL 7.0 0.08 104 99 90 8 2
Ald-CRL 7.0 0.26 51 100 90 4 6
Ald-EDA 7.0 0.09 152 100 88 10 3
Lew105 7.0 0.04 150 62 28 32 2
free CRL 8.0 0.08 120 100 75 11 13
Ald-CRL 8.0 0.11 73 100 88 8 4
a the initial rate in μmol ˆ mgprot´1 ˆ h´1. It was calculated at 10%–30% conversion. b yield of the
monohydroxy acetylated product at 100% conversion.
The Ald-CRL preparation showed the highest activity (three times higher than the soluble
enzyme) and regioselectivity in the monoacetylation of 1 at pH 5 and 7, producing the C-3 hydroxy
monoacetylated thymidine 2 in around 90% yield. The other CRL preparations showed lower
regioselectivity, and no differences in activity compared with the soluble enzyme (Table 2). In particular,
CRL immobilized on Lew105 lost the specificity and the regioselectivity. Also, the results using the
Ald-CRL preparation at pH 8 were better than using the soluble enzyme (Table 2). The role of the
immobilization method on the modulation of the activity and regioselectivity has been shown. In the
case of CRL, immobilization by this strategy generates a particular orientation of the enzyme (from the
protein lid’s opposite side (Figure 1C)) and a strong rigidification of its structure. This phenomenon
alters the open-closed movement of the oligopeptide lid during catalysis and the exact shape of the
open structure which is translated in a significant modulation of the lipase properties. We have already
observed these alterations in lipase enantioselectivity [31], and also in the regioselective deprotection




Lipase from Candida rugosa (CRL), ethylendiamine (EDA), p-nitrophenyl butyrate (pNPB),
dithiothreitol (DTT), polyethyleneglycol (PEG) (Mr 1500, 6000), glycerol, dextran (Mw 1500) and
trehalose were from Sigma Chem. Co (St. Louis, MO, USA). Sepharose 10BCL, octyl-Sepharose and
cyanogen bromide (CNBr) activated Sepharose beads were from GE-Healthcare (Uppsala, Sweden).
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Aldehyde-activated Sepharose or Lewatit VP OC105 (Ald or Ald-Lew105) were prepared as previously
described [33]. 3,5-O-diacetylated thymidine 1 was prepared as previously described [34].
3.2. Lipase Activity Assay
The activities of the soluble lipase (without additives or in the presence of different concentrations
of PEG, glycerol, DTT, trehalose or dextran), supernatant and enzyme suspension were analyzed
spectrophotometrically measuring the increment in absorbance at 348 nm produced by the release
of p-nitrophenol (pNP) (Є= 5.150 M´1¨cm´1) in the hydrolysis of 0.4 mM pNPB in 25 mM sodium
phosphate at pH 7 and 25 ˝C. To initialize the reaction, 0.05–0.2 mL of lipase solution or suspension
was added to 2.5 mL of substrate solution in magnetic stirring. Enzymatic activity is given as one μmol
of p-nitrophenol released per minute per mg of enzyme (IU) under the conditions described above.
3.3. C. rugosa Lipase Purification
The enzyme was purified from commercial crude extract by interfacial adsorption as previously
described [35]. Lipase commercial extract was dissolved in 25 mM sodium phosphate buffer at pH 7
to give 200 mg extract/mL, and submitted to gentle stirring during 1 h at 4 ˝C, and centrifuged at
12,000 rpm during 15 min. The supernatant was separated from the pellet and the protein amount was
calculated by Bradford method [36] (5.5 mg prot/mL). Then 1 mL of this supernatant was diluted in
9 mL of 25 mM phosphate buffer pH 7 and the solution was added to one gram of octyl-Sepharose.
The reaction was performed at 4 ˝C for 1 h. After that, the suspension was filtered by vacuum and the
solid was washed several times with distilled water. More than 95% of the enzyme was immobilized.
For the preparation of the covalent immobilized catalysts, the lipase was desorbed from the
support (one gram of octyl-CRL) adding 20 mL of a solution of 25 mM phosphate buffer pH 7 with
0.4% Triton X-100 (v/v) and incubated it for 1 h. A final solution of 0.27 mg purified lipase/mL
was obtained.
3.4. Preparation of EDA-Aldehyde–Activated Sepharose Support (Ald-EDA)
Sepharose 10 BCL (10 g) was suspended in a mixture solution of 44 mL water, 16 mL acetone,
3.28 g NaOH, 0.2 g NaBH4 and 11 mL epichlorhydrine. The suspension was stirred mildly for 16 h and
washed with an excess of water. One gram of epoxy-Sepharose support was suspended in 10 mL of
ethylenediamine (0.1 M) solution at pH 8 for 6 h. Finally the support was oxidized adding a solution
of 10 mL of water with 140 μmol of sodium periodate per gram of support during 90 minutes and
washed abundantly with distilled water and store at 4 ˝C.
3.5. Multipoint Covalent Immobilization of CRL on Different Aldehyde-Activated Sepharose Supports (Ald)
3.5.1. Immobilization on Aldehyde-Activated Sepharose (Ald) or Aldehyde-Activated Lewatit-105
(Ald-Lew105) at Alkaline pH
First 20 mL of lipase solution (0.27 mglipase/mL) was dissolved in 20 mL solution of 100 mM
sodium bicarbonate pH 8.2 containing 40% PEG1500 (w/v) and the pH was adjusted at pH 10.15. After
that, one gram of Ald-Sepharose or Ald-Lew-105 was added and the reaction was maintained during
16 h at 4 ˝C. Finally the enzyme-support multi-interaction was ended by adding 1 mg of sodium
borohydride per mL of suspension during 30 min [33] (Scheme 1). The immobilization yields are
shown in Table 1.
3.5.2. Immobilization on Aldehyde-Activated EDA-Sepharose (Ald-EDA) at pH 8 and Incubation
at pH 10
One gram of Ald-EDA-Sepharose was added to 10 mL of purified CRL solution (0.27 mg lip/mL)
containing 40% PEG1500 (w/v). Then the suspension was stirred for 2 h at pH 8 and 4 ˝C. Periodically,
samples of the supernatants and suspensions were withdrawn, and the enzyme activity was measured
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as described above. After the preparation was filtrated by vacuum and the solid was incubated in
10 mL sodium bicarbonate buffer at pH 10 for 24 h. Finally, the preparation was reduced by addition of
10 mg sodium borohydride for 30 minutes and then washed with water (Scheme 1). The immobilization
yields are shown in Table 1.
3.6. Inactivation of CRL Immobilized Preparations against T and Co-Solvent
First 0.5 g of biocatalyst were dissolved in 5 mL of 25 mM sodium phosphate buffer (with 30%
(v/v) acetonitrile) at 25 ˝C or incubated at 50 ˝C in acetate buffer at pH 5. The remaining activity at
different times was measured by the assay described above using pNPB as substrate.
3.7. Enzymatic Hydrolysis of 31,51-Di-O-Acetylthymidine (1)
Substrate 1 (5 mM) was dissolved in a mixture of acetonitrile (5%, v/v) in 10 mM sodium
phosphate at pH 7.0 or 10 mM sodium acetate at pH 5.0. 0.2 g of biocatalyst was added to 2 mL of this
solution at 25 ˝C. During the reaction, the temperature and the pH value was maintained constant
using a pH-stat Mettler Toledo DL50 graphic (Mettler-Toledo, LLC 1900 Polaris Parkway, Columbus,
OH, USA). The degree of hydrolysis was analyzed by reverse phase HPLC (Spectra Physic Thermo
SP 100 coupled with an UV detector Spectra Physic SP 8450 (Thermo Fisher-Scientific, Waltham, MA,
USA). For these assays a Kromasil C18 5 μm ϕ (25 cmˆ0.4 cm) column was used and the following
gradient program (A: mixture of acetonitrile (10%, v/v) in 10mM ammonium phosphate at pH 4.2; B:
mixture of miliQ water (10%, v/v) in acetonitrile; method: 0–6 min 100% A, 6–14 min 85% A to 15%B,
14–22 min 100% A, flow: 1.0 mL¨min´1). UV detection was performed at 260 nm. The unit of enzymatic
activity was defined as micromoles of substrate hydrolyzed per minute per mg of immobilized protein.
The monodeprotected 3-OH (2) and 5-OH (3) were used as pure standards. The retention time was
2.4 min for Thymidine, 9.4 min for 2 and 10.2 min 5 and 19 min for 1.
4. Conclusions
Lipase from C. rugosa has been stabilized at alkaline pH to overcome the inactivation problem
by the addition of PEG1500 as a stabilizing agent. Therefore, this has permitted its immobilization
for the first time by multipoint covalent attachment on different aldehyde-activated supports in high
overall yields. Very stable CRL biocatalysts have been prepared; in particular CRL immobilized on
Ald-Sepharose was much more stable than the soluble enzyme. This stable biocatalyst showed
an excellent regioselectivity in the monodeprotection of per-O-acetylated thymidine, producing
the 3-OH-51-OAc-thymidine in 91% yield at pH 5. Therefore, this new biocatalyst represents an
interesting alternative to the octyl-CRL preparation, which has been described as an excellent catalyst
in nucleosides and especially in monosaccharides deprotection [18]. However, Ald-CRL presents the
advantage of being an irreversible catalyst with high stability in the presence of solvent. This strategy
can be also extended to other pH-sensitive enzymes to generate highly stable and active biocatalysts.
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Abstract: The application of biocatalysts in the synthesis of fine chemicals and medicinal compounds
has grown significantly in recent years. Particularly, there is a growing interest in the development of
one-pot tandem catalytic systems combining the reactivity of a chemical catalyst with the selectivity
engendered by the active site of an enzyme. Such tandem catalytic systems can achieve levels
of chemo-, regio-, and stereo-selectivities that are unattainable with a small molecule catalyst.
In addition, artificial metalloenzymes widen the range of reactivities and catalyzed reactions
that are potentially employable. This review highlights some of the recent examples in the past
three years that combined transition metal catalysis with enzymatic catalysis. This field is still
in its infancy. However, with recent advances in protein engineering, catalyst synthesis, artificial
metalloenzymes and supramolecular assembly, there is great potential to develop more sophisticated
tandem chemoenzymatic processes for the synthesis of structurally complex chemicals.
Keywords: tandem catalysis; chemoenzymatic; biocatalysis; dynamic kinetic resolution; artificial
metalloenzyme; asymmetric synthesis
1. Introduction
Living beings do not use enzymes in isolation. However, they build up the living system
by applying multi-step synthesis strategies catalyzed by enzymes acting cooperatively. In that
way, complex molecules are built from simple elements through multi-step biosynthetic routes.
The cooperative action of a sequence of enzymatic reactions unveils the mysteries of “perfect”
reaction systems with maximized energy utilization efficiency and minimal waste generation. Such
synergy inspires biochemists to mimic nature to develop multi-step catalysis for selective synthesis,
termed tandem catalysis. Compared with stepwise synthesis, one-pot tandem reactions offer an
attractive approach to improve the overall synthetic efficiency by eliminating the purification steps
of intermediates, suppressing the side reactions and enhancing selectivity of the product by building
dynamic equilibrium in each step (which improves productivity by allowing equilibrium reactions
to proceed to nearly full conversion). Thus, it is not surprising that from synthetic and industrial
standpoints, there is an increasing interest in eco-friendly tandem processes.
Tandem catalysis employing the same type of catalyst, such as multi-step chemocatalysis
or biocatalysis, has been extensively studied [1,2]. Recently, there is a new trend to combine
chemocatalysis and biocatalysis in one-pot to obtain synergistic synthetic abilities that cannot be
achieved by either separately [3]. Chemocatalysis and biocatalysis are generally considered two
different fields, each with their unique considerations. The catalysts from these fields either catalyze
completely different reactions, or similar reactions with different rates, selectivity and substrate
scopes. Importantly, the catalysts from each of these fields have distinct advantages and limitations.
Organometallic catalysts play a key role in the manufacturing of chemicals. They have wide substrate
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scopes and high productivity, but they usually show poor regio-, stereo- and enantio-selectivity that
have to be overcome by tedious ligand design. Most of the reactions catalyzed by transition-metal
complexes are performed under harsh conditions, such as high temperature and pressure. Biocatalysis
is becoming more widely used in the pharmaceutical industry due to significant advances in enzyme
discovery, supply and improvements. There has also been an increase in applications of these
biocatalysts for chiral catalysis and green chemistry [4–7]. Biocatalysts typically have high regio-,
stereo- and enantio-selectivity, but low productivity. Considering those factors, combining the two
technologies into a tandem one-pot reaction would allow access to more enantiopure compounds.
Unlike developing tandem catalysis with the same type of catalyst, it is more challenging to
combine chemocatalysis and biocatalysis in one-pot due to mutual inactivation. With the exception of
lipases and serine proteases, the majority of enzymes are not able to maintain high catalytic activity in
organic solvents and at high temperatures. Similarly, most transition-metal complexes are inhibited
in aqueous solution with or without cellular components. Several strategies have been developed to
overcome these obstacles, including using biphasic systems, the development of supramolecular hosts
and the development of artificial metalloenzymes to compartmentalize the chemical catalysts. Both
metal catalysts and biocatalysts have been engineered to show higher activity in aqueous solutions or
organic solvents with the utilization of catalyst immobilization and protein engineering respectively.
In this review, we will cover major accomplishments in one-pot chemoenzymatic reactions within the
last three years, including dynamic kinetic resolution, one-pot concurrent transformations in aqueous
solutions, and interfacing transition-metal complexes with living cells.
2. Dynamic Kinetic Resolution
Chiral molecules with non-superimposable mirror images can have striking differences in
biological activities, such as pharmacology, toxicology, pharmacokinetics, and metabolism [8]. In fact,
more than half of the drugs currently in use are chiral compounds. In order to fulfill the increasing
demand for enantiopure compounds, significant advances in asymmetric synthesis and catalysis have
been achieved [9,10]. Dynamic kinetic resolution (DKR) catalyzed by transition-metal racemization
complexes and kinetic resolution enzymes, have been employed as efficient methods to prepare
chiral alcohols and amines that constitute important synthetic building blocks of various chemical
products, such as agrochemicals, food additives, fragrances and pharmaceuticals [11]. Enzymatic
kinetic resolution (KR) of racemic mixtures is the most common approach to access enantiomerically
pure alcohols and amines on an industrial scale due to the high activity and selectivity of enzymes [12].
The resolution of racemic alcohols or amines is generally accomplished through (R)- or (S)- selective
acylation of their enantiomers by using a lipase or a serine protease as the resolving enzyme. However,
enzymatic KR suffers from the limitation that only 50% of the theoretical yield could be obtained for
the desired enantiomer. Integrating a racemization catalyst to continuously replenish the consumed
enantiomer could theoretically drive the resolution up to 100% (Scheme 1). The compatibility between
the enzyme and the isomerization catalyst is essential for a successful DKR system. The KR enzyme
must have sufficient enantioselectivity (kfast/kslow ≥ 20) and the rate of isomerization (krac) must be at
least 10 times faster than the enzyme-catalyzed reaction of the slow reacting enantiomer (kslow).
Since the pioneering work of William [13], Bäckvall [14] and Kim [15] on developing practical
systems that combined metal catalysts with lipases or serine proteases for DKR of alcohols and amines,
a variety of studies have been performed to improve these systems, such as discovering catalysts
that could efficiently racemize alcohols and amines at mild conditions, improving the stability and
catalytic efficiency of enzymes, and expanding the substrate scopes [9,10]. To date, immobilized
Candida antarctica lipase B (CALB) [16] and C. antarctica lipase A (CALA) [3] have been the most
common enzymes of choice to prepare R- or S- enantiomers of alcohols respectively, owing to their
robustness and activity in organic solvents at temperatures up to 100 ◦C.
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Scheme 1. An example of selective chemoenzymatic dynamic kinetic resolution (DKR) of secondary
alcohols or primary amines by recently developed transition-metal complexes. CALB, Candida antarctica
lipase B; CALA, C. antarctica lipase A.
2.1. Dynamic Kinetic Resolution of Secondary Alcohols and Derivatives
For the racemization of alcohols, the most commonly employed chemical catalysts are ruthenium
complexes. Monomeric ruthenium pentamethylcyclopentadiene complex 1 developed by Bäckvall
and co-workers [17] has been widely used in tandem with different enzymes to deracemize a wide
range of functionalized secondary alcohols, including aliphatic alcohols [18,19], allylic alcohols [20–22],
chlorohydins [23], diols [24,25], homoallylic alcohols [26], and N-heterocyclic 1,2-aminos alcohols [27]
with excellent yields and enantiomeric excess (ee). Recently, complex 1 has been employed to synthesize
biologically active 5,6-dihydropyran-2-ones and the corresponding δ-lactones [26]. Several new
ruthenium complexes were developed to be active at room temperature for pairing with thermolabile
enzymes. Nolan and co-workers recently reported cationic ruthenium indenyl complex 2 that could
catalyze racemization of secondary alcohols without a strong base [28]. By coupling 2 with Novozyme®
435 (Strem, Boston, MA, USA) the DKR of various secondary alcohols was achieved in high yield and ee
at room temperature. At the same time, the group of Martín-Matute found that a commercially available
[Ru(p-cymene)Cl2]2 with the ligand 1,4-bis-(diphenylphosphino)butane could be coupled with a lipase
from Pseudomonas stutzeri for the efficient DKR of α-hydroxyl ketones at ambient temperature [29].
The resulting enantiopure compounds provided straightforward access to a variety of diols and amino
alcohols in a diastereo- and enatioselective manner.
Other more cost-effective and readily accessible metal complexes, such as iridium, aluminum
and vanadium complexes, have also been investigated for DKR of secondary alcohols [9]. Akai and
co-workers have demonstrated that the oxyvanadium (V) complex [VO(OSiPh3)3] in tandem with
various lipases allowed for DKR of a wide range of linear and cyclic allylic secondary alcohols [30,31]
(Scheme 2). Recently, they prepared a novel oxyvanadium catalyst (V-MPD), immobilized inside
mesoporous silica (MPS) [32]. This heterogeneous catalyst could be recycled six times without any loss
in activity, and it could mediate the racemization of benzylic, heteroaromatic and propargylic alcohols
(Scheme 2).
The application of transition-metal catalysts in terms of DKR has been mainly limited to
academic research due to their high cost and low stability. In fact, several heterogeneous and
immobilized racemization catalysts have been made to improve the total turnover number (TON) of
catalysts [10,32,33]. In addition, some heterogeneous acid catalysts, such as zeolite and nanozeolite
microspheres, combined with immobilized lipases have been developed for efficient DKR of benzylic
alcohols [10]. Very recently, Tang and co-workers reported a core-shell nanozeolite@enzyme
bi-functional catalyst consisting of CALB immobilized on H-β zeolite microspheres coated with
polydiallydimethylammonium chloride (PDDA) [34,35]. This core-shell structure modulated the
optimum rate of racemization and KR to achieve the best catalytic performance. PDDA also protected
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the interaction between the products and the acidic core to minimize side products. However, this
system was limited to kinetic resolution of benzylic alcohols.
 
Scheme 2. Scope of DKR systems involving vanadium complexes and various enzymes. V-MPD, novel
oxyvanadium catalyst.
In addition to improving the catalytic efficiency of the racemization catalysts, a considerable
amount of work has been carried out to improve the catalytic performance of lipases as biocatalysts
through immobilization, cross-linking, surfactant stabilization or enzyme engineering. For example,
Kim and co-workers recently coated lipoprotein lipase (LPL) from Burkholderia species with dextrin
and ionic surfactant to produce activated lipoprotein lipase (LPL-D1) [36]. LPL-D1 was 3000-fold more
active than its native protein in organic solvent and can facilitate DKR of diarylmethanols that had
sub-optimal yields and enantiopurities. Bäckvall and co-workers applied a focused combinatorial gene
mutagenesis technique to discover a mutant of Candida antarctica lipase A-Y93L/L367I with more than
30 times improvement on enantioselectivity of sec-alcohols in organic solvent [37]. More examples
published before 2015 can be found in several reviews [9,10].
2.2. Dynamic Kinetic Resolution of Amines
The DKR of amines is more challenging due to a lack of efficient amine racemization catalysts.
Amines are strong metal ligands; and high temperatures are utilized to prevent complexation of metals
to the amines. In addition, highly active imine intermediates are likely to take part in several side
reactions, which are more favored at elevated temperatures [9,10]. To date, a ruthenium complex Shvo
analogue 3 coupled with CALB is the most practical method for DKR of aliphatic and benzylic primary
amines at 90 ◦C [38–40].
In recent years, several palladium-based heterogeneous racemization catalysts have also been
developed for DKR of benzylic primary amines. Bäckvall and co-workers developed a DKR system by
using a catalyst consisting of palladium nanoparticles supported on amino-functionalized siliceous
mesocellular foam (Pd(0)-Amp-MCF) to convert 1-phenylethylamine to an amide at 50 ◦C with
sensitive Amano Lipase PS-C1 (Burkholderia cepacia lipase immobilized on ceramic beads) (Scheme 3).
Pd-Amp-MCF is more efficient due to shorter reaction times and high TON compared with Pd
nanoparticles alone [41]. Similarly, Li and co-workers investigated the effect of alkali salts on the
catalytic activity of Pd nanoparticles on micro/mesoporous silica or activated carbon, and discovered
that alkali salts greatly enhanced the selectivity of Pd catalysts [42]. Liang and coworkers used a
similar system to synthesize rasagiline [43]. Moreover, a modified solvent extraction system and a
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continuous flow reactor were developed to compartmentalize the Pd-based nanoparticles and lipases
to overcome the incompatibility of reaction conditions required for the racemization and enzymatic
steps [44–46]. However, Pd nanocatalysts did not work well for aliphatic amines. Raney Ni and Co
displayed preferences for aliphatic primary amine racemization (Scheme 3), but they have inhibitory
effects on the enzyme, resulting in a slow DKR system [47].
Scheme 3. Scope of DKR systems involving Pd(0)-Amp-MCF and Raney Ni or Co. Pd(0)-Amp-MCF,
Pd(0)-aminopropyl-mesocellular foam.
2.3. Other Tandem Reactions by Transition Metal Catalysts and Lipases
Except for DKR of alcohols and amines, lipases have also been coupled with base catalysts or
transition metal catalysts for synthesis of more complex compounds. Ramström and co-workers
recently reported asymmetric synthesis of 1,3-oxanthiolan-5-one derivatives [48] and oxathiazinanones [49]
through dynamic covalent kinetic resolution. In the first case, dynamic hemithioacetal formation
combined with intramolecular, CALB-catalyzed lactonization resulted in the final product in good
conversion with moderate to good enantiomeric excess (ee) (Scheme 4A). In the second case, CALB
catalysis was coupled with a dynamic dominonitrone addition-cyclization pathway to synthesize new,
six-membered N,O,S-containing heterocycles (Scheme 4B).
 
Scheme 4. Asymmetric synthesis of (A) 1,3-oxaathilan-5-one and (B) oxathiazinanones through
dynamic covalent kinetic resolution. TEA, triethanolamine.
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Most recently, Berglund and co-workers integrated heterogeneous Pd(0)-aminopropyl-mesocellular
foam (Pd(0)-AmP-MCF) or Pd(0)-aminopropyl-conrolled pore glass (Pd(0)-AmP-CPG) and CALB
catalysts in one-pot for eco-friendly and asymmetric synthesis of valuable molecules such as
amines and amides from an aldehyde, ketone or an alcohol respectively in good to high overall
yields [50]. In this work, they developed several novel cocatalytic relay sequences, including reductive
amination/amidation (Scheme 5A), aerobic oxidation/reductive amination/amidation (Scheme 5B),
and reductive amination/dynamic kinetic resolution (Scheme 5C).
Scheme 5. Examples of integrated heterogeneous metal/enzymatic multiple relay catalysis
for asymmetric synthesis: (A) reductive amination/amidation; (B) aerobic oxidation/reductive
amination/amidation; (C) reductive amination/dynamic kinetic resolution.
3. One-Pot Chemoenzymatic Transformations
Except for the above-mentioned immobilized lipases and serine proteases, the majority of
biocatalysts have poor stability in organic solvents and at high temperatures. To address the synthetic
challenges of both chemistry and biology, there is an ongoing interest to combine chemocatalytic and
biocatalytic reactions in a one-pot process in aqueous solution and at ambient temperatures. Use of
water as a solvent is ecofriendly and reduces organic solvent usage and waste generation. It also
provides accessibility to all enzymes in nature. Currently one-pot cascade or concurrent reactions
avoid purification of intermediates and thus save time and cost. However, the development of such a
system is generally hampered by incompatible reaction conditions, catalyst inhibition, undesired side
reactions and poor solubility of substrates. Several approaches have been implemented to improve
the one-pot operation of chemocatalysts and biocatalysts, including partitioning in a biphasic system,
incorporation into a supramolecular cage, catalysts compartmentation, and development of artificial
metalloenzymes [51,52].
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3.1. Concurrent Tandem Reactions by Transition-Metal Complexes and Enzymes
Transition-metal catalysis and biocatalysis are two different disciplines in terms of synthesis.
Some metal-catalyzed transformations cannot be accessed by enzymes, such as Pd-catalyzed cross
coupling reactions [53], Wacker-oxidation [54], and Ru-catalyzed metathesis [55,56]. On the other hand,
biocatalysis has strong selectivity on both substrates and products, enabling much cleaner reactions.
The motivation to combine them in one-pot is to exploit the synthetic power that cannot be achieved
by either of them separately.
There are a few successful examples of coupling Pd-catalyzed Suzuki cross-coupling reactions
and Heck reactions in tandem with alcohol dehydrogenase in an aqueous buffer by using either
a biphasic system [57] or additive tagged Pd-nanoparticles [58,59]. Recently, Zhao and coworkers
successfully combined Ru-catalyzed olefin metathesis with a P450-monooxygenase catalyzed oxidation
in a biphasic system for the synthesis of various epoxides [60]. Importantly, this work demonstrated
the power of chemoenzymatic one-pot processes to achieve higher yields compared with the sequential
two-step reactions. In this case, the cooperation of ruthenium metathesis and P450-monooxygenase
led to a dynamic equilibrium of alkenes and a selective epoxidation of the cross-metathesis products 3
(Scheme 6A). The yield of 4 was 1.5 times higher than the hypothetical yield (≤64%) resulting from
stepwise reactions. Later, they developed a similar system by using an engineered P450 to convert
a mixture of alkenes into a single aryl epoxide in high enantiomeric excess and moderate yield
(Scheme 6B) [61].
Scheme 6. Combination of an olefin metathesis with a P450 catalyzed epoxidation in a tandem-type
one-pot process for the synthesis of (A) 10-undecenoic acid epoxide and (B) aryl epoxides. GDH,
glucose dehydrogenase; NADP, nicotinamide adenine dinucleotide phosphate. Adapted from [61].
Copyright American Chemical Society, 2015.
The coordination of transition-metal complex to the enzyme is one of the major factors contributing
to decreased catalytic abilities of both catalysts, thus hampering the progress of coupled tandem
reactions [62,63]. Toste and co-workers addressed this limitation by encapsulating Au(I) or Ru(II)
complexes in a Ga4L6 tetrahedral supramolecular cluster [62]. By doing so, they successfully
47
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coupled Au(I)-Ga4L6 host-guest with lipases and esterases for cascade hydrolysis, followed by a
hydroalkoxylation of alkenes (Scheme 7). They also achieved a Ru(II)-mediated olefin isomerization
of 2-propen-1-ol to give propanal, followed by reduction to propanol by an alcohol dehydrogenase
(ADH). In both cases, the yields were improved relative to applying free cationic catalysts directly.
 
Scheme 7. A schematic view of the Ga4L6 tetrahedral supramolecular assembly (A) in which each
edge of the tetrahedron represents a bisbidentate ligand and each vertex represents a gallium center
(grey balls); (B,C) are metal catalysts encapsulated within a supramolecular complex in tandem
with biocatalysts. ADH, alcohol dehydrogenase; FDH, formaldehyde dehydrogenase. Reprinted by
permission from Macmillan Publishers Ltd.: Nature Chemistry [62]. Copyright 2013.
Catalysts compartmentation is another useful strategy to solve several incompatibility problems
when combining heterogeneous organic or inorganic catalysis with enzyme catalysis. Careful
reaction design led to efficient chemoenzymatic transformations catalyzed by immobilized chemical
catalysts and biocatalysts, which are utilized in different compartments. Those multi-pot reactions
were generally ecofriendly by avoiding intermediate isolation steps [64–66]. Recently, one-pot
compartmentations also have been achieved by using membrane or encapsulation techniques. Gröger
and co-workers combined noncompatible CuCl/PdCl2-catalyzed Wacker oxidation with alcohol
dehydrogenase-catalyzed ketone reduction to convert styrene enantioselectively into 1-phenyl-ethanol
in one-pot with good conversion and ee (Scheme 8) [67]. To overcome mutual inactivation of both
catalysts, Wacker oxidation was conducted in the interior of a polydimethylsiloxane (PDMS) thimble
that enabled the diffusion of only the organic substrate and product into the exterior where the
48
Catalysts 2016, 6, 194
biotransformation takes place (Scheme 8). In another example, they developed a one-pot cascade
reaction combining a co-factor free decarboxylase from Bacillus subtilis named bsPAD with a Ru
metathesis catalyst to produce high-value antioxidants in good yield from bio-based precursors [68].
Encapsulation of bsPAD in an aqueous environment created by poly(vinyl alcohol)/poly(ethylene
glycol) (PAV/PEG) cryogels enabled the enzyme functionalize in pure organic solvent (Scheme 9).
Compartmentation not only overcame the catalytic incompatibility issue, but also realized the recycling
of valuable catalysts in a more convenient manner.
 
Scheme 8. Combination of Wacker oxidation and enzymatic reduction in one-pot aqueous media
through compartmentalization. Adapted from [67]. Copyright WILEY-VCH Verlag GmbH & Co.
KGaA, Weinheim, 2015.
 
Scheme 9. One-pot cascade reaction combining an encapsulated decarboxylase with a metathesis
catalyst for the synthesis of bio-based antioxidants. PVA, poly(vinyl alcohol); PEG, poly(ethylene
glycol); bsPAD, co-factor free decarboxylase from Bacillus subtilis.
3.2. Coupling Visible-Light Photoredox Catalysis with Biocatalysts
Visible-light photoredox catalysis has been considered a highly desirable process in response
to the interest in renewable energy and green chemistry. Organic transformations are afforded by
combining photoredox with transition-metal complexes, or electrocatalysis [69]. Recently, photoredox
has entered the realm of biocatalysis to form a more synergistic framework for catalysis of challenging
reactions under mild conditions. In these examples, biotransformations of organic molecules are
driven by the energy from the photoredox-catalyzed, light-dependent process.
Cheruzel and co-workers developed hybrid P450 BM3 heme domains containing a covalently
attached Ru(II) photosensitizer to afford light-driven hydroxylation of lauric acid with improved
TON and initial reaction rate compared with normal P450 systems (Scheme 10) [70]. This process also
circumvented the use of reductases and NAD(P)H cofactors by employing Ru(II) mediated electron
transfer processes to reduce Fe(III) to Fe(II) in the presence of dithiocarbamate (DTC). In a follow-up
study, Park and co-workers created a cofactor-free light-driven whole cell cytochrome P450 catalysis
for the bioconversion of various substrates, including marketed drugs simvastatin® (Merck & Co.,
Inc., Kenilworth, NJ, USA), lovastatin and omeprazole [71]. Instead of transition-metal photoredox,
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an organic dye, eosin Y that can easily enter the cytoplasm of Escherichia coli (E. coli) and specifically
bind to the heme domain of P450 was used. Under visible-light irradiation, the reductive quenching of
excited eosin Y resulted in electron transfer to Fe(III) in the P450 heme domain. The activated P450
conducted selective organic transformations that were controlled by the catalytic cycle of P450. This
work demonstrated a whole cell platform for co-factor free, reductase-independent P450 photocatalysis.
 
Scheme 10. Cooperative Ru(II) (X = H or OMe) photoredox catalysis and P450 BM3 biocatalysis.
Adapted from [70]. Copyright American Chemical Society, 2013.
Instead of coupling with oxidation enzymes, photoredox catalysts, working as hydride transfer
catalysts, have also been incorporated with reductases such as alcohol dehydrogenase [72] and
glucose dehydrogenase [73] to prepare chiral alcohols and L-glutamate respectively. Unlike the
aforementioned studies in which organic sacrificial electron donors were used, Corma and co-workers
used light-driven and titanium dioxide-promoted water oxidation to drive redox reactions catalyzed
by flavin-based old yellow enzyme (OYE) (Scheme 11) [74]. The protons and electrons were generated
by Au/TiO2 photoredox catalyst via the oxidation of water under UV irradiation, and then were
supplied to the flavin of old yellow enzymes for asymmetrically reducing conjugated C=C bonds.
As the oxidation of water to oxygen is the rate-limiting step of the current process, there should
be room for improvement with some optimization. Most recently, Ru(II) and Ir(II) complexes
were successfully applied as photosensitizers for regeneration of nicotinamide adenine dinucleotide
phosphate (NADPH) in OYE catalytic cycles. However, those systems required an extra sacrificial
electron donor, triethanolamine [75].
Scheme 11. TiO2 and OYE-based photoenzymatic reduction of ketoisophorone. FMN, flavin
mononucleotide, OYE, old yellow enzyme. Reprinted with permission from Macmillan Publishers Ltd.:
Nature Chemistry [74]. Copyright 2014.
3.3. Artificial Metalloenzymes for Selective Transformations
An intense area of research has been the generation of artificial metalloenzymes by incorporating
metal catalysts into protein scaffolds such as streptavidin [76], bovine serum albumin, and
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apo-myoglobin [77]. With the aid of computational, molecular and structural biology, functional
artificial metalloenzymes have been developed by de novo design or protein redesign processes [78].
Not limited to mimicking naturally occurring transformations, biochemists are currently trying to
generate artificial metalloenzymes with catalytic abilities that have no equivalents in either chemical
catalysis or biocatalysis. Additionally, similar to the incorporation of transition-metal complexes
within supramolecular host-guest complexes, the use of artificial metalloenzymes enables the catalytic
activity of transition-metal catalysts in biological environments, allowing synthetic catalysts to work
collaboratively with other enzymes. There are several recent reviews discussing the newest techniques
and examples of various artificial metalloenzymes [51,76,78–84]. To avoid duplication, we will only
highlight the major accomplishments since 2015 in terms of tandem catalysis.
One of the biggest motivations to develop artificial metalloenzymes is to access both the reactivity
and substrate scope of metal complexes together with the regio-, stereo- and enantio-selectivities
afforded by the protein scaffolds. Hartwig and co-workers reported a concise method of replacing iron
in Fe-porphyrin IX (Fe-PIX) proteins with abiological, noble metals to create enzymes that can catalyze
reactions not catalyzed by native Fe-enzymes or other metalloenzymes [85]. They conducted directed
evolution of a modified myoglobin containing an Ir(Me) site. Impressively, the resulting mutants
could catalyze enantioselective C–C bond formation through carbene insertion and also the enantio-
diastereoselective cyclopropanation of unactivated olefins (Scheme 12). This method sets the stage for
the generation of artificial enzymes from innumerable combinations of PIX—proteins scaffolds and
unnatural metal cofactors for various abiological transformations.
 
Scheme 12. Artificial Ir(Me)-based myoglobin-catalyzed C–H insertion for C–C bond formation and
carbene addition to internal or aliphatic olefins: (A) insertion carbenes into C–H bonds; (B) carbene
addition to internal or aliphatic olefins. Reprinted with permission from Macmillan Publishers Ltd.:
Nature [85]. Copyright 2016.
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Instead of performing directed evolution in vitro, Ward and coworkers utilized compartmentalization
and in vivo evolution of a streptavidin (SAV)-biotin based artificial metalloenzyme for olefin
metathesis (Figure 1) [86]. They created an E. coli strain for periplasmic expression of SAV with a
biotinylated Hoveyda-Grubbs catalyst. The periplasm offered an auspicious environment for artificial
metalloenzymes and facilitated artificial metathase-catalyzed metathesis in vivo and its directed
evolution in a high throughput manner. This strategy not only created an artificial metalloenzyme
comparable with commercial catalysts, showing activity for different metathesis substrates, but also
represented the systematic implementation and evolution of an artificial metalloenzyme that catalyzes
an abiotic reaction in vivo with other potential applications, such as non-natural metabolism.
Similar to the supramolecular complex, the protein scaffolds compartmentalize the chemical
catalysts and avoid mutual inactivation of transition metal complexes and enzymes. By embedding a
biotinylated d6-Ir pianostood complex within SAV, Ward and co-workers enabled Ir-based transfer
hydrogenation in the presence of E. coli cell free extracts and cell lysates [87]. In addition, they applied
a similar strategy to create an artificial transfer hydrogenase (ATHase) that was successfully coupled
with various NADH-, FAD- and heme-dependent enzymes for orthogonal redox cascade reactions
that could not have been generated when free Ir-complex was used [88]. Significantly, by coupling
ATHase with monoamine oxidase (MAO-N), NADPH regeneration was achieved and L-pipecolic acid
was prepared with 99% ee (Scheme 13).
SAV
Figure 1. Streptavidin (SAV)-based artificial metalloenzymes for in vivo metathesis. The dashed arrows
indicate the transportation of the chemical catalyst and streptavidin into the periplasm. Reprinted with
permission from Macmillan Publishers Ltd.: Nature [86]. Copyright 2016.
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Scheme 13. Enzyme cascade for the double stereoselective deracemization of amines. Reprinted with
permission from Macmillan Publishers Ltd.: Nature Chemistry [88]. Copyright 2013.
4. Interfacing the Transition-Metal Catalysis with Living Cells
The use of whole cells as a catalytic “factory” to synthesize fine chemicals, pharmaceuticals, and
steroids is an emerging area due to several advantages. The cell could provide natural protection
for the proteins and thus improve their catalytic turnover. The compartmentalization also enables
concurrent chemoenzymatic reactions to occur without inactivation due to incompatibility of the
biocatalysts and other transition-metal complexes [3,89,90]. There has been much progress in
engineering multi-enzymatic steps in cells for chemical production by applying metabolic engineering
strategies [91]. However, the adaption of metal catalysis to the whole cell catalytic system remains
widely unstudied mainly due to the deactivation of metal complexes under biological conditions.
We will highlight recent examples in this area and the progress towards bio-orthogonal catalysis with
organometallic compounds.
Other than the example discussed in Section 3.2 about cofactor-free light-driven whole cell
cytochrome P450 catalysis, a biometallic whole cell catalyst for enantioselective deracemization
of secondary amines was engineered by Lloyd and co-workers [92]. The engineered aerobic
cultures of E. coli, overproducing a recombinant monoamine oxidase (MAO-N-D5) possessing high
enantioselectivity against chiral amines, were coated with nanoscale Pd(0) precipitated via bioreduction
reactions (Scheme 14). The whole cell catalyst was prepared (R)-1-methyltetrahydroisoquinoline (MTQ)
with 96% ee by a dynamic process, in which MAO selectively oxidized S enantiomer of racemic mixture.
The resulting 1-methyl-3,4-dihydroisoquinoline (MDQ) was then reduced back to the racemic amine by
nonselective Pd/H2 reduction. This work is important for the preparation of chiral secondary amines
that are hard to obtain via normal metal-lipase DKR system. More recently, Balskus and co-workers
reported a method for alkene hydrogenation that utilized the Royer Pd catalyst [93] and hydrogen
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gas generated directly by an engineered E. coli (Scheme 15) [94]. This work first demonstrated that
the metabolic output of living microbes and a biocompatible non-enzymatic transformation could be
combined to enable preparative scale chemical synthesis.
Scheme 14. Deracemization of a cyclic secondary amine by engineered biometallic whole cell
catalyst. MTQ, methyltetrahydroisoquinoline; MDQ, 1-methyl-3,4-dihydroisoquinoline; MAO-N-D5,
monoamine oxidase. Adapted from [92]. Copyright American Chemical Society, 2011.
 
Scheme 15. A biocompatible alkene hydrogenation combines organic synthesis with microbial
metabolism. Adapted from [94]. Copyright WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, 2014.
Considerable attention has been focused on improving the biocompatibility of transition-metal
complex-catalyzed bio-orthogonal reactions in living cells. Currently, bio-orthogonal reactions have
many applications for selective labeling and modification of biomolecules in living systems [95]. Except
for the work by Ward and coworkers mentioned in Section 3.3, there are few examples of using such
techniques for chemical production. However those results made researchers more aware of the need
to prepare more biocompatible transition-metal complexes that are able to function in living cells.
For instance, Eric and co-workers published a set of organometallic Ru complexes for the catalytic
uncaging of allylcarbamate (alloc)-protected amines within mammalian cells. They applied this
method in activating a caged anticancer drug, which efficiently induced apoptosis in HeLa cells [96].
Recently Mascareñas and co-workers improved this scenario further by using a designed Ru complex
that accumulated preferentially inside the mitochondria of mammalian cells while keeping its ability to
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uncage alloc-protected amines [97]. Except for the Ru catalysts, Pd complexes have also been applied in
living cells for activation of intracellularly lysine-based proteins by decaging a propargyloxycarbonyl
(Proc)-caged lysine analogue [98].
5. Future Prospects and Conclusions
The combination of chemocatalysis and biocatalysis in a one-pot for concurrent transformations is
still in its infancy. This is particularly true for chemoenzymatic transformations in aqueous media. DKR
catalyzed by transition-metal complexes and lipases or serine proteases have been fully developed
to efficiently prepare most enantiopure primary and secondary alcohols. However, more advanced
racemization catalysts should be developed for more challenging substrates such as chlorohydrins,
alcohols with distant olefin groups and tertiary alcohols. In contrast to alcohols, there are significantly
fewer available DKR systems for amines, especially aliphatic amines and secondary amines, due
to the lack of an efficient racemization strategy. The examples of one-pot tandem chemoenzymatic
reactions involving other enzymes in aqueous media are even sparser, and development of this field
has been slow, mainly due to the mutual inactivation of metal complexes and enzymes. Unlike
multistep enzymatic transformations occurring in cells, resulting in complex molecules, the tandem
processes developed so far generally consist of two or three catalytic steps for simple molecule
synthesis. To address those issues, it is essential to take advantage of several research areas including,
but not limited to, protein engineering, chemical catalyst synthesis, supramolecular assembly, artificial
metalloenzymes and whole cell catalysis.
Synthetic chemists have been focusing on developing water-soluble transition-metal catalysts
that are effective in aqueous solutions. The progress in this area has enabled several metal-catalyzed
reactions in buffer solutions (e.g., olefin metathesis [99–101], Pd-catalyzed hydrogenation [102], and
C–C coupling reactions [103]). Several methods have also been applied for improving enzymes
as biocatalysts. Immobilization of enzymes on heterogeneous catalysts [104–106] and preparation
of cross-linked enzyme aggregates [107] are well-developed methods to improve the activity and
stability of enzymes at extreme conditions, and to facilitate enzyme recycling. In addition, engineering
enzymes by rational design [108,109] and directed evolution [110] are alternative ways to obtain
enzyme mutants with improved properties and new functions. The combination of these techniques
will enable integration of chemocatalysis and biocatalysis for advanced synthesis.
Inspired by naturally occurring reactions processed in different organelles, compartmentalization
is becoming an attractive strategy to avoid mutual inactivation between catalysts from different
disciplines. Creation of supramolecular hosts with hydrophobic cavities and a transition metal
complex is a very appealing strategy for controlling the metal complex properties in competitive water
solvents containing proteins and other cellular components [111]. Similarly, artificial metalloenzymes
have been further developed to integrate transition-metal catalysts into cascade reactions with other
biocatalysts and foster bioorthogonal transformations catalyzed by metal complexes in living cells.
Importantly, generating artificial metalloenzymes is an advanced way to create catalysts with novel
activities to address more challenging transformations. Protein engineering strategies can be further
applied to artificial metalloenzyme development to improve its catalytic performance.
Finally, whole cell fermentation is a well-known technique to produce metabolite-related
chemicals. However, there are very few known processes that integrate bio-orthogonal reactions
catalyzed by transition-metal catalysts into multi-step biocatalytic systems in cells for complex
transformations. The progress of developing biocompatible transition-metal complexes that function
in cells, together with strategies of engineering enzymatic multi-step catalysis in vivo [112,113], will
open new windows for creating new cell factories for chemical production.
In conclusion, interest in combining biocatalysts and chemical catalysts continues to grow.
With recent advances in protein engineering, catalyst synthesis, artificial metalloenzymes and
supramolecular assembly, there is a great potential to develop sophisticated tandem chemoenzymatic
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processes for synthesis of complex chemicals in an ecofriendly manner. Therefore, more accomplishments
in this area are expected in the near future.
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Abstract: Asymmetric hydrogenation of activated alkenes catalysed by ene-reductases from the old
yellow enzyme family (OYEs) leading to chiral products is of potential interest for industrial processes.
OYEs’ dependency on the pyridine nucleotide coenzyme can be circumvented through established
artificial hydride donors such as nicotinamide coenzyme biomimetics (NCBs). Several OYEs were
found to exhibit higher reduction rates with NCBs. In this review, we describe a new classification
of OYEs into three main classes by phylogenetic and structural analysis of characterized OYEs.
The family roots are linked with their use as chiral catalysts and their mode of action with NCBs.
The link between bioinformatics (sequence analysis), biochemistry (structure–function analysis),
and biocatalysis (conversion, enantioselectivity and kinetics) can enable an early classification of a
putative ene-reductase and therefore the indication of the binding mode of various activated alkenes.
Keywords: old yellow enzymes; nicotinamide coenzyme biomimetics; cofactor analogues;
classification of OYE; oxidoreductases; asymmetric hydrogenation; selective reduction; phylogenetics
1. Introduction
The 2001 Nobel prize in chemistry awarded to William S. Knowles and Ryōji Noyori
internationally highlighted the importance of catalysed asymmetric hydrogenation reactions [1].
Particularly, the creation of one to two chiral centres through asymmetric hydrogenation of
C=C bonds is a highly valuable reaction in organic synthesis [2]. Common synthetic routes for
cis-hydrogenation are accomplished via homogeneous chiral catalysts composed of precious metals
such as rhodium (Rh), ruthenium (Ru) or iridium (Ir), and phosphine ligands such as chiral mono-
and di-phosphines, C2-symmetric bisoxazoline ligands or C2-symmetric N-heterocyclic carbenes,
respectively [3]. In comparison, synthetic methods for asymmetric trans-hydrogenation to afford the
stereo-complementary products are scarce [4].
A highly competitive tool for asymmetric trans-hydrogenation is the biocatalytic route using
ene-reductases (ERs) of the old yellow enzyme family (OYEs, EC 1.6.99.1). The performance of
these enzymes is of potential interest for industrial processes due to their high regio-, stereo-
and enantioselectivity, and an expanding substrate scope [5–9]. The substrate spectrum of OYEs
includes activated alkenes with an electron withdrawing group (EWG) such as aldehyde, ketone,
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anhydride [8,10,11], nitro [9,12,13], (di)ester [8,14–17], (di)carboxylic acid [18–20], cyclic imide [21–23],
nitrile [24], β-cyanoacrylate [25], β-nitroacrylate [26], and several other functional groups [27]. There
are many examples of the high industrial potential of OYEs for the synthesis of valuable target
products [28–31]. YqjM was found to produce enantiomerically pure (R)-profens and is applied
in the synthesis of (R)-flurbiprofen methyl ester [32]. Flurbiprofen belongs to the non-steroidal
anti-inflammatory drugs (NSAIDs) and is used at the appearance of dental pain or sore throat.
A library of OYEs was used for the asymmetric reduction of β-cyanoacrylate esters to yield a precursor
of pregabalin, an anticonvulsant for epilepsy or fibromyalgia [33]. A similar OYE library reduced
α-, β- and γ-substituted α,β-unsaturated butyrolactones [34], structural components of macrocyclic
antibiotics [34,35]. A valuable overview for OYE-catalysed reactions from recent studies has been
compiled by Toogood and co-workers, including an extensive substrate profile of isolated OYEs [36].
OYEs are flavin mononucleotide (FMN)-containing ERs and catalyse the selective asymmetric
reduction of activated C=C bonds at the expense of the pyridine nucleotide coenzyme NAD(P)H,
following a bi-bi ping-pong kinetic mechanism (Scheme 1). In the reductive half-reaction, FMN is
reduced through hydride transfer from NAD(P)H (C4) [37]. In the oxidative half-reaction, a hydride
is transferred from the N5-atom of the reduced flavin to the Cβ-atom of the activated alkene.
A tyrosine residue provides a proton to the Cα-atom, thus completing the reduction of the C=C
bond [9,37,38]. This mechanism leads to an anti-addition (trans-fashion) hydrogenation and is
supported by recent quantum mechanics/molecular mechanics calculations [39]. The reductive
half-reaction was experimentally investigated in detail for OYE1 by Massey and co-workers [40].
Binding of NADPH to the oxidised enzyme-FMN complex led to the observation of a transient
concentration-dependent Michaelis complex. After NADPH binding, generation of the reduced
enzyme-NADP+ complex was noticed as a long wavelength absorbance band. Formation of this
charge-transfer complex indicated that the electron and subsequent hydride transfer requires π–π
stacking between the pyridinium ring of the nicotinamide cofactor and the isoalloxazine ring of the
FMN [40,41].
Scheme 1. OYE-catalysed asymmetric hydrogenation of activated alkenes through a bi-bi ping-pong
mechanism producing one to two chiral centres. AD = adenine dinucleotide; R = ribose phosphate;
EWG = electron withdrawing group.
Although NADPH is the preferred physiological coenzyme for OYE, the dependency on
this commercially expensive compound can be circumvented by established recycling systems
with dehydrogenases [12,18,42–45], with alternative sources of hydride [46,47], or through a
nicotinamide-independent disproportionation coupling reaction [48–51]. A highly promising
and elegant alternative is the use of relatively inexpensive nicotinamide coenzyme biomimetics
(NCBs) [52–56]. The latter compounds retain the pyridine ring structure, substituted with varied
functional groups either on the N1 nitrogen (NCBs 1–2, 6–7, Figure 1) or at the C3 carbon (NCBs
3–5) [55]. As with the natural coenzyme, the correct positioning of the pyridine ring in the active site is
crucial for optimal hydride transfer [52,57].
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Figure 1. Nicotinamide coenzyme biomimetics (NCBs) previously used in OYE-catalysed
hydrogenations to replace NAD(P)H [52,55,58].
Since 2013, several OYEs were found to exhibit high catalytic activities with different NCB
analogues [52,57–59]. In a first study, YqjM, TsOYE and RmOYE were screened against NCBs 1–5
(Figure 1) [52], followed by more extensive kinetic studies with a panel of OYEs [59]. Depending on
the applied NCBs, OYEs differ in their reaction rates and the catalytic efficiency (kcat/Km) is at times
even higher with NCBs than with the natural coenzyme, as discussed further in Section 4 [22,58,59].
In this review, we suggest linking the evolutionary history of OYEs with their activity with NCBs
and their use as chiral catalysts on various substrates. To this end, we start with a phylogenetic
classification of OYEs characterised thus far, and relate this classification to their structural and
biocatalytic properties.
2. Phylogenetic Classification of OYEs
OYEs are ubiquitous in Nature [21,60]. Many ERs from the OYE family have been (recombinantly)
expressed and characterised over the last 25 years. Currently, we have access to approximately 63
characterised and “ready-to-use” OYEs from plantae, fungi and bacteria. Tables 1 and 2 indicate the
distribution of those well-characterised OYEs, with respect to their domain eukaryota (Table 1) and
prokaryota (Table 2).
One third of the characterised OYEs have been obtained from eukaryota, mainly from the
kingdom fungi, subkingdom of dikarya, phyla ascomyceta. However, the fungal OYEs originate
from different families such as Saccharomycotina [61,62], and Pezizomycotina [63,64]. Fewer studies
have been performed on OYEs originating from plants. Nevertheless, the enzymes AtOPR1–AtOPR3
from Arabidopsis thaliana [65,66], and LeOPR1–LeOPR3 from Solanum lycopersicum (tomato) [67,68],
were characterised according to their structure, function and physiological role. Two thirds of the
characterised OYEs have been obtained from various classes of bacteria including proteobacteria
(28%) [69,70], actinobacteria (5%) [22,71,72], bacteroidetes (5%) [73,74], firmicutes (10%) [75–77],
deinococcus-thermus (3%) [78–80], and cyanobacteria (17%) [21,81].
The bacterial OYEs investigated until now have been categorised in classical and thermophilic-like
(formerly YqjM-like) enzymes [9]. In 2016, Nizam and co-workers performed a comprehensive study
of 424 putative OYEs from 60 fungal species and indicated a novel group among fungal OYEs [63].
However, none of these enzymes has been characterised thus far.
The first classical OYE (OYE1) was isolated from brewers’ bottom yeast (Saccharomyces
carlsbergensis) in 1932 [5,82]. The same protein was the basis for the first OYE crystal structure,
uncovering a TIM-barrel topology, related to trimethylamine dehydrogenase [83]. Since then, many
classical OYEs were identified from proteobacteria (NCR [84], MR [85], PETNR [8]), flavobacteria
(Chr-OYE2 [74]), cyanobacteria [21], yeasts (OYE1–OYE3 [86,87], CYE [62]) and plants [67], outlined in
Tables 1 and 2.
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Table 1. Sources of biochemically characterised eukaryotic OYEs.
Kingdom Enzyme (Accession Number) Source Reference(s)
Fungi
OYE1 (CAA37666) Saccharomyces pastorianus [61]
OYE2 (AAA83386) Saccharomyces cerevisiae [87]
OYE3 (AAA64522) Saccharomyces cerevisiae [88]
EBP1 (AAA18013) Candida albicans [89]
HYE1 (AAN09952) Ogataea angusta [90]
HYE2 (AAN09953) Ogataea angusta [90]
CYE (BAD24850) Kluyveromyces marxianus [62,91]
KYE1 (AAA98815) Kluyveromyces lactis [6,92]
OYE2.6 (ABN66026) Scheffersomyces stipitis CBS 6054 [93,94]
ArOYE1–3 (AHL17019, AHL1720, AHL17021) Ascochyta rabiei [64]
ClER (EEQ40235) Clavispora lusitaniae ATCC 42720 [95]
MgER (EDK41665) Meyerozyma guilliermondii ATCC 6260 [96]
Plants
LeOPR1 (NP_001234781) Solanum lycopersicum [68]
LeOPR2 (NP_001233868) Solanum lycopersicum [67]
LeOPR3 (NP_001233873) Solanum lycopersicum [67]
AtOPR1 (NP_177794) Arabidopsis thaliana [65]
AtOPR2 (NP_177795) Arabidopsis thaliana [97]
AtOPR3 (NP_001077884) Arabidopsis thaliana [66]
Colours are assigned based on a new classification according to the dendrogram in Figure 2. Yellow (class I) contains
classical OYEs originating from plants. Grey (class II) contains OYE homologues originating from fungal species.
Table 2. Sources of biochemically characterized prokaryotic OYEs.
Group/Order Enzyme (Ncbi Accession) Source Reference(s)
Proteobacteria/
α-Proteobacteria
NerA/GTNR (CAA74280) Agrobacterium radiobacter [98]
NCR (AAV90509) Zymomonas mobilis [84]
GluER (AAW60280) Gluconobacter oxidans DSM 2343 [99]
Proteobacteria/
β-Proteobacteria
FOYE-1 (KRH78075) Ferrovum sp. JA12 [23]
RmER (ABF11721) Cupriavidus metallidurans CH34 [80]
Achr-OYE3 (AFK73187) Achromobacter sp. JA81 [16]
Achr-OYE4 (AFK73188) Achromobacter sp. JA81 [16,17]
Proteobacteria/
γ-Proteobacteria
MR (AAC43569) Pseudomonas putida M10 [85]
PETNR (AAB38683) Enterobacter cloacae PB2 [69]
NemR/NemA (BAA13186) Escherichia coli [100]
NemA2 (AHC69715) Pseudomonas putida ATCC 17453 [101]
XenA (AAF02538) Pseudomonas putida II-B [102]
XenA2 (AHH54488) Pseudomonas putida ATCC 17453 [101]
XenB (AAF02539) Pseudomonas fluorescens I-C [102]
XenB2 (AGS77941) Pseudomonas putida ATCC 17453 [101]
YersER (WP_032896199) Yersinia bercovieri [6]
SYE1 (AAN55488) Shewanella oneidensis [103]
SYE3 (AAN57126) Shewanella oneidensis [103]
SYE4 (AAN56390) Shewanella oneidensis [103]
Actinobacteria
OYERo2 (ALL54975) Rhodococcus opacus 1CP [22]
Nox (ALG03744) Rhodococcus erythropolis [72]
PfvC (AFF18622) Arthrobacter sp. JBH1 [71]
Bacteroidetes/
Flavobacteria
Chr-OYE1 (ALE60336) Chryseobacterium sp. CA49 [73]
Chr-OYE2 (ALE60337) Chryseobacterium sp. CA49 [73]
Chr-OYE3 (AHV90721) Chryseobacterium sp. CA49 [74]
Firmicutes/(Bacilli,
Clostridia)
YqjM (BAA12619) Bacillus subtilis strain 168 [75]
YqiG (BAA12582) Bacillus subtilis strain 168 [104]
GkOYE (BAD76617) Geobacillus kaustophilus DSM7263 [76]
GeoER (BAO37313) Geobacillus sp. 30 [105]
LacER (ADK19581) Lactobacillus casei str. Zhang [10]
TOYE (ABY93685) Thermoanaerobacter pseudethanolicus E39 [77]
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Table 2. Cont.
Group/Order Enzyme (Ncbi Accession) Source Reference(s)
Deinococcus-Thermus
TsOYE (CAP16804) Thermus scotoductus SA-01 [79]





GloeoER (BAC91769) Gloeobacter violaceus PCC7421 [81]
CyanothER1 (ACK64210) Cyanothece sp. PCC 8801 [81]
CyanothER2 (ACK65723) Cyanothece sp. PCC 8801 [81]
LyngbyaER1 (EAW37813) Lyngbya sp. PCC 8106 [81]
AcaryoER1 (ABW29811) Acaryochloris marina MBIC11017 [81]
AcaryoER3 (ABW32756) Acaryochloris marina MBIC11017 [81]
SynER (ABB56505) Synechococcus elongatus PCC 7942 [21]
NospuncER1 (ACC84535) Nostoc punctiforme PCC 73102 [81]
NostocER1 (BAB73564) Nostoc sp. PCC 7120 [81]
AnabaenaER3 (ABA25236) Anabaena variabilis ATCC 29413 [81]
Colours are assigned based on a new classification according to the dendrogram in Figure 2. Yellow (class I) contains
classical OYEs originating from bacteria. Green (class III) contains thermophilic-like OYE homologues originating
from bacteria. Non-highlighted OYEs could not be assigned to classes I–III.
The discovery of a second OYE subclass twelve years ago led Macheroux and co-workers to
publish the structure of YqjM, an OYE from the Bacillus subtilis strain 168 [75,106]. In contrast to all
other OYEs known at the time, YqjM exhibited unique structural properties, such as its occurrence as a
homotetramer, and the presence of an arginine at the C-terminus involved in the substrate binding
of the adjacent monomer. Next, the thermostable TsOYE (formerly CrS) and TOYE were isolated
from Thermus scotoductus SA-01 and Thermoanaerobacter pseudethanolicus, respectively [77–79]. Based on
a sequence alignment of known and putative OYE homologues from mesophilic and thermophilic
organisms, the renaming of the “YqjM” subclass into the “thermophilic-like” was proposed by Scrutton
and co-workers in 2010 [77–79]. Subsequently, the number of characterised OYEs in this subclass has
risen to sixteen (Table 2, highlighted in green).
OYEs from the thermophilic-like class possess shorter protein sequences (between 337 and
371 amino acid residues) than classical OYEs (between 349 and 412 amino acid residues).
Thermophilic-like OYEs have an average increased thermal stability compared to classical ones. High
melting temperatures were observed for TsOYE (Topt = 65 ◦C [79]), TOYE (Tm > 70 ◦C [77]), GkOYE
(Tm = 76–82 ◦C [76]), GeoER (Topt = 70 ◦C [105]), and FOYE-1 (Topt = 50 ◦C [23]). The thermostability
of TsOYE and TOYE was assigned to a high proline content within loops and turns (typical for Thermus
species) as well as to strong inter-subunit interactions through hydrogen bonding and complex salt
bridge networks at the dimerization interface [77,78].
We recently described FOYE-1 as a thermostable OYE [23]. Surprisingly, FOYE-1 showed highest
sequence identity (55% and 50%), and therefore closest phylogenetical relationship, to the mesophilic
counterparts RmER and DrER [23]. DrER and RmER are not an exception with respect to the
non-thermostable OYE relatives YqjM, XenA, and OYERo2, all clustering in the thermophilic-like
subclass. These OYEs have a proline content below 7%, and are mostly stabilized through single
salt bridges. Due to these varieties in the thermophilic-like subclass, we suggest the classification be
updated through a phylogenetic analysis of all biochemically characterized OYEs (Figure 2).
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Figure 2. Dendrogram showing the relationship of 63 characterised OYEs from plants, fungi and
bacteria. Corresponding accession numbers and sources are given in Tables 1 and 2. Class I (yellow)
contains classical OYEs originating from plants and bacteria. Class II (grey) contains classical OYEs
originating only from fungal species. Class III (green) contains the thermophilic-like and mesophilic
OYEs originating from various bacteria. The maximum likelihood distance tree (Mega7-mac computed)
was calculated with replications of 500 bootstraps. Corresponding values are shown as nodes at all
branches. The corresponding alignment was produced via ClustalW alignment applying the GONNET
protein weight matrix.
Calculating the phylogenetic distance tree of 63 characterised OYEs revealed three instead of
two comprehensive branches (Figure 2). Branch 1 (highlighted in yellow) contains many classical
OYEs from plants, actino- and proteobacteria, flavobacteria, but also another distinct subclade from
cyanobacteria. We designate this branch “class I”. Branch 2 (“class II”, highlighted in grey) appears
closely related to branch 1 and contains exclusively classical enzymes from fungi. Branch 3 (“class III”,
highlighted in green) is further away from branch 1 and 2 and contains–like class I–not only bacterial
OYEs from actino-, proteo- and cyanobacteria, but also OYEs from deinococci, flavobacteria and
firmicutes. This branch contains the traditional thermophilic-like OYEs. Furthermore, several
sequences (SYE4, Chr-OYE1, Nox, LacER and YqiG) occurred in a position where they cannot be
assigned yet. They may represent evolutionary intermediates/predecessors of class I and class III
enzymes as they are of bacterial origin. The short distance between class I and class II hints towards a
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close relatedness and therefore a co-driven evolution. Our phylogenetic analysis allowed no distinction
between thermostable and non-thermostable OYEs within class III since thermostability does not
display a logical pattern.
Among conventional phylogeny methods, we considered the amino acid composition of all
analysed OYEs regarding their early/simple (particularly Ala, Thr, and Val) and late/sophisticated
(particularly Cys, Leu, Phe, Trp, and Tyr) amino acid residues [107,108]. The quotient of late over early
amino acids was used to determine a comparable time of evolvement factor. Therefore, a low number
represents a primary chain mostly containing early/simple amino acids. Regarding the OYEs from
class I without the subclade from cyanobacteria, an average factor of 0.76 was determined. By contrast,
class II’s average factor amounted to 0.94. This result would indicate a successive evolution during
which class II evolved from class I. However, the more remote class III could have evolved in a
convergent evolution with class I since the average factor was similar (0.77). The convergent evolution
hypothesis is strengthened by the difference in average amino acid length as well as by the biochemical
and structural properties, which both differ among class I and class III. OYEs from cyanobacteria
(included in class I) seem also to be recruited later due to the average factor of 0.88. To intensify this
finding, main properties of class I, II and III regarding their sequences and structures are discussed in
the following section dealing with the structural classification of those three classes. Furthermore, this
information enables to subclassify class III OYEs and to assign the lost proteins SYE4, Chr-OYE1, Nox,
LacER and YqiG to one of the three classes or to confirm their independent status, respectively.
3. Structural Classification of OYEs: From Sequence to Structure
OYE homologues show high conservation of amino acids involved in the binding of flavin,
substrates and/or inhibitors, as well as for those involved in the formation of the dimeric interface.
However, there are many differences in the conservation of distinct residues depending on the class
of OYEs mentioned above. A multiple sequence alignment was performed with five representative
sequences from each class (Figure S1). This section compares the sequences of OYE classes I–III
enzymes and discusses the significant effects on the structure of OYEs.
3.1. Multiple Sequence Alignment
Approximately 15% (56 amino acids (aa)) are OYE-conserved residues in all three classes
(Figure S1, highlighted in black). Moreover, 40 additional aa are conserved especially in class I
(highlighted in yellow), 32 aa in class II (highlighted in grey) and 43 aa in class III (highlighted in
green). Evidently, class I and class II share significantly more conserved residues when compared to
class III, resulting in the minor distance (Figure 2).
The alignment including the five non-assignable sequences also allows matching of these OYE
enzymes with the defined classes. The sequences SYE-4 and Chr-OYE1 are more closely related to
class I since they share 63% and 45% of the class I conserved residues but only 34% (25%) for class II
and 9% (21%) for class III, respectively. Nox and YqiG are more related to class III, sharing 37% and
40% of class III conserved residues whereas they jointly own only 23% (34%) of class I, and 25% (19%)
of class II conserved residues. LacER shares 39% (class I), 19% (class II) and 30% (class III) and is
somewhere in between. Interestingly, all five proteins do not possess the Cys26 and the Arg336 (YqjM
numbering), which are highly conserved in class III and are involved in flavin and substrate binding.
The alignment shows they contain many general OYE motifs. However, all of them comprise motifs
from class I/II but also from class III generating a reasonable alignment in between of classes I–III.
Therefore, small substitutions of essential amino acids may change binding properties or oligomeric
state performance making those enzymes promising candidates for bioengineering.
3.2. Monomeric Structure and Dimeric Interface
Members of the OYE family were found to exist in different oligomeric states. A remarkable
property observed for class III OYEs is their occurrence in solution as homodimers and
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homotetramers [22,76,105]. Even higher species as octamers and dodecamers, emerged from functional
homodimers, were observed for TOYE and TsOYE [77,79]. A shift between higher multiple oligomeric
states was noticed depending on the protein concentration [22,77]. On the other hand, members
of class I and class II were found to exclusively occur as monomers or homodimers [14,83,109].
Nevertheless, the basic monomer structure is very similar. A typical single domain is represented by
an (α,β)8-barrel structure (TIM barrel) with additional secondary structure core elements, in which
FMN is bound at the C-terminal end (Figure 3). Secondary structure prediction showed that these core
elements are similar in location and length in all three classes (Figure S1, SecStruc). An N-terminal
hairpin of two short β-strands (βA and βB) builds the bottom of the barrel prior to strand β1 (OYE1
numbering) (Figure 3, blue hairpin) [75,78,83].
Figure 3. TIM-barrel structure of OYEs. Three-dimensional model of the crystal structure of
Saccharomyces pastorianus OYE1 (pdb entry: 1OYA). The α-helices and β-strands of the TIM-barrel are
indicated in gold and red, respectively. The N-terminal hairpin of two short β-strands at the bottom of
the barrel is indicated in blue. The C-terminal helices and the large surface loop between β3 and α3 are
indicated in green. The FMN prosthetic group is indicated in yellow.
Additional secondary structure elements occur on surface loops between core building blocks of
β-strands and α-helices. The largest loop occurs between β3 and α3 and differs greatly between all
OYE representatives (Figure 3, green surface loop) [75,78,83]. Class III enzymes are up to 40 amino
acids shorter and therefore more compact. This is due to the shortening of the N-terminal surface loops
between β3 and α3, but also between β5 and α5 and at the C-terminal end of the protein (Figure S1).
However, the capping domain between β3 and α3, which is partly covering the entrance of the active
site, differs greatly in length and type of structural units within subclass III [78]. Each monomer
within the functional dimer is facing the central hole with the same side and contributes the same
residues to the hydrogen bond network that keeps monomers together [77]. Residues Gln330 and
Tyr331 (TOYE numbering) are highly conserved and seem to play a role in monomer interaction [77].
While Gln330 is specific for class III enzymes, Tyr331 is conserved for all OYEs (Figure S1). A variety
of additional residues assist in the formation of the functional dimer–dimer interface such as Thr45,
Ser28/His42/Arg46 and Tyr315 (TOYE numbering) [77,78]. Many of them are conserved only for
class III enzymes. The most influential factor for the formation of the functional dimer–dimer interface
of class III is Arg333 (TOYE numbering). This “arginine finger” stretches into the active site of the
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adjacent monomer and interacts with the respective flavin cofactor. An additional stabilization of some
class III enzymes originating from extremophiles is associated with an increased proline content of
surface loops [23,78], and with the presence of three complex salt bridge networks at the dimerization
interface that increases the subunit interaction strength. The complex five residue salt bridge between
four residues of α2 and an asparagine from α1 is not conserved for class III enzymes. However,
incorporation of this salt bridge within another class III enzyme by site-directed mutagenesis indeed
increased the thermal stability [22].
3.3. FMN Binding
The FMN prosthetic group is bound at the C-terminal end of the β-strands, a typical location for
the active sites of TIM-barrel enzymes (Figure 3) [110]. The re side of the flavin is facing the protein
and is completely hidden from the active site but in contact with strand β1 [111,112]. The si side
of the flavin is facing a solvent filled access channel (20 Å length in PETNR) and therefore forms
the bottom of a wide-open active pocket mainly assembled with aromatic residues [9]. The redox
potential of the FMN cofactor is controlled by the different interactions between the protein and the
flavin. The N3 and O2 atoms of the flavin pyrimidine ring are interacting with a glutamine (Gln102
in YqjM) and the N1 and O2 with an arginine (Arg215 in YqjM) (Figure 4) [75]. Both residues are
strictly conserved in OYEs. Furthermore, a conserved histidine pair is described for all OYEs to be in
hydrogen bonding distance. In YqjM (class III), His167 and His164 donate a hydrogen bond for the
N1 or N3 atom of the flavin, respectively (Figure 4) [75]. However, in PETNR (class I) the pursuant
histidines (His184 and His181) donate the hydrogen bond to the flavin O2 as well as to the activating
group of the substrate/inhibitor [111]. While both histidines are highly conserved in class III, the
second histidine is replaced by an asparagine in several class I and class II enzymes (Figure 4 and
Figure S1). For example, the corresponding asparagine (Asn194) in OYE1 is known to play a key role
in ligand binding [83,111]. Moreover, residues Ala60 and Cys26 (YqjM) were found to be in hydrogen
bonding distance to the FMN O4 atom (Figure 4) [75]. While Ala60 is conserved within all classes
(sometimes glycine in class II), the cysteine residue is a unique feature only for class III enzymes. Cys26
was shown to interact not only with the O4-atom of the flavin but also with Tyr28 (Figure 4), which is
also conserved in class III. In class I/II, Cys26 is replaced by a conserved threonine (Thr37 in OYE1),
which is as well within hydrogen bonding distance to the O4-atom of the isoalloxazine ring [112].
It was shown that both residues modulate the flavin reduction potential after they were exchanged by
mutagenesis [112–114].
The dimethylbenzene moiety of the flavin isoalloxazine ring was described to interact with the
hydrophobic residues Met25, Leu311 and Arg308 (YqjM [75]). The methionine is conserved only for
class III enzymes as well as the leucine, which is replaced by isoleucine in class I/II. The arginine is
also highly conserved for class II but not for class I enzymes. In PETNR, a tyrosine (Tyr351) is in van
der Waals contact with the edge of the dimethylbenzene nucleus [111]. This tyrosine is conserved
for class I/II. In OYE1 the hydrophobic area around the dimethylbenzene ring is more compact and
contains two interacting phenylalanine residues (Phe250 and Phe296). Phe250 is highly conserved in
class II enzymes but also occurs in PETNR (Phe240). However, Phe296 is neither conserved in class I
nor in class II. Instead of the phenylalanines, class III enzymes possess an arginine (Arg336 in YqjM),
a residue involved in both, flavin binding and formation of the dimeric interface (vide supra).
The ribityl chain of the flavin is stabilized in all classes by a conserved proline and an arginine
(Pro24 and Arg215: YqjM numbering). Additionally, class III enzymes were also found to anchor the
cofactor in this part to Ser23, Ser249 and Gln265 (YqjM numbering) [75]. However, Figure S1 shows
that Ser23 is not conserved in class III OYEs, as previously published [9].
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Figure 4. Active site of SYE1 (pdb entry: 2QG9; class I) from Shewanella oneidensis, OYE1 (pdb entry:
1OYA; class II) from Saccharomyces pastorianus and YqjM (pdb entry: 1Z41; class III) from Bacillus subtilis.
The side chains interacting with the flavin in the active site are shown in stick models and coloured
by elements (red = oxygen-containing group; blue = nitrogen containing group). The FMN cofactor is
shown as stick model and coloured by elements with carbons in yellow. Class I and class II proteins
have very similar active sites and are shown in metallic brown. The class III protein is shown in metallic
blue. Note that R336’ in YqjM belongs to the adjacent subunit. The rms distances (rmsd) were obtained
from overlaid structures (see Figure S2) between SYE1 and OYE1 (0.667 Å), SYE1 and YqjM (1.055 Å),
and OYE1 and YqjM (1.262 Å).
3.4. Coenzyme and Inhibitor Binding
In co-crystallisation studies of OYEs, the Fo–Fc electron density map of the uncomplexed, oxidized
enzyme gives a strong positive peak above the flavin isoalloxazine ring. This observation is due to the
binding of an anion from the crystallisation solution such as sulphate [75], chloride [83,111], acetate or
formate [77]. Addition of NADPH resulted in the replacement of the sulphate by two water molecules
and in the reduction of the flavin [75]. In agreement with a bi-bi ping-pong mechanism, great similarity
exists among OYEs in the binding mode of the nicotinamide moiety of NADPH and phenolic inhibitors
such as para-hydroxybenzaldehyde (p-HBA) (Figure 5) or para-nitrophenol (p-NP). Both aromatic
rings are oriented through π–π stacking with the FMN isoalloxazine ring and hydrogen bonding
with His167/Asn194 and His164/His191 (YqjM/OYE1) [115]. The crystal structure of OYE1 (class II)
with an NADP+ analogue showed that the oxygen of the amide on the pyridinium ring is (hydrogen)
bonding with the two conserved histidine residues, thus positioning the C4 atom close to the N5 atom
of FMN for the hydride transfer [83]. The same position was observed for the nicotinamide ring of
tetrahydro-NADH in MR (class I) (Figure 5) and TOYE (class III) [77,116].
Analogues of histidine/asparagine residues are found in all classes of OYE homologues.
A remarkable difference is the binding of the functional group of the phenolic ligand. For instance
the aldehyde group of p-HBA interacts with Tyr375 (OYE1) [83], or Tyr351 (PETNR) [75], respectively.
This tyrosine residue is conserved within all OYE classes (Figure S1), but was never mentioned to
play a role in the catalysis of class III enzymes, which use a different strategy to build their active
sites. A reorientation of the C-terminal end causes the formation of a part of the active site of the
adjacent monomer. Therefore, only an arginine (Arg333 in TOYE) contributes to the opposed active
site. The “arginine finger” causes the formation of a strong hydrogen bond with the nitro-group of
p-NP [75], or the O1P/O1N atoms of tetrahydro-NADH [77]. Replacement of this arginine might be a
biocatalytic tool to broaden/change the substrate spectrum or cofactor specificity of class III enzymes.
Another N-terminal class III conserved tyrosine (Tyr28 in YqjM) is involved in binding of the aldehyde
oxygen of p-HBA [75,78]. Furthermore, Tyr175/Tyr196 (TsOYE/OYE1) was confirmed to be a proton
donor for the substrate 2-cyclohexenone [75,78], and is conserved within all subclasses. To summarize,
the binding partner for the functional group of aromatic substrates is always a tyrosine, which is in
hydrogen bonding distance. Class I and class II use two tyrosines from the central part (Tyr196 in
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OYE1) and the C-terminal protein part (Tyr375 in OYE1), whereas class III enzymes involve the central
part tyrosine (Tyr175 in TsOYE) as well, but a second N-terminal tyrosine (Tyr25 in TsOYE) takes over
the role of the class I/II C-terminal tyrosine due to reorientation.
Figure 5. Ligand binding in OYEs: (Left) NADH:flavin oxidoreductase from Shewanella oneidensis
(SYE1) with para-hydroxybenzaldehyde bound (pdb entry: 2GQ9). The protein is shown in blue cyan,
the flavin cofactor in yellow, and the phenolic inhibitor in orange. (Right) morphinone reductase (MR)
from Pseudomonas putida with tetrahydro-NAD bound (pdb entry: 2R14). The protein is shown in green
cyan, the flavin cofactor in yellow, and the pyridine nucleotide in orange.
The majority of OYEs display a preference for NADPH over NADH as the source of hydride,
as indicated from catalytic efficiencies (kcat/KM) or apparent dissociation constants (KD). The
specificity ratio of NADPH:NADH, obtained from specific activity with trans-2-hexenal by Bruce
and co-workers [117], can vary from 0.02 (MR) to 10 (OYE1), although the cofactor preference
for KYE1, XenA and Yers-ER was shown to differ depending on the substrate, yielding different
NADPH:NADH specificity ratios, a surprising result given the bi-bi ping-pong mechanism described
above [6]. Interestingly, TsOYE displays a similar KD for NADPH and NADH, but a five times higher
reaction rate when using NADPH with respect to NADH [59]. The only OYEs displaying a higher
affinity for NADH are from class I: NerA/GTNR [98], MR [85], SYE1 and SYE3 [103]. LacER, which
falls short of being assigned to a class, although the closest class it relates to seems to be class I as seen
above, also shows a preference for NADH [10].
The group of Hauer recently showed examples of grafted β/α surface loop regions between
OYEs MR, NCR and OYE1 that led to altered as well as new reaction activities and a change in NADH
interactions [118–120]. One example was showcased with NCR (class I), which displayed lower activity
with increasing NAD+ present in the reduction reaction of cinnamaldehyde [118–120]. Through β/α
surface loop grafting from OYE1 (class II) and MR (class I) to form various loop variants of NCR, the
loss of activity with higher presence of NAD+ was significantly reduced [118–120].
4. Reactivity with NCBs
Recently, as mentioned above, NCBs 1–7 in Figure 1 were used as alternative hydride source to
replace NAD(P)H [23,52,58,59]. Kinetic data with NCBs (1–5) are available for PETNR (class I), and for
TOYE, XenA, and TsOYE (class III). Additionally, biocatalytic reactions were performed and conversion
data were acquired for class I (yellow): PETNR, LeOPR1, XenB, MR, and NerA; class II (grey): OYE2
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and OYE3; and class III (green): XenA, TOYE, TsOYE, DrOYE, and RmOYE (Figure 6) [59]. Other
NCBs (6–7) were also screened with MR, NCR, OYE1 and OYE3 [58].
 
Figure 6. Asymmetric hydrogenation of ketoisophorone to (6R)-levodione with a panel of OYEs
from class I (yellow), II (grey) and III (green) and NCBs 1–5 (1-benzyl-1,4-dihydronicotinamide
1, 1-butyl-1,4-dihydronicotinamide; 2, 1-benzyl-1,4-dihydronicotinic acid 3, 1-benzyl-3-acetyl-
1,4-dihydropyridine 4, and 1-benzyl-3-cyano-1,4-dihydropyridine 5) (data adapted from [59]).
4.1. Biocatalytic Conversions
From the full biocatalytic reaction for the reduction of the model substrate ketoisophorone,
moderate to high conversions were obtained with NADPH and NADH and low to high conversions
with NCBs 1–5 (Figure 6) [59]. NCB 5 gave very low conversions (1–10%), except for XenA (80%),
TsOYE (59%) and RmER (43%) [59]. With our new classification, we noted the enzymes accepting
NCB 5 were all from class III, and that OYE2–3 from class II gave lower conversions with the NCBs
in general.
4.2. Kinetic Data: Steady State and Pre-Steady State
The reduction of 2-cyclohexenone under steady-state conditions gave kcat, KM and catalytic
efficiency kcat/KM for PETNR (class I), TOYE and XenA (class III) [59]. Noting that class III TOYE and
XenA gave the highest rates with the NCBs, XenA in particular displayed high catalytic efficiency
(kcat/KM) with NCB 2 (Figure 7).
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Figure 7. Steady-state kinetics with: catalytic activity kcat (A); Michaelis constant KM (B); and catalytic
efficiency kcat/KM (C) for the reduction of 2-cyclohexenone to 2-cyclohexanone by PETNR, TOYE and
XenA with NCBs 1, 2 and 4 (data adapted from [59]).
The rates of the reductive half-reaction showed that PETNR from class I displayed lower rates
when compared to TOYE, XenA and TsOYE from class III (Figure 8A,B) [59]. TOYE gave the highest
reduction rates followed by XenA and TsOYE. NCB 3 clearly afforded the highest reduction rate
values, but also the highest dissociation constant KD for the enzyme-reduced nicotinamide complex
(Figure 8C,D). For each OYE, the order of the best to poorer NCB differed (Figure 8A,B).
Figure 8. Reduction reaction rates kred (A,B); and dissociation constants KD (C,D) for the reductive
half-reaction of PETNR, TOYE, XenA and TsOYE and NCBs 1–5 (data adapted from [59]).
Fast reaction kinetics with MR and PETNR (class I) by the group of Scrutton led to the conclusion
that quantum mechanical tunnelling is crucial for the hydride transfer from the nicotinamide cofactor
to FMN [121]. They proposed that sub-angstrom differences in the donor-acceptor distance affect the
probability of hydride transfer [121–123]. From molecular modelling studies with TsOYE and NCBs
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1–5 [52], as well as with the crystal structures of XenA [59], the NCBs were observed to be in the correct
position, π stacking with the FMN isoalloxazine ring, and the amide oxygen within hydrogen bonding
distance of the two conserved histidine residues (His181 and His178 in XenA). The exception was
NCB 5, which contains a nitrile substituent in place of the amide, thus missing the oxygen and only
hydrogen bonding with one of the two histidines. This analogue was used as a hydride donor by the
OYEs but with less efficiency. Although the coenzyme biomimetics bind to the OYEs’ active site in a
similar way as NAD(P)H, small changes in the orientation of the nicotinamide ring could affect the
rate of hydride transfer. Indeed, different kinetic data was observed for all analogues and OYEs across
the three classes. The NCB giving the highest reduction rate for one OYE, NCB 2 for PETNR (class I),
was different for another OYE, NCB 3 for TOYE, XenA and TsOYE (class III) [59].
The overlaid crystal structures of XenA (from P. putida II-B, class III) with the tetrahydro form of
cofactors NADPH4 and NCB 1–2,4 showed only minimal changes. One exception in all three NCBs
structures was the alternative conformation of the tryptophan residue (Trp302 in XenA), which reduced
the volume of the active site [59].
5. Classification of OYEs with Respect to Substrates
As listed in the introduction, OYEs can reduce a variety of α,β-unsaturated activated alkene
substrates, which are continuously being extended with new activating groups explored for industrial
purposes. In general, the review by Toogood, Gardiner and Scrutton gives an overview of substrate
family scopes for OYEs [9]. Looking at the compilation of substrates, there is a large overlap in
the substrate scope and stereochemical outcome of OYEs within and across the three classes, and
also wide differences within one class. Unfortunately, reported data often varies; in some cases,
the specific activity was reported for each substrate, in other cases, percentage conversion of the
biocatalytic reactions was reported. Furthermore, reaction times vary (4–48 h) and a range of enzyme
concentrations is used, which makes identification of preferred substrates more difficult.
Selecting widely published percentages conversion of biocatalytic reactions on common substrates,
we observed significant trends regarding all members of the OYE family but also noticed differences
between OYE classes I–III (Figures 9 and 10). OYEs in general convert substituted (methylated)
cyclic enones such as 2-methylcyclo-hexenone or -pentenone as well as 3-methylcyclo-hexenone
or -pentenone. Comparing 6- and 5-membered ring substrates in Figure 9 shows that ring size
is not so important with respect to biocatalytic conversions. It does, however, have a significant
effect on the stereochemical outcome of the product (Figure 11). Stereochemical outcome can be
influenced by the configuration of the C=C double bond, the orientation of the substrate in the active
site and the stereospecificity of the hydrogen addition [124]. For most OYEs, 2-methylcyclopentenone
gave the (S)-enantiomer whereas 2-methylcyclohexenone afforded the (R)-enantiomer (Figure 11).
For β-methylated substrates, the conversion was lower in all cases (classes I–III). This effect
was repeatedly observed [11,12,42], and is due to steric hindrance. The formed products from
β-methylated cyclic enones were (S)-enantiomers, independent from the ring size (Figure 11).
Interestingly, class I enzymes display significantly lower conversions from the 2-methyl- (80%) to
the 3-methyl-cyclohexenone (20%), whereas for class II enzymes this difference goes from 72% to
40%. Class III enzymes have averaged 45% conversion of 2-methylcyclohexenone and none of the
tested enzymes were active on the β-methylated substrate. Similar values were found for substituted
cyclopentenones. With α-methylated substrates all classes gave a similar average conversion (between
48% and 63%). For β-methyl unsaturated substrates, class III enzymes afforded no conversion, whereas
the average conversion of class II enzymes is slightly higher (30%) than that of class I enzymes (20%).
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Figure 9. Cyclic enones substrate preference of OYEs according to the classification. Negative values
represent conversions below 1%. Blank spaces correspond to no measurements. References for
conversion values: PETNR [44], NemR [44], MR [44], NCR [42], EBP1 [44], OYE1 [42], OYE2 [42],
OYE3 [42], RmER [80], DrER [80], TOYE [77], TsOYE [52], OYERo2 [22], FOYE-1 (unpublished data)
and YqjM [12,18].
Figure 10. Dicarboxylic acids, aldehyde, maleimide, nitroalkenes substrate preference of OYEs
according to the classification. Negative values represent conversions below 1%. Blank spaces
correspond to no measurements. References for conversion values: PETNR [44], NemR [44], MR [44],
LeOPR1 [12,18], NCR [42], EBP1 [44], OYE1 [42], OYE2 [42], OYE3 [42], RmER [80], DrER [80], FOYE-1
(unpublished data) and YqjM [12,18].
Other α-substituted unsaturated cyclic ketones such as ketoisophorone and carvones are also
alternative substrates for all three classes. However, several non-thermostable class III enzymes
such as RmER, OYERo2 [22,80], and FOYE-1 (unpublished data) gave very low conversions on
those substrates. Poor conversions are supported by very poor activities towards these typical
substrates (ketoisophorone or cyclohexenone), mainly in class III (YqjM, FOYE-1, OYERo2, XenA,
TsOYE, DrOYE, and RmOYE) [22,23]. In contrast, these enzymes showed highest specific activities
on several maleimides (up to 70 U/mg) [22,23]. Comparably, the specific activities on maleimides
for classes I and II enzymes are much lower [6,8,21], but all classes reduce maleimides with high
conversion yield (Figure 10). YqiG is highly active towards maleimide (56 U/mg) and shows little
activity toward carboxylic acids and cyclic ketones (<3 U/mg) [104]. This non-assigned OYE exhibits
high temperature stability and is closely related to class III (see Section 3). With ketoisophorone,
(R)-carvone, 2-methyl-N-phenylmaleimide and 2-methylmaleimide, all investigated OYEs led to the
(R)-enantiomer (Figure 11). In general the enantiomeric excess was lower with ketoisophorone due
to known product racemisation [8]. (Dimethylated) dicarboxylic acids show remarkable differences
between the three classes. Itaconic acid was only converted by class II enzymes (average conversion:
25%). The two isomers, mesaconic acid and citraconic acid, were transformed by all three classes.
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However, class II showed on average 50% higher conversions with respect to the other two classes
and always preferred a distinct enantiomeric product: (S)-enantiomer with itaconic and citraconic
acid; (R)-enantiomer with mesaconic acid. Only with the cis-substrate (citraconic acid), class III was
the more active enzyme class (Figure 10). Class I enzymes exclusively led to the (R)-enantiomer with
dimethylated dicarboxylic acids, whereas the stereochemical outcome for class III enzymes was not
investigated until now. The aliphatic dimethylated dienal substrate citral was shown to be a great
substrate for class I and class II. Only low to modest citral conversions were obtained within class III
with YqjM and DrER (Figure 10) [12,80], as well as with TsOYE [52].
 
Figure 11. Stereochemical outcome of various OYE-catalysed asymmetric hydrogenations. The order
of OYEs used for each substrate is from top (PETNR) to bottom (YqjM). Blank spaces correspond to
no measurements. References for ee values used in this diagram: PETNR [44], NemR [44], MR [44],
NCR [42], EBP1 [44], OYE1 [42], OYE2 [42], OYE3 [42], RmER [80], DrER [80], TOYE [77], TsOYE [52],
OYERo2 [22], FOYE-1 (unpublished data) and YqjM [12,18].
To summarise, class I and class II prefer cyclic ketones, especially 2-methylcyclohexenone,
ketoisophorone and carvones. On dicarboxylic acids, class II enzymes show best conversion rates.
Maleimides are excellent substrates for the entire OYE family, class III enzymes especially, displaying
remarkable activities on maleimides (about 50-times higher than on all other substrates).
A correlation between the protein structure and the sequence patterns for the stereopreference
with respect to reduction of 1-nitro-2-phenylpropene was attempted to be established for 12
independent OYE structures [125]. LeOPR3, NCR, YqjM, XenA, TOYE, TsOYE, and GkOYE reduced
1-nitro-2-phenylpropene to the S-enantiomeric product whereas LeOPR1, OYE1, PETNR and NemR
produced the (R)-enantiomer (Figure 11). However, the group of Pietruszka showed that the
stereoselectivity of an uncharacterised OYE could not be predicted solely based on the primary
sequence pattern of the surface loop β2 [126].
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Stereoselectivity was also investigated by the group of Stewart, who determined how subtle
changes in the residues control the orientation of substrate binding in OYEs [127,128], and showed that
mutations can lead to inverted enantioselectivity [129,130]. The stereochemical outcome was influenced
by mutagenesis of Trp116 in OYE1. For instance, (S)-carvone displayed an inverted stereoselectivity
for six different variants. The same observation was made for (Z)-β-aryl-β-cyanoacrylate when
Trp116 was changed. Substitution of this amino acid against smaller residues resulted in a classical
orientation of the substrate and gave the (S)-enantiomer. Substitution against more bulky residues
resulted in a switch of stereoselectivity affording the (R)-enantiomer. This tryptophan is conserved
for classes I and II enzymes and might be a major residue for changing enantioselectivity of different
prochiral substrates [25]. Class III enzymes possess a conserved alanine at this position. Directed
evolution performed on YqjM by Reetz and co-workers enabled control of the enantioselectivity for
the bioreduction of substituted cyclopentenone and cyclohexenone substrates [131]. A recent review
by Stewart and Amato on protein engineering of OYEs gives a good overview on the possibilities of
stereochemical outcome [130].
6. Conclusions
We provide a new classification for the currently available and ready to use 63 OYEs, divided into
three classes. The structural classification of OYEs displayed the conserved as well as the differing
residues among the three classes.
Class I are monomeric OYEs originating from plants and bacteria. They prefer α-methylated
cyclic enones as substrates and showed highest reduction rates with NCB 2. Class II enzymes are
fungal OYEs likely developed in a co-driven evolution from class I. Both classes are phylogenetically
and structurally closely related resulting in similar substrate preferences, although class II members
display higher conversions on certain substrates and those tested did not accept NCBs as well.
Class III OYEs are likely driven by a convergent evolution to class I/II resulting in a substantial
distance on sequence level according to the dendrogram. Due to remarkable variances in conservation
compared to the two foreign subclasses but great conservation within their own members, class III
OYEs have a different structure, biochemical behaviour and substrate preference. They form oligomers
built from homodimers and are often thermostable. They highly prefer maleimides as substrates and
NCB 3 as the hydride donor, and accept the nitrile-substituted NCB 5 best of all classes.
The symbiosis of bioinformatics, biochemistry and biocatalysis enables a closer analysis of an
industrially attractive biocatalyst, OYE, to determine from which class it should be chosen for a
targeted product, and to allow further improvements with specially designed NCBs.
Supplementary Materials: The following are available online at www.mdpi.com/2073-4344/7/5/130/s1,
Figures S1 and S2.
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Abstract: The control of cellular N-acetylmannosamine (ManNAc) levels has been postulated to be
an effective way to modulate the decoration of cell surfaces with sialic acid. N-acetylglucosamine
2-epimerase catalyzes the interconversion of N-acetylglucosamine (GlcNAc) and ManNAc. Herein,
we describe the cloning, expression, purification and biochemical characterization of an unstudied
N-acetylglucosamine 2-epimerase from Pedobacter heparinus (PhGn2E). To further characterize the
enzyme, several N-acylated glucosamine derivatives were chemically synthesized, and subsequently
used to test the substrate specificity of PhGn2E. Furthermore, NMR studies of deuterium/hydrogen
exchange at the anomeric hydroxy group and C-2 positions of the substrate in the reaction
mixture confirmed for the first time the postulated epimerization reaction via ring-opening/enolate
formation. Site-directed mutagenesis of key residues in the active site showed that Arg63 and
Glu314 are directly involved in proton abstraction and re-incorporation onto the substrate. As all
mechanistically relevant active site residues also occur in all mammalian isoforms, PhGn2E can serve
as a model N-acetylglucosamine 2-epimerase for further elucidation of the active site mechanism in
these enzymes.
Keywords: sialic acid metabolism; N-acetylglucosamine 2-epimerase; deprotonation/reprotonation
mechanism; Neu5Ac analogues; synthesis of sialic acid analogues
1. Introduction
Sialic acids are naturally occurring carbohydrate derivatives of neuraminic acid and
2-keto-3-deoxy-D-glycero-D-galactonononic acid [1]. Sialic acids are generally found at the termini
of protein and lipid linked glycoconjugates on cell surfaces, and have been demonstrated to play
a crucial role in cell recognition, modulation of cell receptors, tumor metastasis and pathogen
binding [2–6]. In recent years, remarkable efforts have been undertaken towards further understanding
the biosynthesis and regulation of the sialic acid metabolism on a cellular level [7,8]. ManNAc has
been postulated to be the main sialic acid precursor. The biosynthesis of N-acetylneuraminic acid
(Neu5Ac) from ManNAc can be either achieved via phosphorylation by ManNAc 6-kinase and
aldol addition of phosphoenolpyruvate (PEP) by sialic acid 9-P-synthase following an enzymatic
dephosphorylation (Scheme 1, route A) [9,10], or the direct (reversible) aldol addition by sialic acid
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aldolase (Scheme 1, route B) [11]. The resulting sialic acid is then converted into its activated precursor
form CMP-N-acetylneuraminic acid and transported into the Golgi apparatus, where it is ultimately
utilized by various sialyltransferases to decorate oligosaccharide chains [12]. As ManNAc is the sole
carbohydrate precursor in the biosynthesis of N-acetylneuraminic acid, a better understanding of
the ManNAc biosynthesis will therefore also lead to a more profound knowledge of the sialic acid
metabolism in cells.
The biosynthesis of ManNAc in mammals is regulated in two different ways (Scheme 1, top): in the
liver, UDP-GlcNAc is epimerized to UDP-ManNAc and subsequently hydrolyzed to ManNAc by the
bifunctional enzyme UDP-GlcNAc 2-epimerase [13]. Alternatively, GlcNAc can be directly epimerized
to ManNAc by GlcNAc 2-epimerase (mainly in kidneys) [14,15]. Several GlcNAc 2-epimerases of
either mammalian or bacterial origin have been functionally characterized so far [15–22]. The major
difference between the two types of enzymes is that mammalian isoforms require nucleotides as
co-factor, whereas bacterial isoforms may show enhanced activities in the presence of nucleotides but
have no co-factor requirements [20,23].
Scheme 1. Sialic acid biosynthesis.
GlcNAc 2-epimerases are interesting targets for the development of novel inhibitors of sialic
acid biosynthesis. However, the main limitation in the development of effective inhibitors is
the lack of information on the epimerization mechanism. Despite speculations by Samuel and
Tanner that the mechanism of the closely related enzyme UDP-GlcNAc 2-epimerase is based on
deprotonation/reprotonation or on elimination [24], no experimental studies have yet been reported
to support either of these theories. Crystallographic studies of mammalian (porcine) and bacterial
(Anabaena sp.) GlcNAc 2-epimerase apoproteins have indicated the involvement of various amino acid
residues in the reaction mechanism [18,25]. Therefore, we performed a mutational analysis to further
elucidate the role of these amino acids. Furthermore, we describe the purification and biochemical and
mechanistic characterization of a novel GlcNAc 2-epimerase originating from the soil bacterium
Pedobacter heparinus, confirming for the first time the postulated deprotonation/reprotonation
mechanism for this class of enzymes.
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2. Results
2.1. Cloning and Homology Analysis of PhGn2E Gene
A gene canditate encoding a putative GlcNAc 2-epimerase was selected from the genome of
Pedobacter heparinus. The full length open reading frame (ORF) of the gene was successfully cloned and
consisted of 1212 base pairs. A homology search revealed that PhGn2E is closely related to the GlcNAc
2-epimerase from mammals showing 35% identity to the human, bovine, murine and rat isoforms
and 34% to the porcine isoform (Supplementary Figure S1). Among bacterial GlcNAc 2-epimerases,
PhGn2E showed high amino acid sequence similarity with characterized isoforms from Bacteroides
ovatus (48%) and Anabaena sp. (37%).
2.2. Protein Expression and Purification
The putative gene product was successfully expressed in soluble form. The recombinant protein
containing an additional hexa-histidine tag at the C-terminus was purified to homogeneity as judged
by SDS-PAGE (Figure 1A). The purified sample migrated as a single protein band with a molecular
weight between 40 kDa and 50 kDa, which is in good agreement with the calculated mass of 47.1 kDa
(including the 1.3 kDa hexa-histidine tag). The identity of the purified protein band was confirmed
using tryptic peptide mass fingerprinting by matching the obtained MALDI-TOF MS data with the
Mascot software database (Supplementary Table S1). The protein concentration of the purified PhGn2E
was determined to be 2.73 ± 0.05 mg/mL and relative enzymatic activity was determined to be
3.59 U/mg (1 U is defined as the amount of enzyme which generates 1 μmol of N-acetylmannosamine
in 1 min at 37 ◦C).
Figure 1. (A): SDS-PAGE analysis of heterologous expressed PhGn2E in E. coli. M: protein marker; 1: cell
pellets before induction; 2: cell pellets after induction; 3: supernatant of cell lysate; 4: Ni-NTA purified
enzyme; (B): Substrate promiscuity of PhGn2E. PhGn2E showed activity towards N-acetylglucosamine
(1a); N-propanoylglucosamine (1b); N-butanoylglucosamine (1c); N-hexanoylglucosamine
(1d); N-octanoylglucosamine (1e); N-decanoylglucosamine (1f); N-benzoylglucosamine (1h);
N-picolinylglucosamine (1i); N-glycolylglucosamine (1j); N-thioglycolylglucosamine (1k) and
N-azidoacetylglucosamine (1l). PhGn2E showed no activity towards N-octadecanoylglucosamine
(1g). Data are presented as mean values ± standard deviation of three independent experiments; (C):
Reaction scheme of the synthesis of GlcNAc analogs by treatment with NHS (N-hydroxysuccinimide),
DCC (Dicyclohexylcarbodiimide) and the corresponding acid using glucosamine as the starting material
and epimerization to ManNAc analogs using PhGn2E yielding ManNAc analogues (2a–2l).
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2.3. Substrate Specificity
The screening of various chemically synthesized substrates (Figure 1B, Supplementary
Figures S2 and S3) revealed that recombinant PhGn2E was able to catalyze the epimerization
reaction when GlcNAc derivatives bearing small N-acyl groups such as N-propanoylglucosamine,
N-butanoylglucosamine, N-hexanoylglucosamine, N-octanoylglucosamine, N-glycolylglucosamine
or N-thioglycolyl- glucosamine (Figure 1C, compounds 1b, 1c, 1d, 1e, 1j and 1k, respectively).
However, the activity decreased significantly when substrates with bulkier modifications such as
N-decanoylglucosamine and N-octadecanoylglucosamine were used (Figure 1C, compounds 1f and
1g, respectively). PhGn2E was also able to catalyze the epimerization reaction of GlcNAc derivatives
bearing a hydroxyl (1j), a thiol (1k) or azido (N-azidoacetylglucosamine, 1l) moiety in the N-linked
substituent. Low, but detectable activities towards GlcNAc derivatives containing aromatic side-chains
(N-benzonylglucosamine, 1h and N-picolinylglucosamine, 1i) were also observed. Both NMR analysis
and platereader based activity assays indicated that PhGn2E showed no activity towards glucosamine,
α-methyl GlcNAc, β-methyl GlcNAc and UDP-GlcNAc. Furthermore, all the synthesized GlcNAc
derivatives except 1g could be successfully converted into sialic acid analogues and linked onto X-gal
following the synthetic route shown in Figure 2 and Supplementary Figures S4–S6.
Figure 2. Reaction scheme of the synthesis route of X-gal sialosides. 2a–l was achieved by
PhGn2E using 1a–l as substrates. The resulting X-gal sialosides (5a, 5b, 5c, 5d, 5e, 5f, 5h,5i,
5j, 5k and 5l) were synthesized by a four-enzyme reaction starting with N-acetylglucosamine
(1a); N-propanoylglucosamine (1b); N-butanoyl- glucosamine (1c); N-hexanoylglucosamine
(1d); N-octanoylglucosamine (1e); N-decanoylglucosamine (1f); N-benzonylglucosamine (1h);
N-picolinylglucosamine (1i); N-glycolylglucosamine (1j); N-thioglycolylgluco- samine (1k) and
N-azidoacetylglucosamine (1l) as initial substrates with relative conversion rates of 37%, 33%, 37%,
15%, 16%, 2.3%, 3.1%, 13%, 39%, 3.2%, and 38%, respectively. No yield from 1g was observed to
obtain 5g.
2.4. Biochemical Characterization
PhGn2E activity was tested in a coupled enzymatic assay, by monitoring the
N-acyl-D-mannosamine dehydrogenase-catalyzed reduction of NAD+ in the presence of ManNAc
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to NADH, which can be followed in a plate reader-based photometric assay. The optimum reaction
temperature was determined to be 37 ◦C (Figure 3A). Above 37 ◦C, enzymatic activity rapidly
decreased with increasing temperatures. The enzyme showed reasonable thermal stability when
incubated at 45 ◦C or below for 2 h, and showed no loss of activity when incubated at 30 ◦C or below
for 24 h (Supplementary Figure S7). The enzyme showed good activity in a relatively broad pH range
from pH 7.0 to pH 10.0, but decreased rapidly below and above this range (Figure 3B). Considering
that small proportions of GlcNAc may also epimerize into ManNAc under stronger basic conditions,
pH 8.0 was chosen for further experiments. The addition of Ca2+, Mg2+, Mn2+, Zn2+, Cu2+, Co2+ or
EDTA had no effect on the enzyme’s activity, while Fe2+, Fe3+ and Al3+ slightly inhibited and Ni2+
slightly increased the activity of PhGn2E (Figure 3C). Denaturants (urea and 2-mercarptoethanol)
and detergents (SDS and Triton X-100) showed significant inhibitory effects on the enzymatic activity
(Supplementary Figure S8). The effect of nucleotides on PhGn2E was also examined (Supplementary
Figure S9A), showing that ATP but no other nucleotide enhanced the activity of PhGn2E. To evaluate
the influence of adenine-derived nucleotides on PhGn2E activity, the inhibition of AMP, ADP and ATP
was further studied in a dose-dependent manner (Supplementary Figure S9B). Whereas AMP and
ADP had no significant effect at any measured concentration, the addition of 100 μM of ATP resulted
almost in a doubling of enzymatic activity and the addition of 1 mM of ATP led to a 4-fold increase.
The KM value of PhGn2E was 82 ± 7 mM for GlcNAc, the Vmax value 197 ± 4 μM·min−1 and the
kcat value 340 ± 3 min−1. A mutational analysis of PhGn2E was performed in order to confirm the
residues which are involved in the epimerization reaction. Arg63, His244, Glu314 and His378 were
chosen as the target amino acids for this study. The activities of PhGn2E mutants H244A and H378A
were 13.6% ± 1.0% and 6.9% ± 0.9% of that of the wild type enzyme, whereas the mutants R63A and
E314A showed no epimerase activity (Figure 3D).
Figure 3. Biochemical characterization of PhGn2E. (A): Temperature dependency of recombinant
PhGn2E; (B): pH-dependency of recombinant PhGn2E; (C): Impact of metal ions on the enzymatic
activity of PhGn2E; (D): Activity study of PhGn2E active site mutants. Negative controls contained
heat-inactivated wild-type (WT) PhGn2E. Data are presented as mean values ± standard deviation of
three independent experiments.
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2.5. Hydrogen/Deuterium Exchange Analysis
1H-, 13C-, TOCSY-, and HSQC-NMR spectra of GlcNAc and ManNAc provided by the BMRB
repository [26] were used for the accurate assignment of the obtained NMR signals. After the
epimerization reaction in deuterated water (D2O), the acquired 1H-NMR spectrum revealed the
disappearance of the signal corresponding to the C-2 linked proton of ManNAc (ManNAc H2,
4.5–4.3 ppm) indicating a hydrogen/deuterium exchange at this position (Figure 4A–D). Similarly,
the relative integral value of the multiplet between 4.1 and 3.3 ppm (protons linked to C-2, C-3, C-4,
C-5 and C-6) of the reaction mixture showed a ratio of 5:1 with respect to the anomeric proton signals
(4 signals: 5.19, 5.12, 5.02 and 4.71 ppm) instead of the expected ration of 6:1, which is in agreement with
hydrogen/deuterium exchange at C-2 of GlcNAc (GlcNAc H2, 4.1–3.3 ppm) (Figure 4D). On the other
hand, a deuterium/hydrogen exchange could be also observed in the anomeric alcohol of GlcNAc
after the addition of heat-inactivated PhGn2E. However, integrating the relative areas of the signals
corresponding to the anomeric proton of the β anomer (βH1, 6.44 ppm) and the anomeric alcohol
of the β anomer (βOH1, 4.93 ppm) showed 6% of deuterium/hydrogen exchange when GlcNAc
was incubated for 15 min using D2O as the solvent in the presence of the inactivated epimerase
(Figure 5A–C); while the almost complete disappearance of the signal corresponding to the anomeric
alcohol was observed when active PhGn2E was added (Figure 5D).
Figure 4. (A): Reaction scheme of PhGn2E-catalyzed deuterium substitution at the C-2 position of
GlcNAc allowing the formation C-2 deuterated ManNAc; (B): 1H-NMR spectrum of GlcNAc in D2O;
(C): 1H-NMR spectrum of ManNAc in D2O; (D): 1H-NMR spectrum of GlcNAc after incubation with
PhGn2E in D2O.
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Figure 5. (A): Reaction scheme of the hydrogen/deuterium exchange on the anomeric alcohol of
GlcNAc. The pyranose ring opening involves the formation of a double bond at the anomeric carbon to
form an intermediate aldehyde. The C-5 oxygen of the intermediate then attacks the anomeric carbon,
closing the ring again. The anomeric oxygen is deuterated by the solvent; (B): 1H-NMR spectrum of
GlcNAc in DMSO-d6; (C): 1H-NMR spectrum of the reaction mixture containing 20 mM GlcNAc and
inactivated PhGn2E in D2O after 15 min incubation at 37 ◦C (spectrum was recorded in DMSO-d6);
(D): 1H-NMR spectrum of the reaction mixture containing 20 mM GlcNAc and PhGn2E in D2O after
15 min incubation at 37 ◦C (spectrum was recorded in DMSO-d6).
3. Discussion
3.1. Characterization
The recombinant form of PhGn2E could be successfully purified and was observed as a single
protein band of expected molecular weight on SDS-PAGE. The enzyme showed good expression levels
and had, after purification, a high specific activity of 3.59 U/mg. Furthermore, microplate reader-,
HPLC-, and NMR-based methods unambiguously demonstrated the enzymatic epimerization activity
of PhGn2E.
Although PhGn2E showed no activity at temperatures of 50 ◦C and above, the enzyme showed
reasonable stability when incubated at 37 ◦C for up to 12 h. This makes PhGn2E potentially
suitable for biotechnological applications at ambient temperatures with longer incubation times,
such as continuous biotransformations. The optimum temperature of PhGn2E was determined to
be 37 ◦C. This value is comparable with the reported temperature optimum for the cyanobacterium
Synechocystis sp. PCC 6803 [27], whereas B. ovatus, porcine, and A. variabilis isoforms showed higher
temperature optima (45 to 60 ◦C, respectively) [19,28,29]. The pH optimum of PhGn2E lies slightly
higher than other characterized epimerases, which were reported to lie between 6.8–8.5 for the porcine,
Anabaena sp., B. ovatus, and Synechocystis sp. PCC6803 homologues [22,23,27,29]. The addition of
EDTA or metal ions did not significantly decrease or inhibit PhGn2E activity, which indicates that
metal ions are not involved in the catalytic mechanism of the enzyme. Kinetic analysis showed that
the measured KM value of 82 mM was higher compared to other reported KM values (between 7
and 32 mM) [22,23,27,29,30], which might be an advantage for biotransformations performed at high
substrate concentrations.
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While several bacterial GlcNAc 2-epimerases show activity in absence of nucleotides, the addition
of ATP has been reported to enhance enzymatic activity for some isoforms. For example, the activity of
Anabaena sp. epimerase was enhanced in the presence of ATP and the non-hydrolyzable γ-phosphate
analogue 5′-adenylyl imidodiphosphate [23]. It has been demonstrated that the addition of ATP
stabilizes the B. ovatus epimerase leading to an increased denaturation temperature and an enhanced
pH activity range [31]. In a similar manner, the activity of PhGn2E also increased significantly in
the presence of ATP. While mammalian epimerases can be activated in presence of a wide range of
nucleotides such as AMP, ADP, ATP, CTP, GTP or UTP [30], PhGn2E activity remained unchanged in
the presence of these nucleotides. Two different theories of how ATP-binding effects the activity of
GlcNAc 2-epimerase currently exist; Liao et al. suggested an ATP-binding site in Anabaena sp. GlcNAc
2-epimerase site 151-KDNPKGKYTK-160 (Supplementary Figure S1), and that the residues Lys151
and Lys160 are required for ATP binding [23]. A second hypothesis by Sola-Carvajal et al. suggests
that the lysine residues in a different motif located at the C-terminus of the analyzed B. ovatus isoform
(392-KGGKWKG-398, Supplementary Figure S1) are responsible for ATP binding [31]. This motif
was also found in the C-terminal region of PhGn2E (369-KGNLFKG-375), and in other functionally
described isoforms from Anabaena sp. and mammals (Supplementary Figure S1), suggesting that the
lysine residues at the C-terminal region may be responsible for the binding of ATP.
3.2. Chemoenzymatic Synthesis of Mannosamine and Sialic Acid Derivatives
The synthesis of mannosamine and sialic acid derivatives is one of the main limitations in studying
them as potential inhibitors of the sialic acid metabolic pathway [32–37]. In this field, several research
groups have reported the synthesis of mannosamine derivatized with N-linked aliphatic chains.
This is generally achieved by using NHS-activated acids [38,39], or alternatively, can also be achieved
by treatment of isobutyl chloroformate with an acid, yielding an amine-reactive anhydride [36,40].
Sampathkumar et al. reported the synthesis of peracetylated ManNAc analogues by treatment with
naphthaldehyde for N-activation using ManN hydrochloride as starting material [41]. However, the
high price of mannosamine is a major limitation in the synthesis of sialic acid analogues. Incorporating
PhGn2E into the synthetic route allows the use of glucosamine-based analogues, which reduces the
cost of the synthesis to a fraction of that of the mannosamine-based synthesis.
The mannosamine derivatives obtained from the PhGn2E-catalyzed reaction were used as
precursors for the synthesis of Neu5Ac (3a) analogues. These Neu5Ac analogues bearing alternative
N-linked acyl chains could be synthetized by the sialic acid aldolase-catalyzed addition of pyruvate.
Several chemical strategies to generate Neu5Ac derivatives with C-5 modifications have been
successfully applied so far, including modification with benzyl- and azido groups [42,43]. A free
amino group has been demonstrated to be a suitable nucleophile for protection with Fmoc, Alloc
or Boc carbamates [42,43]. Unprotected neuraminic acid had also been used for the addition
of trifluoroacetamido, trichloroethoxycarbonyl or 4-O-oxazolidinone groups, replacing the acetyl
group [43]. Keppler et al. used a whole cell biotransformation to produce N-propanoyl, N-butanoyl
and N-pentanoyl neuraminic acids by fermentation in Madin-Darby canine kidney cells using the
corresponding ManNAc derivatives as the starting material [44]. The same strategy was applied
by Lundgren et al. to produce a sialic acid derivative from N-butanoylglucosamine in genetically
engineered E. coli [45]. The chemoenzymatic synthesis of various sialosides based on mannosamines
derivatized with fluoride-, azido- or methoxide groups in a one-pot, three-enzyme approach with
recombinant enzymes was later reported by the group of Chen [38,46]. The herein characterized
PhGn2E epimerase may also be easily integrated into reported synthetic procedures, which would
allow the use of glucosamine derivatives as a starting material.
3.3. Mechanistic Studies
Recorded NMR spectra showed hydrogen/deuterium exchange at C-2 in both GlcNAc and
ManNAc when the reaction was performed in D2O. This result can be explained considering that the
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enzyme is catalyzing the deprotonation of GlcNAc at C-2 and, at the same time, the incorporation of
deuterium on the opposite face, promoting the epimerization of GlcNAc to C-2 deuterated ManNAc
(Figure 4A). Four different mechanisms have been described for epimerization reactions in sugars:
the mutarotation mechanism, the transient oxidation-reduction mechanism, the elimination mechanism
and the deprotonation/reprotonation mechanism (Supplementary Figure S10) [24]. The mutarotation
mechanism is only applicable for epimerization reactions at the anomeric center and can be therefore
excluded. As GlcNAc 2-epimerases contain no co-enzymes such as FAD or NAD+, a transient
oxidation-reduction mechanism, with no observable proton/deuterium exchange in the substrate, can
be also excluded as possible mechanism. In both the deprotonation/reprotonation mechanism and the
elimination mechanism, two different residues are involved in the proton capture and proton donation
steps, allowing hydrogen/deuterium exchange. To discern between the two possible mechanisms,
the activity of PhGn2E towards anomeric O-substituted GlcNAc derivatives was studied. PhGn2E
showed no activity towards methyl α-GlcNAc, methyl β-GlcNAc or UDP-GlcNAc, indicating that the
enzyme is not capable of catalyzing the epimerization reaction in closed ring formation. In addition,
deuterium exchange on the anomeric alcohol is faster in presence of PhGn2E (Figure 5C,D). According
to the described mechanism for UDP-GlcNAc 2-epimerase, an elimination mechanism for the
GlcNAc/ManNAc enzymatic epimerization would involve the release and subsequent incorporation
of the hydroxyl group [47], which would consequently lead to no hydrogen/deuterium exchange in
the anomeric alcohol. Thus, the hydrogen/deuterium exchange is produced via pyranose ring opening
and closure (Figure 5A). This result is in agreement with the deprotonation/reprotonation mechanism
wherein the ring opening occurs in order to stabilize by enolate intermediate the anion formed in C-2
after the abstraction of the proton (Figure 6), confirming that the catalytic activity of PhGn2E is based
on a deprotonation/reprotonation mechanism.
The deprotonation/reprotonation mechanism requires the participation of two proximate amino
acid residues in the active site of the epimerase [24]. Itoh et al. obtained the crystal structure of the
porcine isoform, and showed that four amino acid residues (Arg60, His248, Glu251 and His382) are
close enough to the active center to be potentially important for catalytic function [18]. While the
X-ray diffraction of the enzyme was performed in presence of GlcNAc, the resolution of the substrate
was not high enough to carry out further crystallographic refinements and, for this reason, the exact
residues involved in the proton abstraction/donation steps could not be identified. Lee et al. reported
the three-dimensional structure of GlcNAc 2-epimerase from Anabaena sp., and that the substitution
of amino acids in the active site using site-directed mutagenesis showed that Arg57, His239, Glu308,
His372, are essential for the epimerization reaction [25]. The sequence alignment of PhGn2E, porcine
and Anabaena sp. isoforms (Supplementary Figure S1) show high similarities, especially close to the
above mentioned amino acids surrounding the active site. In order to identify the two residues involved
in the proton capture/donation steps, the activity of PhGn2E mutants was further investigated.
Despite the results of Lee et al., which suggest that His244 and H378 should be responsible for
the deprotonation/reprotonation mechanism [25], the PhGn2E mutants H244A and H378A could
efficiently catalyze the epimerization reaction from GlcNAc to ManNAc. On the other hand, the
PhGn2E mutants E314A and R63A were not capable of catalyzing the epimerization reaction indicating
that Arg63 and His372 are the residues involved in the proton abstraction/donation steps (Figure 3D).
Thus, one of these residues must participate in abstracting the hydrogen linked to C-2 of GlcNAc
followed by incorporation of the hydrogen in the same carbon but in the opposite face by the other
residue producing the inversion of configuration.
In order to assign the role of each residue, hydrogen/deuterium exchange studies of PhGn2E
mutants E314A and R63A were performed. However, no hydrogen/deuterium exchange could be
observed using either ManNAc or GlcNAc as initial substrate. Reports on the B. ovatus epimerase
indicated that the epimerization reaction from GlcNAc to ManNAc is faster than the epimerization
reaction from ManNAc to GlcNAc [22]. The reason for this may be pKa values of arginine (pKa ≈ 12.5)
and glutamic acid (pKa ≈ 3.1) residues, which indicate that a high proportion of protonated arginine
94
Catalysts 2016, 6, 212
and deprotonated glutamic acid residues exist at physiological pH conditions. Based on these
preconditions, we can propose that a GlcNAc in open conformation enters in the central cavity between
Arg63 and Glu314. Then, Glu314 deprotonates C-2 of GlcNAc while Arg63 incorporates the proton
on the same carbon but on the opposite face yielding ManNAc (Figure 6). Due to the reversibility of
the mechanism, GlcNAc 2-epimerase can also catalyze the epimerization from ManNAc to GlcNAc
through the deprotonation of ManNAc in C-2 by Arg63 followed by the reprotonation by Glu314
to obtain GlcNAc. This makes GlcNAc 2-epimerases unique among deprotonation/reprotonation
epimerases which commonly employ residues containing carbonyl, carboxylic acid and ester groups
as key amino acids for the reaction [24].
Figure 6. Deprotonation/reprotonation mechanism model of PhGn2E. Glu314 is able to deprotonate
and protonate C-2 of GlcNAc while Arg63 is the responsible of the deprotonation and protonation in
C-2 of ManNAc.
PhGn2E is highly homologous with mammalian GlcNAc 2-epimerases. Arg63 and Glu314 can be
found in the human, bovine, murine, porcine and rat GlcNAc 2-epimerase sequences (Supplementary
Figure S1). Furthermore, the crystal structure of porcine GlcNAc 2-epimerase showed that the
corresponding arginine and glutamic acid residues are also symmetrically located in the active site
(Supplementary Figure S11) [18]. The existence of these homologous residues in the active site of the
porcine epimerases, as well as a high similarity in the surrounding residues, is a strong indication
that mammalian epimerases also employ a deprotonation/reprotonation mechanism to carry out the
C-2 inversion.
4. Materials and Methods
4.1. General
DNA polymerases were purchased from Takara (Dalian, China); Restriction endonucleases and
T4 ligases were obtained from Thermo Fisher Scientific (Shanghai, China); DNA Gel Purification and
Plasmid Extraction kits were from Axygen (Beijing, China). Oligonucleotide primers were purchased
from GenScript (Nanjing, China). Buffers, salt and other chemicals used in this study were purchased
at the highest grade from various suppliers.
4.2. Bacterial Strains
Pedobacter heparinus (DSM 2366) was obtained from the German Collection of Microorganisms
and Cell Cultures (DSMZ, Darmstadt, Germany). E. coli Mach 1 cells (Life Technologies, Shanghai,
China) were used for plasmid amplification and manipulation. E. coli BL21 (DE3) cells (Invitrogen,
Shanghai, China) were used for protein expression experiments.
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4.3. Gene Cloning and Construction of the Expression Vector
Genomic DNA was isolated from stored lyophilized culture samples of Pedobacter heparinus
according to the method described by Mahuku [48]. The oligonucleotide primers for amplifying
a putative GlcNAc 2-epimerase were designed based on the P. heparinus genome information
provided by the Pathosystems Resource Integration Center (PATRIC) [49] (ph.ggbrc.com) as
follows: 5′-GGAATTCCATATGGTTATAGAATATACATTAGAAAAAT-3′ (forward primer) and
5′-CCGCTCGAGTTGAGCCGTATAGGAAGCA-3′ (reverse primer). Gene amplification was carried
out using Primestar HS DNA polymerase based on the manufacturer’s instructions. Briefly, the
PCR amplification was performed using 35 PCR cycles consisting of denaturation at 95 ◦C for 10 s
annealing at 55 ◦C for 30 s, and elongation at 72 ◦C for 1 min. The PCR fragments were purified on an
agarose gel, digested with the restriction endonucleases Nde I and Xho I and subsequently ligated
into a pET-30a expression vector, which was pre-digested using the same restriction endonucleases.
The ligation mixtures were transformed into E. coli Mach1 T1 competent cells and were selected on
Luria-Bertani (LB) agar containing 50 μg/mL kanamycin. Transformants containing the expected
plasmid construct were screened by Sanger DNA sequencing (Genscript, Nanjing, China). A clone
containing the expected plasmid construct was stored at −80 ◦C and used for further experiments.
The extraction of plasmids, endonuclease treatments, ligation, DNA purification and transformation
procedures were carried out using standard protocols.
4.4. Expression and Protein Purification
E. coli BL 21 (DE3) cells were transformed with the expression plasmid bearing the PhGn2E gene.
A single colony was transferred into 5 mL of LB medium containing 50 μg/mL kanamycin for overnight
shaking at 37 ◦C. The cells were then transferred into 400 mL LB medium and shaken (200 rpm) at 37 ◦C
until the optical density at 600 nm (OD600) reached a value between 0.5 and 0.8. Recombinant protein
expression was induced by adding 1 mM IPTG to the fermentation broth. After further 24 h of shaking
at 18 ◦C, cells were harvested by centrifugation (15 min at 5000 g), re-suspended in lysis buffer (50 mM
Tris, 100 mM NaCl, 1% (w/v) Triton X-100, adjusted to pH 8.0 with HCl) and disrupted by sonication
(40 on/off cycles with 20 μm probe amplitude for 15 s). The supernatant of the cell lysate was collected
(20 min centrifugation at 14,000 g), and loaded onto a Ni2+-nitrilotriacetate agarose affinity column
(2 mL bed volume, Qiagen, Shanghai, China) equilibrated with washing buffer (50 mM Tris/HCl,
50 mM NaCl, pH 8.0). After washing the column with 30 mL of washing buffer, the bound target
protein was then eluted in 1 mL fractions of elution buffer (50 mM Tris/HCl, 50 mM NaCl, 500 mM
imidazole, pH 8.0). The progress of protein expression, cell lysis and protein purification was analyzed
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized using Coomassie brilliant blue
G-250. Elution fractions showing the highest purity were pooled and stored in 30% glycerol (w/v) at
−80 ◦C for further experiments. The protein concentration of this pool was measured using a Bradford
protein quantification kit (Sangon Biotech, Shanghai, China). Furthermore, Coomassie-stained gels of
purified proteins were subject to in-gel tryptic digest and subsequent MALDI-TOF mass spectrometric
analysis (Bruker Ultraflex Extreme, Bremen, Germany).
4.5. Enzymatic Assay
PhGn2E activity was detected based on the method described by Sola-Carvajal et al. [22] with
slight modifications. In general, 10 μL assays containing 400 mM of GlcNAc and 0.58 μM of PhGn2E
in citrate/phosphate buffer (50 mM, pH 8.0) and were incubated at 37 ◦C for 5 min. The epimerase
activity was quenched by adding 70 μL of cold methanol and the protein was denatured by storing
the samples for 2 h at −80 ◦C. After solvent evaporation, 80 μL of deionized H2O were added to the
samples. The formation of ManNAc was analyzed using 3.4 μM of commercial N-acyl-D-mannosamine
dehydrogenase (Qlyco, Nanjing, China) and NAD+ (2 mM) as a co-factor in a continuous platereader
assay at 37 ◦C (Thermo Multiscan FC, Shanghai, China). An increase in absorbance at 340 nm
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resulted from the reduction of NAD+ to NADH when ManNAc was enzymatically oxidized to the
corresponding lactone.
4.6. Biochemical Characterization
The temperature optimum of PhGn2E was determined by incubating reaction mixtures at various
temperatures between 4 ◦C to 70 ◦C and the generation of ManNAc was subsequently determined
with the assay conditions described above. The pH optimum was investigated using a series of citric
acid/phosphate buffers (50 mM) ranging from pH 4.0 to pH 10.5. The thermal stability of PhGn2E was
examined by incubating the enzyme at temperatures between 22 ◦C and 52 ◦C for various durations.
Negative controls were prepared without the presence of enzyme. To evaluate the effect of metal
ions on the activity of PhGn2E, epimerization reactions were performed in the presence of either
1 mM Ca2+, Mg2+, Mn2+, Zn2+, Cu2+, Co2+, Fe2+, Fe3+, Ni2+, Al3+ (all in their chloride form) or 1 mM
ethylenediaminetetraacetate (EDTA).
The effect of several denaturants and detergents on PhGn2E was assessed for 2-mercaptoethanol
(10 mM, 50 mM, 100 mM), urea (0.5 M, 1 M, 2 M), Triton-X 100 (0.1%, 0.5%, 1%) and SDS (0.1%,
0.5%, 1%). A series of nucleotides (AMP, ADP, ATP, CMP, CTP, GMP, GDP, GTP, UTP) was added
in various concentrations to investigate their effect on the recombinant PhGn2E. Kinetic parameters
were determined by using different concentrations of GlcNAc (ranging between 50 mM and 1200 mM).
Vmax, KM and kcat values were calculated by applying a non-linear regression model using Labplot
data analysis software (Version 2.0.1.) (labplot.kde.org).
4.7. Synthesis of N-Substituted Glucosamine Derivatives and Determination of PhGn2E Substrate Promiscuity
GlcNAc analogues bearing different N-linked substituents were synthesized using a similar
activated ester method (AES) as described previously [50]. In brief, 1 mmol of N-hydroxysuccinimide
(NHS), 1 mmol dicyclohexylcarbodiimide (DCC) and 1 mmol of acid (acetic acid, propionic acid,
butyric acid, hexanoic acid, octanoic acid, decanoic acid, stearic acid, benzoic acid, 2-picolinic
acid, glycolic acid, thioglycolic acid, or azidoacetic acid) were dissolved in ethyl acetate (6 mL)
and stirred overnight at room temperature. The reaction mixture was centrifuged at 14,000 g for
10 min. The supernatant was added drop-wise into 4 mL of a glucosamine solution (0.8 mmol GlcN in
10% (v/v) methanolic triethylamine). The resulting solution was stirred for 2 h at room temperature,
the solvent was evaporated under reduced pressure and the resulting solid re-dissolved in 1.6 mL of
an aqueous methanol solution (10% v/v). All substrates showed good solubility, with the exception of
N-octadecanoylglucosamine (solubility of 8.8 mg/mL in 10% aqueous methanol at 37 ◦C). The substrate
promiscuity of PhGn2E was measured using the platereader-based assay described in Section 4.5.
NMR analysis was used to evaluate enzyme-catalyzed reactions towards glucosamine, α-methyl
GlcNAc and β-methyl GlcNAc. 1H-NMR spectra were acquired on a 400 MHz NMR instrument
(Bruker, Bremen, Germany) using deuterium oxide as the solvent.
4.8. Enzymatic Synthesis and Analysis of Indoxylsialosides
Sialic acid analogues were synthesized based on a method previously reported by Cao et al. for
p-nitrophenyl-linked sialosides [38]. This one-pot, four-enzyme reaction (Scheme 1, Route B) consists
of the C2-epimerization of the GlcNAc derivatives, followed by an aldolase catalyzed aldol reaction to
obtain C5-derivatized neuraminic acids. These derivatives were then activated using CMP-sialic acid
synthetase and transferred to the acceptor substrate 5-bromo-4-chloro-3-indolyl-β-D-galactose (X-gal)
by a sialic acid transferase. The expression and purification of the three latter enzymes was performed
as previously described [51]. The reaction mixture consisted of 50 mM GlcNAc analogue, 2 mM CTP,
2 mM MgCl2, 10 mM pyruvate, 2 mM X-gal, 50 mM MES (pH 6.5), 3 μM PhGn2E, 3 μM E. coli aldolase,
3 μM Neisseria meningitidis CMP-sialic acid synthetase and 5 μM Photobacterium damsalae sialic acid
transferase. After 16 h of incubation at 37 ◦C, samples were analyzed using reversed phase HPLC with
online UV and ESI-MS detection (Shimadzu MS-2020, Tokyo, Japan). The analytes were separated
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using a HyperClone 5 μm ODS column (250 × 4.6 mm, Phenomenex), with an ammonium formate
eluent (50 mM, pH 4.5, 1 mL/min) mixed with increasing concentrations of acetonitrile (from 10%
to 60% in the first 8 min) and detected at a UV wavelength of 300 nm. The ESI-mass detection was
performed in negative ionization mode scanning an m/z range between 300 and 1000.
4.9. Mechanistic NMR Studies
1H-NMR spectra were recorded on a Bruker AV-400 instrument, using the residual deuterium
oxide and dimethyl sulfoxide-d6 (DMSO-d6) residual solvent signals as internal standards. For studying
the C-2 hydrogen/deuterium exchange, approx. 3 mg of purified PhGn2E were dialyzed for 72 h
against deionized water and subsequently lyophilized. The dried enzyme was re-dissolved in 600 μL
of deuterium oxide containing 100 mM GlcNAc and incubated at 37 ◦C overnight. Spectra were
recorded without any further sample treatment. For the hydrogen/deuterium exchange analysis of the
anomeric alcohol, 3 mg of lyophilized epimerase was dissolved 300 μL of deuterium oxide containing
20 mM GlcNAc, and incubated at 37 ◦C for 15 min. After the solvent was evaporated, 1H-NMR spectra
were collected in deuterated DMSO-d6. Negative control experiments were performed by inactivating
the lyophilized epimerase with methanol.
4.10. Activity Screening Using PhGn2E Mutants
Complementary oligonucleotide primers containing the desired mutation were used to generate
PhGn2E mutant genes (Supplementary Table S2) according to the QuikChange overlap PCR
Site-Directed Mutagenesis protocol (Stratagene). Verified plasmids containing the desired mutation in
the target gene were transformed into E. coli BL21 (DE3) competent cells. PhGn2E mutant proteins
were expressed and purified as described in Section 4.4. Activity tests were performed in 40 μL reaction
mixtures containing 50 mM GlcNAc, 3 μM PhGn2E mutant or wild type in citrate/phosphate buffer
(50 mM, pH 8.0), and were incubated at 37 ◦C for 4 h. Negative controls contained heat-inactivated
PhGn2E (95 ◦C for 15 min) instead of the native enzyme. The reaction mixture was then analyzed
using the platereader-based assay described in Section 4.5.
5. Conclusions
Our study describes the biochemical characterization and the substrate promiscuity of a previously
unstudied GlcNAc 2-epimerase from Pedobacter heparinus. For the first time, experimental evidence of
the proposed deprotonation/reprotonation mechanism for this type of enzyme could be demonstrated.
This was achieved in NMR experiments by observing the hydrogen/deuterium exchange at C-2 and
in the anomeric alcohol of the substrates. An activity study of PhGn2E mutant enzymes suggests that
the proton abstraction/addition is catalyzed by Arg63 and Glu314. These residues do also appear in
the active site of the closely homologous mammalian GlcNAc 2-epimerase, indicating that mammalian
GlcNAc 2-epimerases also employ a deprotonation/reprotonation mechanism for epimerization.
These biochemical and mechanistical findings in PhGn2E may help to gain a deeper understanding of
the metabolism of GlcNAc and consequently sialic acids in living cells. Crystallization studies of the
PhGn2E haloenzyme are a part of our current research program.
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Abstract: The Mn(TpCPP)-Xln10A artificial metalloenzyme, obtained by non-covalent insertion
of Mn(III)-meso-tetrakis(p-carboxyphenyl)porphyrin [Mn(TpCPP), 1-Mn] into xylanase 10A from
Streptomyces lividans (Xln10A) as a host protein, was found able to catalyze the selective photo-induced
oxidation of organic substrates in the presence of [RuII(bpy)3]2+ as a photosensitizer and
[CoIII(NH3)5Cl]2+ as a sacrificial electron acceptor, using water as oxygen atom source.
Keywords: artificial metalloenzyme; manganese porphyrin; light induced oxidation
1. Introduction
Over the past few decades, the need for economically and environmentally compatible chemical
processes has increased exponentially, along with global environmental concerns. As a result,
the concept of green chemistry has emerged, which endorses the use of mild chemical reaction
conditions, such as the use of non-polluting reactants, visible light as main energy source, and water
as solvent, which, in addition, serves as O atom and electron sources [1]. In this context, oxidation
reactions such as the conversion of alkanes into alcohols—one of first steps in the synthesis of products
issued from the petrochemical industry—would benefit from significant improvements. Current
chemical processes take place in wasteful organic solvents at high temperature, in addition to lacking in
efficiency and/or selectivity [2,3]. Although promising metal catalysts have been developed and show
encouraging implementation potential [4], several aspects such as efficacy, regio- and stereoselectivity,
compound stability, or environmental toxicity remain to be addressed. In addition, these reactions
often resort to oxidant reactants that might have a direct or indirect impact on the environment [2,3].
Natural enzymes provide us with astonishing examples of extremely efficient, selective, and stable
catalysts. Oxidases constitute a widely investigated class of enzymes, most of which contain one
or several metal ions at the heart of their redox center. For example, a non-heme iron enzyme such
as phenylalanine hydroxylase (PAH) [5] catalyzes the hydroxylation of the aromatic side-chain of
phenylalanine to generate tyrosine, whereas di-iron enzymes such as methane monooxygenases (MMO)
allow the transformation of methane into methanol [6,7]. Cytochrome P450 enzymes constitute a large
family of hemoproteins that can perform the oxidation of various substrates at high catalytic rates
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using molecular oxygen as the sole source of oxidant through a reductive activation mechanism [8].
During the catalytic cycle, two electrons are provided by redox mediators, Nicotinamide Adenine
Dinucleotide (NADH), Nicotinamide Adenine Dinucleotide phosphate (NADPH), etc., allowing the
formation of a very reactive high-valent iron-oxo intermediate responsible for substrate oxidation.
Over the years, P450 enzymes have been largely studied and utilized for catalytic purposes.
However, electron delivery to the iron center remains the principal hurdle to high catalytic efficiency.
On the one hand, natural redox cofactors are expensive, requiring the need to recycle them or to
avoid their use. On the other hand, the electrons are not directly transferred to the heme iron,
but instead are delivered through a P450 reductase that involves two flavin redox cofactors, i.e., Flavin
Adenine Dinucleotide (FAD) and Flavin Mononucleotide (FMN). Two electrons are initially transferred
from NADPH to FAD to yield FADH2, which then transfers them to FMN. The obtained FMNH2,
then delivers sequentially, one by one, these two electrons to the iron atom at precise steps of the
catalytic cycle [9]. Such a complex process, which is also driven by protein conformational changes,
is then far from reproducible, and numerous approaches have been developed to mimic this catalytic
reaction. For instance, approaches like the use of alternative oxygen atom donors (PhIO, ROOH, H2O2,
KHSO5, etc.) [10], chemical or electrochemical reductions [11], and, more recently, reductase proteins
that were substituted with ruthenium-based photosensitizers capable of gathering electrons upon light
irradiation and transferring them to cytochrome (P450) enzymes [12,13].
This latter field of research is appealing because it utilizes visible light as the sole energy
input in the chemical reaction, which can be used either under reductive or oxidative experimental
conditions. The former pathway relies on the photo-reduction by diethyldithiocarbamate (DTC) of
a RuII-chromophore that is covalently attached to the apo-P450, which then catalyzes the reductive
activation of oxygen leading, in the presence of H+, to a high-valent P450FeV-oxo species that performs
the oxidation of fatty acids [12,13]. Conversely, the oxidative pathway relies on the ability to quench
the excited state of a [RuII(bpy)3]2+ chromophore with an irreversible electron acceptor such as
[CoIII(NH3)5Cl]2+, in order to form the highly oxidative [RuIII(bpy)3]3+, which then catalyzes the
two-electron oxidation of an iron-bound water molecule with formation of the high-valent iron-oxo













b) Path a: P = P450, M = Fe 




Scheme 1. Reaction pathways for the two-electron oxidation of an organic substrate by light-driven
activation of a catalyst: Path (a) two-electron oxidation of an iron-bound water molecule into
high-valent P-450-iron-oxo species by [RuIII(bpy)3]3+, generated by quenching of the excited state
of [RuII(bpy)3]2+ by an irreversible electron acceptor ([CoIII(NH3)5Cl]2+) [14]; Path (b) one-electron
oxidation of an MnIII-OH complex into a porphyrin-MnIV-oxo species by [RuIII(bpy)3]3+, followed by
the disproportionation of the MnIV-oxo species into MnIII and MnV=O [15,16].
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The oxidative pathway was also used with biomimetic systems involving manganese porphyrins
as catalysts and water as an oxygen source, which were reported originally by Calvin’s group [15],
and more recently by Fukuzumi et al. [16]. In these systems, the authors showed that the
photogenerated highly oxidative [RuIII(bpy)3]3+ can oxidize the MnIII-OH complex into an MnIV-oxo
species. In this case, the MnV-oxo species was not directly formed by a second one-electron oxidation,
but rather arose from the disproportionation of the MnIV-oxo species into MnIII and MnV=O (Scheme 1,
Path b) [16]. Such a system could catalyze the oxidation of water-soluble substrates, including
alkenes, alkanes, and sulfides [16]. Previous work from our group also showed that the moderately
enantioselective light-induced oxidation of thioanisole by water as the oxygen atom source could occur
in the presence of a system that associated a protein that induced chirality, BSA (Bovine Serum Albumin),
a manganese corrole as oxygen atom transfer catalyst, and [RuII(bpy)3]2+ as photosensitisizer [17].
In parallel, other work also allowed us to show the strong affinity of manganese
sodium tetra-para-carboxylatophenyl-porphyrin (Mn-TCPP) for xylanase 10A (Xln10A) from
Streptomyces lividans, a glycoside hydrolase that catalyzes the hydrolysis of (1-4)-β-D-xylosidic bonds
in xylan biopolymers to release xylose [18]. Xylanase 10A is an abundant and resistant protein.
It is easily purified and its sequence and three-dimensional structure are known, which makes it
a good candidate as a protein scaffold for the production of biohybrid catalysts resulting from the
combination of a natural protein and an artificial metal complex. We expected this combination of
enzymatic and molecular catalysis to yield hybrid catalysts showing improved efficacy, selectivity,
and stability. Studies on the reactivity of the Mn-TCPP-Xln10A hybrid showed that it possessed good
mono-oxygenase activity for the epoxidation of styrene-type compounds, in addition to yielding
important enantiomeric excesses, in particular for the epoxidation of p-methoxystyrene by oxone.
This selectivity was further illustrated by molecular modeling studies that showed the existence
of hydrogen bonds between the methoxy substituent of the substrate and a tyrosine residue of the
protein [18].
We thus decided to use our Mn-TCPP-Xln10A biohybrid as a catalyst for the selective
photo-induced oxidation of organic substrates in the presence of [RuII(bpy)3]2+ as a photosensitizer
and [CoIII(NH3)5Cl]2+ as a sacrificial oxidant, with water as an oxygen atom source. We report that
both Mn-TCPP and its complex with xylanase 10A can catalyze the photoinduced sulfoxidation of
thioanisole and 4-methoxythioanisole with slight enantiomeric excesses, using water as an oxygen
atom source.
2. Results
2.1. Preparation of the Catalysts
Meso-tetrakis-para-carboxyphenylporphyrin 1 was first prepared in a 10.5% yield by condensation
of p-carboxybenzaldehyde with pyrrole in propionic acid according to the procedure of
Adler et al. [19,20]. Its Electon Spray Ionisation Mass (ESI-MS) and Ultra-Violet-visible (UV-vis)
spectroscopy characteristics were found identical to those already reported [19]. The insertion of
manganese was performed by treatment of 1 with an excess of Mn(OAc)2, 4 H2O in 50 mM AcONa
buffer, and pH 4.0 at 100 ◦C for 4 h, as described in the experimental section. The excess manganese salt
was then removed by two successive purifications, first on P6DG exclusion gel, and second on Chelex.
After lyophylization, 1-Mn was obtained in a quantitative yield and characterized by ESI-MS and
UV-vis spectroscopy, in agreement with those already reported [18] and with an Mn(TpCPP) structure
(Figure 1).
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Figure 1. Manganese(III)-meso-tetrakis-para-carboxyphenylporphyrin, 1-Mn.
To prepare the 1-Mn-Xln10A artificial hemoprotein, xylanase 10A (Xln10A) was first purified from
the supernatant of S. lividans culture as reported earlier [21]. Solutions of the artificial hemoprotein
were then prepared by incubating Xln10A in 50 mM sodium phosphate buffer, pH 7.0 with various
amounts of 1-Mn for 30 min. at room temperature. 1-Mn-Xln10A was then characterized by UV-visible
spectroscopy as described above, and its UV-visible spectrum was similar to that of 1-Mn alone,
with maxima at 468, 566 and 599 nm in 50 mM sodium phosphate buffer pH 7.0.
UV-visible spectroscopy could thus not be used for the determination of the stoichiometry and
of the dissociation constant of the 1-Mn-Xln10A. Since, in addition, 1-Mn-Xln10A dissociates under
mass spectrometry analysis conditions, the binding affinity of the 1-Mn complex for Xln10A was
then studied by measuring the quenching of the fluorescence of the tryptophan residues of Xln10A,
5 μM in 50 mM sodium phosphate buffer pH 7.0 at 25 ◦C as a function of the 1-Mn concentration
as previously reported [18]. The quenching was complete and selective, and suitable data were
obtained from plots of fluorescence intensity versus the Xln10A/1-Mn ratio. A double reciprocal plot
of the residual fluorescence intensity at 340 nm as a function of the 1-Mn final concentration allowed
calculation of a KD value of 1.5 μM for 1-Mn-Xln10A and determined that only one ligand was bound
per protein [18]. This KD value was similar to that already reported for the Fe(TpCPP)-Xln10A complex
(KD = 0.5 μM) [21], and was in agreement with the fact that the binding of the porphyrin cofactor
occurred thanks to interactions of three of its carboxylate substituents with amino-acid side chains of
the protein and that no amino-acid side chain was interacting with the metal cation. This could be
explained after molecular modeling calculations [18].
Taking into account the KD values measured for 1-Mn-Xln10A, it was possible to calculate the
theoretical concentration of protein necessary to bind 100% of the metal cofactor. It was thus found that
four equivalents of Xln10A were necessary to bind one equivalent of the 1-Mn cofactor. Accordingly,
when the effect of the Xln10A/1-Mn ratio on the oxidation of styrene derivatives by KHSO5 catalyzed
by 1-Mn-Xln10A in 50 mM phosphate buffer, pH 7.0, it appeared that the total yield of the reaction as
well as its chemoselectivity and the enantiomeric excesses observed for the obtained epoxides were
optimal when four equivalents of Xln10A were used with respect to 1-Mn. It was thus decided to
perform the photoassisted oxidation of sulfides in the presence of Xln10A and 1-Mn in a 4/1 ratio
as catalyst.
2.2. Catalysis
The oxidation of thioanisole (3200 eq.) 99 mM in 50 mM phosphate buffer solution (pH 7.0) was
first assayed in the presence of 0.42 mM [RuII(bpy)3]2+ (13 eq.) as a photosensitizing agent, 12 mM
[CoIII(NH3)5Cl]2+ (390 eq.) as an irreversible electron acceptor and 32.5 μM 1-Mn (1 eq.) in the presence
of 130 μM Xln10A (4.2 eq.) (Xln10A/1-Mn ratio = 4) as catalyst (Scheme 2).
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Scheme 2. Photoassisted oxidation of thioanisole and p-methoxythioanisole in the presence of
[RuII(bpy)3]2+ as a photosensitizing agent, [CoIII(NH3)5Cl]2+ as an irreversible electron acceptor and
1-Mn or 1-Mn-Xln10A as a catalyst.
When control experiments were run either in the absence of catalyst or in the absence of the
[RuII(bpy)3]2+ photosensitizing agent, no oxidation products were formed. On the contrary, when
the reaction was run in the presence of [RuII(bpy)3]2+ and of either 1-Mn or 1-Mn-Xln10A as catalyst,
methylphenylsulfoxide was obtained as the major product. A Turnover number (TON) of 125 ± 5
was obtained after the photo driven reaction of 1-Mn with [RuII(bpy)3]2+ in the absence of protein,
which corresponds to a 64% yield with respect to [CoIII(NH3)5Cl]2+. Minor amounts of sulfone
(6 ± 1 TON) were also formed (Table 1). Further HPLC analysis showed that a racemic mixture of
methylphenylsulfoxide was produced, and thus that the reaction was not enantioselective. When the
experiment was performed in the presence of Xln10A, methylphenylsulfoxide was obtained as the
sole product with a TON of 25 ± 2 (13% yield with respect to [CoIII(NH3)5Cl]2+). After HPLC analysis,
no enantiomeric excess could be measured, showing that under those conditions the protein did not
induce any stereoselectivity.
Table 1. Products obtained upon photoassisted oxidation of thioanisole in the presence of [RuII(bpy)3]2+








Thioanisole (R = H)
1-Mn a 6 ± 1 125 ± 5 0 This work
1-Mn-Xln10A a - 25 ± 2 0 This work
Mn-Corrole 1.6 32 ± 3 0 [17]
Mn-Corrole-BSA - 21 ± 7 12–16 [17]
RuPhot-RuCat-H2O b - 745 - [22]
p-Methoxy-thioanisole
(R = OCH3)
1-Mn a - 100 ± 4 0 This work
1-Mn-Xln10A a - 10 ± 1 7 ± 1 This work
RuPhot-RuCat-H2O b - 709 - [22]
p-Bromo-thioanisole
(R = Br)
RuPhot-RuCat-H2O b - 314 - [22]
RuPhot-RuCat-H2O c - 201 - [23]
2-(CH3-thio)ethanol Mn-TMPS c 30 [16]
a Conditions as described in the experimental section; [RuII(bpy)3]2+ = ruthenium-tris-bipyrridyle,
[CoIII(NH3)5Cl]2+ = Cobalt-pentammine chloride, Xln 10A = xylanase 10A, Manganese(III)-meso-tetrakis-
para-carboxyphenylporphyrin = 1-Mn b RuPhot-RuCat-H2O = ([(bpy)2Ru(4-Me-BPy-terPy)Ru(bpy)-(OH2)]4+;
b RuPhot-RuCat-H2O = ([(bpy)2Ru(tpphen)Ru(bpy)-(OH2)]4+, Cat/Substrate/[CoIII(NH3)5Cl]2+ ratio = 1/500/1000;
c Mn-TMPS (Mn(III)-5,10,15,20-tetrakis (2,4,6-trimethyl-3-sulfonatophenyl)porphyrin 0.1 mM, Cat/[RuIII(bpy)3]2+/
Substrate/[CoIII(NH3)5Cl]2+ ratio = 1/10/1000/1000.
We thus thought about investigating other sulfide derivatives that could lead to an enantioselective
sulfoxidation under the same conditions. In this respect, we were inspired by the epoxidation of
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p-methoxy-styrene by oxone, in the presence of the Mn-TCPP-Xln10A hybrid as catalyst, which was
previously demonstrated to be highly enantioselective (80% ee in favor of the R isomer). This was due to
a preferential orientation of the re face of the styrene derivative towards the manganese-oxo oxidizing
intermediate, provided by the formation of a H-bond between the O atom of the p-methoxy substituent
and tyrosine 172 of Xln10A (Scheme 3A) [18]. We thus thought about using p-methoxy-thioanisole
as substrate, expecting that in a similar way to p-methoxy-styrene, an H-bond between the O atom
of the p-methoxy substituent and tyrosine 172 of Xln10A would preferentially orientate the sulfide
towards the Mn-porphyrin-derived oxidizing species in order to get the R sulfoxide (Scheme 3B).
The photoassisted sulfoxidation of 84 mM p-methoxy-thioanisole (2700 eq.) was then assayed in 50 mM










Scheme 3. Selective orientation of (A) p-methoxystyrene and (B) p-methoxythioanisole towards the
putative porphyrin-Mn-oxo oxidizing species using 1-Mn-Xln10A as catalyst
When 1-Mn alone was used as an oxidizing catalyst, methyl-p-methoxyphenylsulfoxide was
obtained as the only product with a TON of 100 ± 4 (51% yield with respect to [CoIII(NH3)5Cl]2+),
but the reaction was not stereoselective, as no enantiomeric excess could be measured after HPLC analysis.
When the same reaction was performed in the presence of Xln10A, methyl-p-methoxyphenylsulfoxide
was formed with a TON of 10 ± 1 (5% yield with respect to [CoIII(NH3)5Cl]2+), but this time
an enantiomeric excess of 7% ± 1% in favor of the R Isomer could be measured, showing that
under those conditions the protein induced a slight stereoselectivity in favor of the expected R-isomer.
2.3. Influence of the Xln10A/1-Mn Ratio on Catalysis
The influence of the Xln10A/1-Mn ratio on the stereo selectivity was investigated. For this
purpose, the oxidation of 116 mM methoxy-thioanisole in 50 mM phosphate buffer solution (pH 7.0)
was performed in the presence of 0.42 mM [RuII(bpy)3]2+ (14 eq.) and 12 mM [CoIII(NH3)5Cl]2+
(390 eq.), as described above, using 37.0 μM 1-Mn (1 eq.) as catalyst in the presence of increasing
amounts of xylanase 10A, ranging from 37.0 μM (1 eq.) to 148 μM (4.2 eq.). After extraction and analysis
of the products, it appeared that the TON decreased from 54 to 24 TON when the Xln10A/1-Mn ratio
increased from 1 to 4.2, whereas, surprisingly, no change in the enantiomeric excess was observed.
One likely explanation for this could be that, when the protein is in excess with respect to 1-Mn, it acts
as a competitive substrate for the electron withdrawing reaction by the highly oxidative [RuII(bpy)3]3+
complex, leading to protein radicals that would initiate protein oligomerization. Further experiments
were then performed to verify this hypothesis using sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) analysis of the protein.
2.4. Evolution of the Catalyst during the Reaction
To explain the weak enantiomeric excesses observed during the light-induced oxidation of
thioanisole derivatives, the xylanase 10A protein was examined by denaturing SDS-PAGE after the
reaction. This experiment was performed with 130 μM Xln10A as catalyst in 50 mM phosphate
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buffer solution (pH 7.0), with 99 mM thioanisole, 0.42 mM [RuII(bpy)3]2+, 12 mM [CoIII(NH3)5Cl]2+,
and 32.5 μM 1-Mn (Figure 2).
As shown in Figure 2, the starting pure Xln10A was characterized by a concentrated single band
at 32 kDa, indicative of monomeric form, whereas, after the reaction, a band at higher MW (>250 kDa)
could be observed, showing potential oligomerization of the protein over the course of the reaction.
Figure 2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of xylanase
10A. lane 1, molecular weight markers; lane 2, analysis of the pellet obtained after centrifugation of the
reaction medium after the light induced oxidation reaction; lane 3, xylanase 10A purified before the
reaction; lane 4, supernatant obtained after centrifugation of the reaction medium after catalysis.
2.5. Mechanistic Studies
Labeling experiments were realized to determine the origin of the oxygen atom of the obtained
sulfoxide. Thus, the oxidation of p-methoxy-thioanisole was assayed under the same conditions as
reported above, but 19.4% H218O was introduced for the preparation of the 50 mM phosphate buffer
(pH 7.0) solvent. After extraction with ethyl acetate, the products were analyzed by High resolution
(HR)-ESI MS. Twenty percent of the resulting sulfoxide contained 18O, as shown by the peaks observed
at 171.0480 and 173.0477 that correspond to [M + H]+ species for CH3S16OC6H5 and CH3S18OC6H5
methyl phenyl sulfoxides, respectively (Figure 3). This confirmed that the inserted O-atom in the
oxidation product originated from water molecules of the solvent medium.
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Figure 3. High-resolution Electron Spray Ionisation-Mass (ESI-MS) spectrum of the p-methoxy-
thioanisole sulfoxide, obtained after the photoassisted oxidation of p-methoxy-thioanisole, in the
presence of [RuII(bpy)3]2+, [CoIII(NH3)5Cl]2+ and 1-Mn-Xln10A as catalyst, in 50 mM phosphate buffer
(pH 7.0) containing 19% H218O. Peaks at 171.0480 and 173.0477 correspond to [M + H]+ species for
CH3SOC6H5 and CH3S18OC6H5 methyl phenyl sulfoxide, respectively.
3. Discussion
The aforementioned results show that both the manganese(III)-meso-tetrakis-para-
carboxyphenylporphyrin 1-Mn and its complex with xylanase 10A, the 1-Mn-Xln 10A hemozyme,
catalyze the photo-assisted oxidation of thioanisole derivatives with formation of the sulfoxide as
major product (Scheme 2, Table 1). With both thioanisole and p-methoxy-thioanisole, the reaction is
highly chemoselective and leads to the corresponding sulfoxide as a major product with greater yields
with 1-Mn alone as catalyst (125 ± 5 TON and 100 ± 4 TON, respectively) than with 1-Mn-Xln10A as
catalyst (25 ± 2 TON and 10 ± 1 TON, respectively). This could indicate that the insertion of 1-Mn
into the hydrophobic pocket of Xln10A [18] hinders the electron transfer from the manganese center to
the photo-activated ruthenium complex. The results observed in the presence of 1-Mn-Xln10A are,
however, comparable to those obtained under the same conditions for the oxidation of thioanisole
catalyzed by an Mn-corrole complex and Mn-corrole-BSA artificial metalloenzyme, which respectively
lead to the chemoselective formation of the corresponding sulfoxide with 32 ± 3 and 21 ± 7 TON
(Table 1) [17]. In addition, as studies in the presence of H218O show the incorporation of 18O in the
obtained sulfoxide, and no reaction occurs in the absence of the [RuII(bpy)3]2+ photoactivator, it is
reasonable to propose that the reaction follows a mechanism similar to that depicted in Scheme 1. Water
would thus act as the oxygen source, leading to an MnIII-OH that would be oxidized into an MnIV-oxo
species by the photogenerated highly oxidative [RuIII(bpy)3]3+ species. For the 1-Mn homogenous
catalyst, the final MnV-oxo oxidizing species would likely arise from the disproportionation of
the MnIV-oxo species into MnIII and MnV=O (Scheme 1, Path b) as reported for other manganese
porphyrin complexes [15,16] whereas it would be formed upon oxidation of the MnIV-oxo by the
photogenerated [RuIII(bpy)3]3+ in the 1-Mn-Xln10A system (Scheme 1, pathway a) [14] because
disproportionation between complexes embedded in Xln10A is unlikely.
Since the oxidation of 2-(CH3-thio)ethanol catalyzed by the Mn(III)-5,10,15,20-tetrakis
(2,4,6-trimethyl-3-sulfonatophenyl)porphyrin (Mn-TMPS) under the same conditions was also reported
to lead to the formation of the corresponding sulfoxide with 30 TON (Table 1) [16], 1-Mn-Xln10A
is an equally interesting artificial metalloenzyme for the chemoselective photoinduced oxidation
of sulfides in water. It is noteworthy, however, that these results illustrate lower yields relative to
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those obtained in the presence of supramolecular assemblies in which a ruthenium-tris-bipyridyl
photoactivable moiety (RuPhot) is covalently attached to another Ru(tpy)(bpy)(H2O) catalytic moiety
(Rucat) that photoinduces the sulfoxidation of thioanisole derivatives, such as thioanisole, p-Methoxy-,
and p-bromo-thioanisole using water as an oxygen source, in the presence of [CoIII(NH3)5Cl]2+ as
sacrificial reductant with 200–745 TON (Table 1) [22,23].
As expected, no enantioselectivity was observed for the oxidation of thioanisole and p-methoxy
thioanisole with that of 1-Mn alone as catalyst (Table 1). Surprisingly, no enantioselectivity could
be observed for the oxidation of thioanisole in the presence of Xln10A, which contrasted with the
12%–16% ee observed for the same reaction in the presence of Mn-Corrole-BSA as catalyst [17] (Table 1).
The oxidation of p-methoxy-thioanisole, which was chosen in the hope of a selective pro-R positioning
of the sulfide similar to that previously reported for p-methoxy-styrene [18] (Scheme 3) was only slightly
enantioselective, though it led to the R sulfoxide as the major enantiomer, as was expected. However,
the ee value, 7% ± 1%, was far from that obtained for the epoxidation of p-methoxy-styrene by oxone
catalyzed by 1-Mn-Xln10A, (80% ee in favor of the R epoxide). This could be due to a denaturation of
the protein during catalysis. Indeed, when the Xln10A/1-Mn ratio increases, the ee remains constant,
whereas the TON decreases, in agreement with a radical polymerization initiated by its direct reaction
with the [RuII(bpy)3]3+ intermediate.
4. Materials and Methods
4.1. Physical Measurements
ESI-HRMS was determined on a micrOTOF-Q II 10027 apparatus (Bruker Daltonics, Billerica,
MA, USA), UV/Vis spectra were recorded on an UVIKON-XL spectrophotometer (BioTek Instruments,
Inc., Winooski, VE, USA) fluorescence spectra were recorded on a CARY Eclipse fluorometer (Agilent
Technologies, Santa Clara, CA, USA). Gas chromatographs (Shimadzu Scientific Instruments, Inc.,
Columbia, MA, USA) were obtained with a Shimazu GC 2010 plus apparatus equipped with a Zebron
ZB-SemiVolatiles Gas Chromatography (GC) column (30 m × 0.25 mm × 0.25 μm). HPLC (Agilent
Technologies, Santa Clara, CA, USA) was performed on an Agilent Infinity 1260 apparatus equipped
with a chiral column (Chiralcel OD-H, Daicel Co., Osaka, Japan, 250 mm × Φ4.6 mm).
4.2. Synthesis of MnIII-meso-tetrakis(para-carboxyphenyl)porphyrin (1-Mn)
meso-Tetrakis(para-carboxyphenyl)porphyrin (1) was prepared in 10.5% yield by condensation of
p-carboxybenzaldehyde with pyrrole in propionic acid according to the procedure of Adler et al. [19,20],
and its molecular properties were found to be identical to those already reported [19]: 1H-NMR
(d6-DMSO) 8.85 (8H, s), 8.38 (8H, d, J = 8 Hz), 8.32 (8H, d, J = 8 Hz), −2.95 (2H, s, NH); Matrix-assisted
Laser Desorption-Time Of Flight (MALDI-TOF)-MS: m/z = 791.21 (M + H+). The insertion of
manganese was performed by treatment of 1 (2.5 mM) in AcONa buffer (pH 4.0, 50 mM) with
Mn(OAc)2, 4H2O (11 equiv.) at 100 ◦C for 4 h. The progress of the reaction was monitored by UV/Vis
spectroscopy. After 2 h under reflux, the Mn metalation was quantitative. The excess of manganese
salt was then removed by successive purifications on P6DG exclusion gel and then on Chelex. After
lyophylisation, 1-Mn was obtained as a purple solid in a quantitative yield. Its properties were found
to be identical to those already reported [18]: UV/Vis (pH 7.0, sodium phosphate buffer, 50 mM):
λmax (ε): 468 (93 × 103 M−1·cm−1), 565, 600 nm; MALDI HR-MS (ESI): m/z = 843.12396, calculated for
C48H28MnN4O8, and m/z = 843.12132 (Δm = 5.04 ppm).
4.3. Preparation and Characterization of the Artificial Metalloenzyme 1-Mn-Xln10A
Xylanase 10A was first purified from the supernatant of S. lividans culture as reported earlier [19].
The various 1-Mn-Xln10A hemozyme samples were then prepared by incubation for 30 min at room
temperature (RT) of Xln10A in sodium phosphate buffer (50 mM, pH 7.0) with various amounts of
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1-Mn. 1-Mn-Xln10A was then characterized by UV/Vis and fluorescence spectroscopy studies as
already reported [18].
4.4. UV/Vis Spectroscopy Experiments
1-Mn (5 μM) was incubated with Xln10A (1.5 equiv.) in 50 mM sodium phosphate buffer (pH 7.0)
at room temperature for 30 min, and the UV/Vis spectrum was recorded between 280 nm and 700 nm.
The spectrum obtained was found identical to that already reported [18]: UV/Vis (pH 7.0, sodium
phosphate buffer, 50 mM): λmax (ε): 468 (92.3 × 103 M−1·cm−1), 565,600 nm.
4.5. Determination of the KD Values for 1-Mn-Xln10A Complexes
The KD value for 1-Mn-Xln10A complexes as well as the 1-Mn/Xln10A stoichiometry were
determined as follows: the fluorescence spectrum of Xln10A, 5 μM in 50 mM sodium phosphate buffer,
pH 7.2, at 25 ◦C was first recorded between 300 and 400 nm after excitation of the sample at 290 nm.
The quenching of fluorescence was then followed by progressive addition of a 500 μM solution of 1-Mn
in 50 mM phosphate buffer pH 7.0. A double reciprocal plot of the residual fluorescence intensity at
340 nm as a function of the 1-Mn final concentration afforded a KD value of 1.5 μM for the 1-Mn-Xln10A
complex and a 1/1 1-Mn/Xln10A stoichiometry.
4.6. Photoassisted Oxidation of Sulfides
For a typical photo-oxidation reaction, 150 μM of pure xylanase 10A, 37.5 μM porphyrin, 130 μL of
3.04 mM [RuII(bpy)3]2+ in phosphate buffer saline PBS, and either 11 μL thioanisole or 30 μL 4-methoxy
thioanisole were added to a 800 μL degassed 50 mM phosphate buffer solution (pH 7.0) containing
14 mM [CoIII(NH3)5Cl]2+. The solution was degassed by three freeze/thaw cycles, and the samples
were illuminated with a 450 nm diode and stirred for 10 minutes at RT. The final concentrations of
each component were 12 mM [CoIII(NH3)5Cl]2+ (390 eq.), 130 μM xylanase 10A (4.2 eq.), 32.5 μM
Mn-porphyrin (1 eq.), 0.42 mM [RuII(bpy)3]2+ (14 eq.), and 84 mM 4-methoxy thioanisole (2700 eq.),
or 99 mM thioanisole (3200 eq.). Control experiments without protein were performed maintaining the
above concentrations. Control experiments without chromophore were performed by substituting the
[RuII(bpy)3]2+ solution by the equivalent PBS solution.
4.7. Extraction and Analysis of the Oxidation Products
After reaction, the content of the vial was eluted through a short (3 cm) silica plug to which
100 μL 10−2 M acetophenone solution acting as internal standard had been previously added.
The column was washed with 2 mL ethyl acetate in order to elute all the components. The aqueous
phase of the resulting filtrate was removed and the organic phase was dried using NaSO4 prior to GC
analysis. For detection of thioanisole and its oxidation products, the applied temperature gradient
was as follows: from 100 ◦C to 130 ◦C at 5 ◦C/min, and then 130 ◦C to 300 ◦C at 50 ◦C/min, which
was further held constant for 3 min. The injector and flame injector detection (FID) temperature were
set at 300 ◦C. Elution retention times were (min): acetophenone (4.03), thioanisole (4.32), thioanisole
sulfoxide (7.56), and thioanisole sulfone (8.04). To study the enantiomeric excess of the obtained
sulfoxide, the solvent was evaporated and the residue was re-dissolved in the minimum amount
of isopropanol prior to HPLC analysis. The enantiomeric excesses were then determined by HPLC
analysis using a chiral column (Chiralcel OD-H, Daicel Co., IlKirch, France, 250 mm × Φ4.6 mm).
For the oxidation of thioanisole, samples were eluted with hexane/isopropanol (95:5, v/v, 1.0 mL/min),
and, for the oxidation of p-methoxy-thioanisole, elution was done with hexane/isopropanol (97:3, v/v,
1.2 mL/min). All products were detected at 254 nm. Authentic samples of each sulfoxide enantiomer
were prepared by the method previously described by Li et al. [24], and their retention time under the
above described conditions are, respectively, 17 min and 21 min. for the R and S thioanisole sulfoxides,
and 32 min and 36 min. for the R and S p-methoxy-thioanisole sulfoxides.
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5. Conclusions
The aforementioned results demonstrate that an anionic manganese porphyrin, Mn(III)-meso-
tetrakis-para-carboxyphenylporphyrin 1-Mn, as well as its complex with xylanase 10A, the 1-Mn-Xln10A
artificial metalloenzyme, can be activated by visible light via a ruthenium chromophore. The resulting
oxidized form of these complexes was found to catalyze the chemoselective and slightly
enantioselective oxidation of thioanisole derivatives into the corresponding sulfoxides. The presence
of H218O in the reaction medium led to the insertion of 18O in the product, which confirmed the
role of water as the O-atom source in the reaction. Thus, our results clearly illustrate that oxidation
catalysis can be performed in aqueous medium, using no other oxygen atom source than water itself
and using visible light as the only energy input. A slight enantiomeric excess in favor of the R sulfoxide
could be obtained, which is likely to be related to protein polymerization and could be initiated by its
direct reaction with intermediate ruthenium or Mn-porphyrin active species outside the binding site.
A better strategy to limit those reactions, and then to increase the stereoselectivity of the reaction, could
consist of covalently attaching the Ru complex to the protein, in a place close the catalyst, in order to
minimize oxidation of the protein backbone, as it has already been realized in the case of cytochromes
P450 [12,13].
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Abstract: Benzoylformate decarboxylase (BFDC) and pyruvate decarboxylase (PDC) are
thiamin diphosphate-dependent enzymes that share some structural and mechanistic similarities.
Both enzymes catalyze the nonoxidative decarboxylation of 2-keto acids, yet differ considerably
in their substrate specificity. In particular, the BFDC from P. putida exhibits very limited
activity with pyruvate, whereas the PDCs from S. cerevisiae or from Z. mobilis show virtually no
activity with benzoylformate (phenylglyoxylate). Previously, saturation mutagenesis was used to
generate the BFDC T377L/A460Y variant, which exhibited a greater than 10,000-fold increase in
pyruvate/benzoylformate substrate utilization ratio compared to that of wtBFDC. Much of this change
could be attributed to an improvement in the Km value for pyruvate and, concomitantly, a decrease in
the kcat value for benzoylformate. However, the steady-state data did not provide any details about
changes in individual catalytic steps. To gain insight into the changes in conversion rates of pyruvate
and benzoylformate to acetaldehyde and benzaldehyde, respectively, by the BFDC T377L/A460Y
variant, reaction intermediates of both substrates were analyzed by NMR and microscopic rate
constants for the elementary catalytic steps were calculated. Herein we also report the high resolution
X-ray structure of the BFDC T377L/A460Y variant, which provides context for the observed changes
in substrate specificity.
Keywords: Thiamin diphosphate; X-ray crystallography; NMR spectroscopy; enzyme evolution
1. Introduction
The decarboxylases form the largest group of thiamin diphosphate (ThDP)-dependent enzymes [1].
The archetypal member of this group is pyruvate decarboxylase (PDC), which catalyzes the
nonoxidative decarboxylation of pyruvate to yield acetaldehyde and carbon dioxide, a reaction
critical to the fermentation pathway of several yeast and bacteria [2]. X-ray structures of PDCs from
a variety of species show that, in addition to ThDP, the active site contains two ionizable acidic
residues as well as two contiguous histidine residues that are located on an ordered loop [3–6].
The latter has been termed the HH-motif, and mutagenesis and kinetic studies have revealed that both
histidines play significant roles in catalysis [7–10]. X-ray structures of several other ThDP-dependent
decarboxylases reveal that, even though a variety of residues may line the substrate-binding pocket,
thereby explaining the observed differences in substrate specificity, most possess the HH-motif and
the two acidic residues [11–13].
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Benzoylformate decarboxylase (BFDC) is the penultimate enzyme in the mandelate pathway,
a secondary metabolic pathway that allows various pseudomonads to grow using R-mandelate as
their only source of carbon [14–16]. Also a ThDP-dependent enzyme, BFDC catalyzes the nonoxidative
decarboxylation of benzoylformate, generating benzaldehyde and carbon dioxide [14]. Given the
similarity of their reactions, and their using the same cofactor, it may have been expected that the
active sites of PDC and BFDC would be similar. However, this proved not to be the case, for the
active site of BFDC was found to contain two leucine residues occupying positions equivalent to the
HH-motif [17]. That said, the active site of BFDC does contain two histidine residues (His70 and
His281) and mutagenesis studies suggest that they too are catalytically important [18,19]. Another
difference was that the BFDC active site lacked the two acidic residues found in the HH-motif family.
Instead, BFDC’s only other ionizable residue is a serine, Ser26, which has also been implicated in the
catalytic mechanism [18].
Although their active sites and substrate preference may differ, the catalytic cycles of BFDC
and PDC can still be broken into the same series of steps (Scheme 1) [20]. The first two steps are
the deprotonation of the C2 carbon of ThDP to generate either an ylid [16,21,22] or a carbene [23],
followed by non-covalent binding of the 2-keto substrate to provide the Michaelis complex. Addition
of the C2 carbanion/carbene of ThDP to the carbonyl of the substrate gives rise to the first
covalent tetrahedral intermediate, which subsequently loses carbon dioxide resulting in the formation
of carbanion/enamine intermediate typical of all ThDP-dependent enzymes. In decarboxylases
such as BFDC and PDC, protonation of this enamine generates a second tetrahedral intermediate,
which finally breaks down, releasing the product aldehyde and regenerating ThDP.
Scheme 1. Mechanism of benzoylformate decarboxylase (BFDC) and pyruvate decarboxylase (PDC)
with intermediates and net rate constants.
Over the past few years, the steady-state distribution of the covalent intermediates has been used
to determine net rate constants for the elementary catalytic steps of several ThDP-dependent enzymes
including PDC [24] and BFDC [25]. For the former, decarboxylation and product release were found
to be partially rate-limiting, but formation of lactyl-ThDP (LThDP), the first covalent intermediate,
was quite rapid [24]. Conversely, the rate-limiting step for BFDC was found to be the formation
of the first covalent intermediate, mandelyl-ThDP (MThDP) [18,25]. Further, BFDC was found to
decarboxylate its first covalent adduct an order of magnitude faster than any other ThDP-dependent
enzyme studied to date [25].
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As with many ThDP-dependent decarboxylases, BFDC and PDC are both are capable of
stereoselective carboligation reactions leading to chiral α-hydroxy ketones [26]. These have been used
as versatile building blocks in the pharmaceutical (and other) industries [26–28]. As a consequence
there is considerable interest in expanding the capabilities of the decarboxylases to accept alternative
substrates. While both BFDC and PDC exhibit some substrate promiscuity neither enzyme is
particularly efficient at decarboxylating the other’s in vivo substrate [29]. Recently, as part of our
ongoing efforts to understand the evolution of substrate specificity in ThDP-dependent enzymes,
we used site-saturation mutagenesis in an attempt to convert a BFDC into a PDC [30]. The BFDC
T377L/A460Y variant was observed during screening to have greatly enhanced PDC activity.
Subsequently it was shown to have a 10,000-fold increase in its substrate utilization ratio between
pyruvate and benzoylformate compared to that of wtBFDC [30].
Here we describe our efforts to identify the reasons for that change in specificity. In the first
instance, we used NMR spectroscopy to analyze the intermediates obtained in the reaction of BFDC
T377L/A460Y with both benzoylformate and pyruvate. The microscopic rate constants were calculated
for the elementary catalytic steps in the reaction of both substrates. Further, in an attempt to understand
the structural basis for the altered substrate specificity exhibited by the T377L/A460Y variant, its high
resolution X-ray structure was determined.
2. Results and Discussion
2.1. Substrate Profile of T377L/A460Y
Our earlier study compared the reactions of wtBFDC, ScPDC and the T377L/A460Y variant only
with benzoylformate and pyruvate. Here the comparison was extended to include a variety of straight-
and branched-chain 2-keto acids, as well as phenylpyruvate (Table 1). The steady-state kinetic constants
for reaction of wtBFDC with pyruvate could only be determined under V/K conditions, i.e., at substrate
concentrations well below the Km value, which was estimated to be easily in excess of 100 mM [30].
By contrast the T377L/A460Y variant has a Km value for pyruvate of 4.6 mM, which is comparable
to the pyruvate S0.5 value for ScPDC. In addition to improving utilization of pyruvate, the double
variant was found to decarboxylate several other aliphatic 2-keto acids at a faster rate than wtBFDC.
While it was most efficient with 2-ketohexanoate and 4-methylthio-2-ketobutanoate as substrates,
there was only a 60-fold difference in kcat/Km values between the best substrate, 2-ketohexanoate,
and its least efficient substrate, pyruvate. In many ways pyruvate is still the exception as its Km value
was significantly higher than those of other aliphatic substrates. With regards to kcat, there is less than a
15-fold decrease between the substrate that is turned over the fastest, 3-methyl-2-ketopentanoate,
and the substrate that the T377L/A460Y variant decarboxylates the slowest, 2-ketopentanoate.
With the exception of benzoylformate, the T377L/A460Y variant was able to decarboxylate its
substrates more efficiently than wtBFDC. Similarly, only pyruvate and its longer chain analogues,
2-ketobutanoate and 2-ketopentanoate were better substrates for ScPDC.
Overall, the data in Table 1 clearly demonstrate that the T377L/A460Y variant is able to
decarboxylate a wide range of aliphatic substrates and, in most cases, more efficiently that either
wtBFDC or ScPDC. That said, it is also apparent that the ability of this variant to decarboxylate
either benzoylformate or pyruvate is considerably less than that of wtBFDC or ScPDC, respectively.
The similarity of substrate Km values suggests that substrate binding is not likely to be the issue,
rather the changes in active site geometry are having a significant effect on one or more of the
individual catalytic steps.
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2.2. Intermediate Distribution Analysis for Reaction of T377L/A460Y with Benzoylformate
To explore this possibility the microscopic rate constants for the BFDC T377L/A460Y variant were
determined for the decarboxylation of both benzoylformate and pyruvate. These have been determined
previously for the reaction of wtBFDC with benzoylformate [25]. In that study it was shown that
the rate-limiting step was the formation of MThDP by addition of the ThDP ylid to benzoylformate,
and that BFDC carried out its decarboxylation step at least two orders of magnitude faster than any
other ThDP-dependent enzyme [25].
All three major intermediates, unreacted ThDP, MThDP, and 2-hydroxybenzyl-ThDP (HBzThDP),
can be detected at steady-state when T377L/A460Y reacts with benzoylformate (Figure 1).
While the MThDP signal is close to the limits of resolution, it is clearly visible. Following correction for
non-enzymatic decarboxylation of MThDP [25] analysis reveals that ~37% of the active sites contain
C2-unsubstituted ThDP and 3% contain MThDP. The remaining 60% are occupied by HBzThDP.
This is distinctly different to the result obtained with wtBFDC where a similar analysis provided values
of 79%, 3% and 18% for ThDP, MThDP and HBzThDP, respectively [25]. A comparison of the derived
kinetic constants for wtBFDC and T377L/A460Y can be seen in Table 2. In wtBFDC addition of the
ThDP ylid to benzoylformate (i.e., C–C formation, k2′) is clearly rate limiting. Conversely, protonation
of the enamine/elimination of benzaldehyde (k4′) has been reduced ~100-fold in the T377L/A460Y
variant and has now become rate limiting. It is notable that for both variants decarboxylation of
MThDP (k3′) is significantly faster than other steps in the reaction (Table 2). Further, even though the
rate for T377L/A460Y has decreased considerably compared to that of the wild-type enzyme it is still
faster than decarboxylation of LThDP by pyruvate-utilizing enzymes [20,31,32].
Figure 1. The 2′-CH3 and 4-CH3 singlet signals of thiamin diphosphate (ThDP) and of
benzoylformate-conjugated covalent intermediates were used for the assignment and quantitative
analysis of the following intermediates: ThDP (2.64 and 2.57 ppm), mandelyl-ThDP (MThDP) (2.48 and
2.41 ppm), and 2-hydroxybenzyl-ThDP (HBzThDP) (2.45 and 2.40 ppm). Intermediates and cofactor
were isolated from the protein by acid quench after a reaction time of 1 s and analyzed by 1H NMR at
pH 0.75 at 25 ◦C as described in Materials and Methods. Relative concentrations of intermediates were
determined from the relative integrals of the corresponding signals, which were used to calculate all
microscopic rate constants of the catalytic cycle.
2.3. Intermediate Distribution Analysis for Reaction of T377L/A460Y with Pyruvate
The microscopic rate constants for reaction of wtBFDC with pyruvate could not be determined as
only trace amounts of the reaction intermediates were observable at steady-state using the NMR-based
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approach. This is not surprising as activity of wtBFDC with pyruvate could only be measured under
V/K conditions [30]. The lack of any observable reaction intermediates, coupled with a pyruvate Km
value in excess of 100 mM, indicates that the rate-limiting step is the initial formation of the Michaelis
complex and/or the subsequent C–C bond formation (k2′) that provides LThDP.
For T377LA460Y the steady-state distribution of intermediates showed that, when pyruvate
is used as substrate (Figure 2), all the key catalytic intermediates are present: ThDP, 2-lactyl-ThDP
(LThDP) and 2-hydroxyethyl-ThDP (HEThDP). This finding indicates that all major steps of catalysis
are on the same time scale. In addition to those anticipated intermediates, a minor fraction of






1H Chemical shift (ppm)
Figure 2. The C6′-H singlet signals of ThDP (thiamin diphosphate) and of pyruvate-conjugated covalent
intermediates were used for the assignment and quantitative analysis of the following intermediates:
ThDP (8.01 ppm), LThDP (lactyl-ThDP) (7.27 ppm), HEThDP (2-hydroxyethyl-ThDP) (7.34 ppm) and
ALThDP (2-acetolactate-ThDP) (7.30 ppm). Intermediates and cofactor were isolated by acid quench
after a reaction time of 8 s and analyzed by 1H NMR at pH 0.75 at 25 ◦C as described in Materials and
Methods. Relative concentrations of intermediates were determined from the relative integrals of the
corresponding signals, which were used to calculate all microscopic rate constants of the catalytic cycle.
Table 2. Net rate constants (s−1) for reaction of BFDC and PDC variants with benzoylformate
and pyruvate.





BF 450 500 16,000 2400
Pyruvate <0.05 b NDc ND c ND c
BFDC T377L/A460Y
BF 15 40 500 24
Pyruvate 3.3 6 24 10
ScPDC d Pyruvate 38 294 105 105
ZmPDC e Pyruvate 150 2650 397 265
a Values for wtBFDC with BF were obtained from Bruning et al. [25]; b Value for wtBFDC with pyruvate was
obtained from Yep and McLeish [30]; c Not determined; d Values for ScPDC were obtained from Joseph et al. [33];
e Values for ZmPDC were obtained from Tittmann et al. [24].
ALThDP arises during an off-pathway reaction in which a second molecule of pyruvate acts as
the electron acceptor for the post decarboxylation carbanion intermediate. ALThDP has previously
been observed during the determination of the microscopic rate constants for acetohydroxyacid acid
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synthase [34–36]. The presence of ALThDP during the reaction cycle of the BFDC T377L/A460Y
variant suggests that the reaction may generate acetolactate. However, the only carboligation product
detected was acetoin. While this seems at odds with the presence of ALThDP, Beigi et al. [37] recently
described an α-hydroxy-β-keto acid rearrangement-decarboxylation reaction in which acetolactate
spontaneously decarboxylates to yield acetoin. Currently, it is unclear if ALThDP decarboxylates to
yield acetoin or if the decarboxylation of acetolactate occurs after it is released. Regardless, it would
seem that the longer lifetime of the pyruvate-derived carbanion/enamine results in an increase in
formation of a carboligation product.
If this off-pathway reaction is ignored, then the calculation of the forward net rate constants is
possible. These are provided in Table 2. Examination of those rate constants shows that C–C bond
formation (k2′) is the slowest step in the reaction of BFDC T377L/A460Y with pyruvate. Further,
while the variant is clearly more efficient in binding pyruvate, the rate constant for the formation of the
LThDP (6 s−1) is still 50- to 400-fold lower than those of the true PDCs. By comparison, decarboxylation
of the LThDP intermediate (k3′) is ca. four-fold faster, and the subsequent steps involving enamine
protonation/product release (k4′) are, at best, partially rate-limiting. These results are in sharp contrast
with those found in previous studies with ZmPDC [24] and ScPDC [33] where formation of LThDP
was the fast step and both decarboxylation and product release were appreciably slower (Table 2).
That said, it is not without precedent, as initial C–C bond formation (k2′) is the slow step in the reaction
of acetohydroxyacid synthase (AHAS) with pyruvate [32]. Finally, it is notable that decarboxylation of
LThDP catalyzed by BFDC T377L/A460Y is the fast step in the overall process, and only approximately
four-fold slower when compared to ScPDC. It seems that, even with a relatively poor substrate,
the active site of BFDC seems to favor decarboxylation over the other reaction steps.
2.4. X-ray Structure of BFDC T377L/A460Y
In an attempt to understand how the BFDC T377L/A460Y variant resulted in a better binding site
for pyruvate and, potentially, to explain the decrease in the rate of decarboxylation of benzoylformate,
the X-ray structure for T377L/A460Y was determined. The structure was solved to a resolution
of 1.56 Å and the coordinates have been deposited with the Protein Data Bank as PDB ID 4MZX.
The refinement statistics are provided in Table 3.
The overall fold was found to be almost identical to that of wtBFDC holoenzyme, and both
the space group and cell dimensions were also the same. There was a RMSD deviation of 0.28 Å
between the BFDC T377L/A460Y variant and wtBFDC enzyme for the Cα atoms of a single monomer.
As previously observed with BFDC structures, the region comprising residues 461–470 had the highest
B-factors found in the protein.
During the initial rounds of refinement, positive electron density adjacent to the C2 atom of the
thiazolium ring was observed when ThDP was modeled into the active site. This was indicative of the
oxidation of ThDP to thiamin thiazolone diphosphate (TZD). Consequently TZD was modeled into the
active site during subsequent rounds of refinement. This oxidation of ThDP to TZD has been observed
previously in BFDC, as well as other ThDP-dependent enzymes, and has been attributed to radiation
damage [38,39]. As seen in several earlier BFDC structures, the diphosphate tail of TZD is coordinated
to Ca2+, rather than Mg2+. Presumably due to its high concentrations in the crystallization buffer,
Mg2+ is often displaced by Ca2+ during the crystallization of BFDC [17,38]. In addition to the cofactors,
electron density indicative of two glycerol molecules was also observed in the asymmetric unit.
One glycerol was H-bonded to the side chains of Arg294 and Asp312, while the second was coordinated
to the oxygen atoms of the backbone carbonyl of Asp477 and the side chain of Gln443. Finally,
a sodium ion was found coordinated between the main chain carbonyl oxygens of Leu118, Arg120,
and Asn117 from two separate monomers at the dimer–dimer interface. The BFDC T377L/A460Y
structure retained the backbone conformation of the wtBFDC enzyme at the points of the mutations,
but, not surprisingly, additional electron density was seen in the difference maps. This density
corresponded to leucine and tyrosine residues at positions 377 and 460, respectively.
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Comparison of the active sites of the wtBFDC and the T377L/A460Y variant showed that the
side chain of His281 is displaced by more than 1 Å compared to the wtBFDC holoenzyme (Figure 3).
The only other notable change was Leu110 being found in two rotamer conformations, one of which
had not previously been observed in BFDC or its variants [17,18,25,38,40,41]. The net result was that
the active site was reduced in volume by ~20%.
Table 3. Data, model, and crystallographic statistics for BFDC T377L/A460Y structure a.
Data Collection Statistics BFDC T377L/A460Y (PDB 4MZX)
Beam line APS, GM/CA-CAT, 23 ID-B
Wavelength 1.03 Å
Space group I222
Cell constants a = 80.98 Å; b = 95.56 Å; c = 137.2 Å; α = β = γ = 90◦
Total reflections 75885
Unique reflections 75885
Resolution limit (Å) 1.56
Completeness (%) 99.8 (100)
Redundancy 7.3 (7.2)
I/σI 27.5 (7.3)
Rmerge (%) 5.8 (29)
Refinement statistics
Resolution range (Å) 1.56–19.71

















Bond lengths (Å) 0.017
Bond angles (◦) 1.50
a Value in parentheses are for the highest-resolution shell.
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Figure 3. Superposition of the active sites of wtBFDC (yellow) and the BFDC T377L/A460Y variant
(cyan) reveals a shift in the position of His281 accompanied by multiple conformations of Leu110.
In addition, ThDP was oxidized to thiamin thiazolone diphosphate (TZD). Figure prepared using
PyMOL (Schrödinger, Inc., Portland, OR USA) using data from PDB ID 1BFD (wtBFDC) and 4MZX
(BFDC T377L/A460Y).
The data in Table 1 show that the Km value of wtBFDC for pyruvate was in excess of 100 mM,
and for the T377L/A460Y variant, the Km value was reduced to <5 mM. Clearly the latter must have a
binding site much better able to accommodate pyruvate. To see how this was achieved we compared
the binding of the LTHDP to PDC and to BFDC T377L/A460Y. Previously, the ZmPDC E473D structure
in complex with LThDP was solved [42]. In this structure the methyl substituent of the lactyl moiety is
within 5 Å of 11 atoms evenly distributed across seven different residues.
Superimposition of the LThDP intermediate on ThDP in the active site of wtBFDC revealed
only three atoms within 5 Å of the methyl group (Figure 4A). By contrast, superimposition of
LThDP on TZD in the T377L/A460Y structure (Figure 4B) shows that this variant now has 10 atoms
contributing to the methyl-binding site. Thus the active site has become more like that of ZmPDC.
There were some differences for, unlike the evenly distributed interactions which make up the ZmPDC
methyl-binding pocket, 7 of the 10 potential interactions in the BFDC T377L/A460Y variant arise from
the engineered residues, Leu377 and Tyr460. This suggests that changes in other active site residues
may be able to further improve pyruvate binding and, potentially, in positioning the “new” substrate
for decarboxylation and subsequent steps.
While this relatively simplistic modeling of LThDP offers an explanation for how the active site of
the T377L/A460Y variant has improved pyruvate binding, there are still several issues to be addressed.
For example, while the active site volume has been reduced by 20% from wtBFDC, the Km value for
benzoylformate is only increased by a factor of two. Indeed, at 0.45 mM, it remains 10-fold lower than
that of pyruvate (Table 2). To understand how this could be achieved, the tetrahedral intermediate
from the reaction of wtBFDC with methyl benzoylphosphonate (MBP) [41] was superimposed on
the TZD in the active site of T377L/A460Y. The MBP-ThDP intermediate is an analogue of MThDP,
thus can be used to get an indication of potential changes in benzoylformate binding.
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Figure 4. (A) wtBFDC (PDB: 1BFD) with LThDP (gray) placed into the active site by superposition of
the LThDP on the corresponding atoms of ThDP. In total, three atoms are within 5 Å of the methyl
group of LThDP; (B) BFDC T377L/A460Y PDB 4MZX) with LThDP (gray) superimposed on TZD.
In total 10 atoms, from four residues, are within 5 Å of the methyl group of LThDP. In both
structures blue lines indicate distances of <5 Å. Figure prepared using PyMOL with LThDP data from
PDB ID 3OE1 [42].
This simple model indicates a potentially severe steric clash between the phenyl group of the
inhibitor and the engineered mutations (Figure 5). The γ-methyl of Leu377 is within <2.5 Å of several
carbon atoms of the phenyl ring of MBP, whereas Tyr460 has a potential edge-to-edge contact with
MBP that is also within <2.5 Å. While this appears to be at odds with the kinetic data indicating only
a modest effect on Km value for benzoylformate, there is structural evidence that wtBFDC is able to
accommodate unnaturally large substrates by slight rotations of active site residues [43]. Therefore it is
not unreasonable to suggest that the side chains of Tyr460 and Leu377 could rotate to avoid or, at least,
ameliorate unfavorable interactions with the MThDP. Equally plausible is that the phenyl group of the
MThDP could rotate to prevent steric clash with these residues. Either scenario provides a rationale
for the binding of benzoylformate being relatively unaffected.
Figure 5. BFDC T377L/A460Y with MBP-ThDP (black) placed into the active site. Red lines indicate
distances of <2.5 Å. Superposition carried out with PyMOL as described in Materials and Methods
using MBP-THDP data from PDB ID 3FSJ [41]
Figure 5 may also provide a partial explanation for the reduction in net rate constants for the
decarboxylation of benzoylformate (Table 2). It is clear that some active site rearrangements will be
necessary to avoid potential steric clashes and permit substrate binding. Conceivably, these may make
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it more difficult for the ThDP ylid to attack the carbonyl of benzoylformate, thereby explaining the
observed 12-fold decrease in the rate of formation of the MThDP intermediate (k2′).
Figure 3 shows that the mutations have caused modest, but potentially significant changes
in the orientation of Leu110 and His281. Together these changes provide some insight into the
considerable decrease in the observed rate for the decarboxylation of the MThDP intermediate (k3′),
as well as the release of benzaldehyde (Scheme 1). While its precise role in catalysis is not obvious,
mutagenesis and crystallographic data suggest that Leu110 plays a vital role in the mechanism of
BFDC. The L110A mutation results in greater than four-orders of magnitude decrease in kcat/Km,
due to a simultaneous increase in Km and decrease in kcat values [44]. Analysis of the structure of
wtBFDC in complex with MBP indicates that Leu110 may be responsible for positioning the glyoxylate
moiety of benzoylformate [25,41]. In the T377L/A460Y variant, Leu110 adopts multiple conformations
potentially reducing its ability to lock the glyoxylate moiety into the perpendicular arrangement of the
carboxylate group to the thiazolium-C2α bond. This geometry is thought to promote decarboxylation
by allowing maximum overlap of π electrons of the thiazolium ring and the p-orbital of the scissile
bond [25,45]. The conformation has been observed in the X-ray structures of all the first tetrahedral
intermediates, and intermediate analogues [25,42,46–48]. Further, Ser26 has been proposed to assist in
the decarboxylation step by carrying out a nucleophilic attack on carboxylate group of MThDP [40].
In wtBFDC, not only does the perpendicular arrangement assure maximum orbital overlay, but also
it positions the hydroxyl group of Ser26 within striking distance of the carboxylate group. Taken
together, the alternative conformations of Leu110 observed may help explain the decrease in the rate
of MThDP decarboxylation (k3′).
The net rate constant associated with product release (k4′) incorporates the protonation of the
enamine/carbanion intermediate, as well as the breakdown of the resultant tetrahedral intermediate
and subsequent release of benzaldehyde. The T377L/A460Y variant exhibits a 100-fold decrease in k4',
i.e., the largest decrease of all net rate constants. Mutagenesis studies suggest that His281 is involved in
the protonation of the enamine/carbanion intermediate [18], whereas His70 has been implicated in the
abstraction of the proton from the HBzThDP intermediate, thereby facilitating product release [18,19].
Since these two steps of the mechanism are incorporated into this single net rate constant, it is difficult
to say which step has been more affected in the T377L/A460Y variant. The X-ray structure shows that
the position of His70 is largely unaffected by the mutations but that there is a 1 Å displacement of the
imidazole ring of His281 (Figure 3). It is conceivable that this change could reduce proton transfer
efficiency, resulting in an increase in the lifetime of the carbanion/enamine. It is well known that the
BFDC H281A variant has been associated with an improvement in carboligation efficiency [49–51],
which was attributed to the longer lifetime of the enamine. It is also notable that an increase in
the lifetime of the carbanion/enamine in ZmPDC gave rise to formation of acetoin/acetolactate [52].
Given that the 1H NMR spectrum of the intermediates in the reaction of T377L/A460Y with pyruvate
(Figure 2) showed the presence of 2-acetolactate-ThDP, it is reasonable to speculate that displacement
of His281 is contributing to the decrease in k4'. That said, there is a clear increase in the steady-state
concentration of HBzThDP, which certainly indicates that its breakdown and product release—i.e., k5'
(Scheme 1)—also must be greatly reduced.
3. Materials and Methods
3.1. Materials
Plasmids containing genes for recombinant alcohol dehydrogenase from Equus caballus (HLADH)
and C-terminally His6-tagged pyruvate decarboxylase from Saccharomyces cerevisiae were kind gifts
from Bryce Plapp (University of Iowa) and Frank Jordan (Rutgers University), respectively. NADH,
IPTG, yeast alcohol dehydrogenase (YADH), and the various 2-keto acids were purchased from
Sigma-Aldrich (St Louis, MO, USA). Other assay reagents were purchased from either Sigma-Aldrich
or Fisher Scientific (Waltham, MA, USA) and were of the highest commercially available grade.
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3.2. Protein Expression and Purification
Expression and purification of wtBFDC and the BFDC T377L/A460Y variant was carried out as
described in Yep et al. [30]. The protein was exchanged into storage buffer (100 mM KPO4, 1 mM
MgSO4, 0.5 mM ThDP, pH 6.0, 10% glycerol v/v), and concentrated using EMD Millipore Amicon Ultra
filters (Fisher Scientific). Expression and purification of ScPDC was carried out in a similar manner.
In all cases purity was assessed by SDS-PAGE, and the protein concentration was determined by the
Bradford method [53] using BSA as the standard.
3.3. Analysis of Substrate Spectrum
The activity assays with the purified enzymes have been described in detail elsewhere [30].
The assay contained the appropriate 2-keto acid substrate, NADH, and HLADH (YADH for short
straight-chain aliphatic substrates) in 100 mM potassium phosphate buffer (pH 6.0) with a final volume
of 1 mL. The reaction was carried out at 30 oC and was initiated by the addition of the enzyme. Kinetic
data were fitted to the Michaelis-Menten equation using SigmaPlot 9.0.1.
3.4. Steady State Analysis of Reaction Intermediates by Acid Quench/NMR Spectroscopy
Prior to the chemical quench/NMR studies, excess ThDP was removed from the BFDC
T377L/A460Y sample by dialysis overnight against 50 mM potassium phosphate buffer, pH 6.5,
supplemented with 2.5 mM MgSO4. Enzyme concentrations were adjusted to 15 mg/mL and reacted
with one equivalent volume of either 50 mM benzoylformate or 100 mM pyruvate prepared in the
same buffer as the enzyme. After 1–10 seconds the reaction was quenched by manual mixing with the
addition of 1 volume of an acidic solution comprising 65% (v/v) D2O, 25% (v/v) of trichloroacetic acid
and 10% (v/v) concentrated HCl [24,25]. Samples were vortexed to facilitate complete quenching and
protein denaturation. Samples were then centrifuged and the supernatant passed through a 0.22 μm
filter. The filtrate, containing the intermediates, substrates and products, was analyzed by 1H NMR
spectroscopy. NMR data collection, assignment of peaks, and calculation of net forward unimolecular
rate constants was performed as previously described [24,25].
3.5. Crystallization of BFDC T377L/A460Y
Crystals of the BFDC T377L/A460Y variant were grown by the hanging drop diffusion method
under the conditions used for the crystallization of wtBFDC [17]. Storage buffer was exchanged for
crystallization buffer (0.1 mM MgCl2, 0.2 mM ThDP, 25 mM NaHEPES pH 7.0). The well solution
consisted of 0.1 M Tris (pH 8.5), 0.15 M CaCl2 and 22% PEG 400 (v/v). Equal volumes of protein
solution (10 mg/mL) and well solution were pipetted onto a silanized glass slide and mixed. A heavy
precipitate quickly formed and single crystals emerged from the precipitate within days. Crystals
were transferred to fresh crystallization buffer containing 36% glycerol (v/v) as a cryoprotectant and
mounted on Hampton CryoLoops immediately prior to being flash-frozen in liquid nitrogen.
3.6. X-ray Data Collection
Diffraction experiments were carried out at 100 K on the 23-ID-B beamline administered by
GM/CA-CAT at the Advanced Photon Source at Argonne National Laboratory. Datasets for the
BFDC T377L/A460Y variant were scaled to the I222 space group. Data reduction and processing of
dataset was done with HKL2000 software package and the CCP4 suite of programs [54]. Molecular
replacement was performed using the search model wtBFDC (PDB 1BFD) with metals and waters
removed. The asymmetric unit for each variant contained a single monomer.
3.7. Structure Solutions and Refinements
Refinement was performed using Phenix.refine [55]. After each round of refinement, the
electron density was manually inspected and models were built using Coot [56]. Model refinement
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continued until the free R factor and the crystallographic R factor had converged. Validity of the
model was checked using the Molprobity server [57,58]. All images were generated with PyMOL
(Schrödinger Inc.).
3.8. Modeling of Reaction Analogues and Intermediates
Using PyMOL and the coordinates from PDB ID 3OE1, the lactyl-ThDP intermediate was placed
into the active sites of both wtBFDC (PDB ID: 1BFD) and the T377L/A460Y structure. Further, using
the coordinates from PDB ID 3FZN, the phosphonomandelyl-ThDP (MBP-ThDP) was also placed
into the active site of the T377L/A460Y structure. In this process, the Cα atoms of the protein
structures were first superimposed. Next, the atoms corresponding to the ThDP moiety of lactyl-ThDP
and MBP-ThDP were aligned with the corresponding atoms of either ThDP, found in wtBFDC,
or the thiamin thiazolone diphosphate (TZD) found in the BFDC T377L/A460Y structure. No energy
minimization was carried out.
4. Conclusions
The BFDC variant T377L/A460Y effectively acts as a “pseudo” PDC. This is reflected in a
broad substrate spectrum more akin to that of ScPDC than wtBFDC. NMR-based analysis of the
steady-state reaction intermediates for the reaction of BFDC T377L/A460Y with pyruvate revealed
that the rate-limiting step for this variant is the formation of the LThDP intermediate. This is in
contrast to the reactions catalyzed by ZmPDC and ScPDC, where product release is rate-limiting.
Comparing the methyl-binding pocket of T377L/A460Y to ZmPDC suggests that both are likely to
have a similar number of interactions with the lactyl moiety. However, the contacts within the ZmPDC
methyl-binding pocket are evenly distributed across seven residues compared to only four residues
in T377L/A460Y. Further, the seven residues of ZmPDC are arranged to surround the methyl group
thereby providing steric restraints from every direction. Presumably this arrangement would also
allow for the maximum orbital overlap, thereby permitting attack of the ThDP ylid and facilititating
the subsequent decarboxylation of the LThDP intermediate. On the other hand, the four residues
comprising the T377L/A460Y methyl binding pocket are unevenly arranged and do not provide the
precise substrate positioning seen in a native PDC. This likely accounts for the higher Km value for
pyruvate, and the lower rate of formation of LThDP observed with the BFDC variant. Given that
several aliphatic 2-keto acids are better substrates than pyruvate for T377L/A460Y, it is reasonable to
predict that further evolution could well bring the properties of the “pseudo” PDC significantly closer
to those of the native enzyme.
Over the years there have been many attempts to interconvert or otherwise alter substrate
specificity in ThDP-dependent enzymes. This has been met with a resounding lack of success [1].
The results here provide some rationale for the difficulty. They highlight the fact that, in spite of the
similarity in overall mechanism, ThDP-dependent enzymes often have different rate-determining
steps. This means that the enzymes have evolved so that individual residues will provide an optimal
alignment for (effectively) several substrates (intermediates) in the catalytic cycle. Thus, making a
change that may be expected to improve binding for a new substrate may have a deleterious effect
on another step in the mechanism. In the BFDC T377L/A460Y variant, for example, not only do we
see a new ability to catalyze pyruvate decarboxylation, but it is done without greatly affecting its
ability to bind benzoylformate. Rather, the decrease in kcat value for reaction with benzoylformate is
due primarily to a change in rate-determining step. This result implies that structure-based redesign
of ThDP-dependent enzymes will prove difficult. Rather, a more random approach will be required,
probably involving saturation mutagenesis at a combination of sites identified on the basis of X-ray
structures or homology models.
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Abstract: The microbial production of D-lysine has been of great interest as a medicinal raw
material. Here, a two-step process for D-lysine production from L-lysine by the successive microbial
racemization and asymmetric degradation with lysine racemase and decarboxylase was developed.
The whole-cell activities of engineered Escherichia coli expressing racemases from the strains
Proteus mirabilis (LYR) and Lactobacillus paracasei (AAR) were first investigated comparatively.
When the strain BL21-LYR with higher racemization activity was employed, L-lysine was rapidly
racemized to give DL-lysine, and the D-lysine yield was approximately 48% after 0.5 h. Next, L-lysine
was selectively catabolized to generate cadaverine by lysine decarboxylase. The comparative
analysis of the decarboxylation activities of resting whole cells, permeabilized cells, and crude
enzyme revealed that the crude enzyme was the best biocatalyst for enantiopure D-lysine production.
The reaction temperature, pH, metal ion additive, and pyridoxal 5′-phosphate content of this two-step
production process were subsequently optimized. Under optimal conditions, 750.7 mmol/L D-lysine
was finally obtained from 1710 mmol/L L-lysine after 1 h of racemization reaction and 0.5 h of
decarboxylation reaction. D-lysine yield could reach 48.8% with enantiomeric excess (ee) ≥ 99%.
Keywords: D-lysine; racemase; decarboxylase; two-enzyme cascade system
1. Introduction
D-Amino acids are being used increasingly used as a starting raw material in the production
of valuable pharmaceuticals [1]. Among them, D-lysine has been employed for the synthesis of
luteinizing-hormone-releasing hormone analog, or as a drug carrier in the form of polylysine [2,3].
Nowadays, several chemical or biochemical synthesis methods for D-lysine synthesis have been
described [3]. In a previous study, D-lysine was successfully prepared from L-lysine by chemical
racemization and microbial asymmetric degradation [4]. However, the chemical racemization of amino
acids to prepare DL-amino acids is a complex process and requires severe reaction conditions, such
as high temperature, strong acid, or alkali [3,4]. Meanwhile, the chemical resolution of DL-amino
acids is inefficient with low optical purity of products, and requires expensive chiral resolving agent.
Therefore, an efficient bio-based process for the commercial production of D-lysine is highly desirable.
The enzymatic synthesis of D-amino acids can be performed by hydrolases, or D-amino acid
aminotransferases with synthetic intermediates and prochiral substrates as starting materials [5].
Currently, industry has an overcapacity for L-lysine with an annual production of more than
2 million tons [6]. We therefore focused on the use of L-lysine as a raw material for D-lysine
production. Considering the current preparation process, a two-step reaction containing racemization
and asymmetric degradation of L-lysine was regarded as a simple and economical process to
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synthesize D-lysine effectively (Figure 1). In the first step, amino acid racemase was employed
to catalyze racemization of L-lysine to DL-lysine. Amino acid racemases, which are widely prevalent in
many living organisms, are divided into two groups: pyridoxal 5′-phosphate (PLP)-dependent and
PLP-independent enzymes [7]. However, lysine racemase, one of the PLP-dependent enzymes, has
only been described in a small number of bacteria, such as Proteus mirabilis [8] and Oenococcus oeni [9].
The heterologous expression of lysine racemase for large-scale production of DL-lysine has rarely
been reported.
Figure 1. Scheme of enantiopure D-lysine production catalyzed by a two-enzyme cascade system
of lysine racemase and lysine decarboxylase. The two enzymes were expressed in Escherichia coli
(E. coli) respectively.
In order to obtain enantiopure D-lysine, chiral-selective degradation of L-lysine from the reaction
mixture of DL-lysine is necessary. In previous reports, when DL-amino acids were employed as
starting materials, D-amino acids, such as D-glutamate, D-arginine, or D-homoserine, have been
synthesized by N-acyl-D-amino acid amidohydrolase, L-amino acid oxidase, or D-succinylase [10–12].
However, the related enzymes that are active with lysine were only found in few microorganisms, and
their catalytic efficiency was too low to meet the demand of the high optical purity of D-lysine [13,14].
Therefore, it was vital to develop an efficient process that degraded L-lysine stereoselectively in the
DL-lysine mixture to prepare the enantiopure D-lysine.
In our study, the two racemases from Proteus mirabilis (P. mirabilis) and Lactobacillus paracasei
(L. paracasei), which have been reported to be active with L-lysine, were heterologously expressed
in Escherichia coli (E. coli), and their activities to generate DL-lysine from L-lysine were compared.
Subsequently, L-lysine was selectively catabolized to cadaverine by lysine decarboxylase, and the
activities of resting whole cells, permeabilized cells, and crude enzyme were compared to identify the
best biocatalyst for enantiopure D-lysine production. After defining the optimal conditions, an efficient
bioconversion system for D-lysine production from L-lysine was described by racemization and
asymmetric degradation with lysine racemase and decarboxylase, as shown in Figure 1.
2. Results
2.1. Construction of a Highly Efficient E. coli Whole-Cell Biocatalyst for DL-Lysine Production
In this study, amino racemases from P. mirabilis BCRC10725 (LYR) and L. paracasei (AAR), which
have been reported capable of racemizing L-lysine to D-lysine, were selected [8,15]. The recombinant
E. coli BL21 (DE3) harboring plasmid pET-28a-LYR or pET-28a-AAR was induced with IPTG (Figure 2a).
The recombinant racemase expression was confirmed by SDS-PAGE analysis. It was found that protein
LYR (45 kDa) and protein AAR (43 kDa) were all expressed in E. coli (Figure 2b), whose molecular
weight was consistent with the prediction by gene sequencing. However, protein AAR was found to be
highly insoluble in E. coli. Next, the specific activities of the two recombinant strains were compared.
As shown in Figure 2c, the whole-cell BL21-LYR exhibited higher catalytic conversion activity of
L-lysine to product D-lysine than BL21-AAR.
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Figure 2. Comparison of specific activities of the whole cell BL21-LYR and BL21-AAR. (a) The racemases
from Proteus mirabilis BCRC10725 (lysine racemase, LYR) and Lactobacillus casei (amino acid racemase,
AAR) were cloned into plasmid pET-28a to generate plasmid pET-28a-LYR and pET-28a-AAR and
transformed into E. coli BL21 (DE3) respectively; (b) Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) of cell extracts of E. coli BL21-LYR and BL21-AAR grown in Luria–Bertani
(LB) medium at 30 ◦C. Equal amounts (20 μg) of protein were applied to each lane. Vertical lanes are
labeled by M (protein size marker), C.E. (crude extract), or Pe. (pellet); (c) The specific activities of the
whole cell BL21-LYR and BL21-AAR.
2.2. A Two-Step Process for Enantiopure D-Lysine Preparation
Using the whole-cell biocatalyst BL21-LYR, L-lysine was transformed to DL-lysine.
Subsequently, to prepare the enantiopure D-lysine, it was necessary to selectively degrade L-lysine to a
compound that could be easily separated from D-lysine. In our research, the recombinant E. coli ATS3,
which has been engineered for the efficient bioconversion of lysine to cadaverine [16], was employed
for the asymmetric degradation of L-lysine to cadaverine. As shown in Figure 3, L-lysine was rapidly
racemized to generate DL-lysine with a D-lysine yield of 48% at 0.5 h. Next, whole cells of E. coli ATS3
(5.0 of OD600) were added into the reaction mixture. Within 0.5 h, 85.3% of L-lysine (215 mmol/L)
could be converted to cadaverine. However, 14.7% of L-lysine still remained in the reaction solution
after 3 h. The enantiomeric excess of D-lysine was only 83%.
To improve the purity, we developed two other processes that permeabilized cells, and crude
extracts of the strain ATS3 were used as the biocatalysts to compare their effects on D-lysine
enantiomeric excess (Figure 3). Whole cells of AST3 (5.0 of OD600) were treated with 0.5% Triton
X-100 to obtain permeabilized cells, while the crude enzyme was prepared by sonic disruption.
The permeabilized cells were found to exhibit higher activities than whole cells, and the enantiomeric
excess of D-lysine reached 92.2% (Figure 3). Then, 0.2 g/L crude enzyme, which was equal to the protein
amount in 5.0 of OD600 of whole cells, was used to perform the asymmetric degradation experiment.
As shown in Figure 3, L-lysine could be completely degraded after 0.5 h, and the enantiomeric excess of
D-lysine reached 99.9% with a yield of 46.5%. The decarboxylation reactions were all performed with
the addition of 1 mM PLP. Our results demonstrated that the crude enzyme was the best biocatalyst
for enantiopure D-lysine production.
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Figure 3. Comparison of the decarboxylation activities of resting whole cells, permeabilized cells,
and cell extracts of E. coli AST3 expressing lysine decarboxylase. The whole-cell BL21-LYR was first
employed to racemizing L-lysine to generate DL-lysine. Subsequently, L-lysine in the DL-lysine mixture
was degraded by the biocatalysts of E. coli ATS3.
2.3. Optimization of Reaction Conditions for the Two-Step D-Lysine Production Process
2.3.1. Characterization of the Whole-Cell BL21-LYR
To improve the catalytic efficiency of the whole-cell BL21-LYR, it was essential to characterize
the effect of the biocatalytic conditions on LYR activity. When the reaction pH ranged from 4.0 to 7.0,
it was found that the LYR activity clearly increased with a rise in reaction pH, and reached a maximum
at pH 7.0 (Figure 4a). At pH values over 7.0, the LYR activity decreased considerably. To determine
the optimal reaction temperature, the bioconversion was carried out at 20, 25, 30, 37, 40, or 45 ◦C for
10 min. The optimum enzyme activity was exhibited at 37 ◦C (Figure 4b). Moreover, the addition
of metal ions including Ca2+, Co2+, Fe2+, Fe3+, K+, Ni2+, Mg2+, Mn2+, Cu2+, and Zn2+ (1 mM) had
no significant effect on LYR activity (Figure 4c). It has been reported that LYR is a PLP-dependent
enzyme [17], and so the effect of PLP concentration was also examined. Our results showed that the
addition of PLP could not further improve the specific activity of the whole-cell BL21-LYR (Figure 4d).
Figure 4. Characterization of the recombinant whole-cell BL21-LYR. (a) Optimal pH of the recombinant
BL21-LYR; (b) optimal temperature of the recombinant BL21-LYR; (c) metal ion preference of the
recombinant BL21-LYR; (d) the effect of PLP on the activity of the whole-cell BL21-LYR. Data are
mean ± SD for three replicates.
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2.3.2. Characterization of the Recombinant Lysine Decarboxylase
The activity of the whole-cell ATS3 containing lysine decarboxylase has been characterized in
a previous study [15]. Here, the effects of pH, temperature, metal ion additive, and PLP content on
the crude enzyme of ATS3 were investigated. As shown in Figure 5a, the highest specific activity of
lysine decarboxylase occurred at pH 6.0, similar to the lysine decarboxylase from E. coli MG1655 [18].
We found that lysine decarboxylase was sensitive to pH variance. From pH 5.0 to 7.0, more than 83%
of the maximum activity could be retained (Figure 5a). However, enzyme stability decreased rapidly
when pH was higher than 7.0. The specific activity sharply decreased to 8.0 U/mg at pH 7.5 (Figure 5a).
Figure 5. Characterization of the recombinant lysine decarboxylase. (a) Optimal pH of the recombinant
lysine decarboxylase; (b) optimal temperature of the recombinant lysine decarboxylase; (c) metal
ion preference of the recombinant decarboxylase; (d) optimization of the concentration of Fe2+;
(e) optimization of the concentration of pyridoxal 5′-phosphate (PLP). Data are mean ± SD for
three replicates.
The effect of reaction temperature from 20 to 80 ◦C on the specific activity of lysine decarboxylase
is shown in Figure 5b. The optimum activity was observed when the reaction was carried out at 50 ◦C.
Metal ions (Ca2+, Co2+, Fe2+, Fe3+, K+, Ni2+, Mg2+, Mn2+, Cu2+, and Zn2+) (1 mM) were added into
the reaction media. It was found that Fe2+ was the optimum metal ion additive. The metal ions Ca2+,
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Co2+, Fe2+, Fe3+, K+, Ni2+, and Mg2+ also showed positive effects on lysine decarboxylase (Figure 5c).
Subsequently, Fe2+ concentration in the reaction medium was further optimized. The highest enzyme
activity was obtained at a concentration of 10 mM Fe2+ (Figure 5d), which was approximately 1.7-fold
higher than that without the addition of Fe2+.
Lysine decarboxylase is one of the PLP-dependent enzymes [5–7]. Therefore, the effect of PLP
concentration in the reaction medium was examined. The specific activity of lysine decarboxylase
was only 3.8 U/mg in the absence of PLP (Figure 5e). However, when 0.1 mM of PLP was added,
the specific activity of lysine decarboxylase increased to 23.4 U/mg. With further increase of PLP
concentration, only moderate increase was observed in enzyme activity. Taking into account the
economic benefits, we determined 0.1 mM PLP to be the optimum concentration.
2.4. Determining the Optimal Condition of the Two-Step D-Lysine Production Process
To determine the optimal conditions of the two-enzyme cascade system, the impact factors on
lysine racemase and lysine decarboxylase were compared. As has been described, the optimal pH for
the whole-cell BL21-LYR was 7.0, while the specific activity of lysine decarboxylase was the highest at
pH 6.0. Considering that lysine decarboxylase was more sensitive to pH variance, the two-enzyme
cascade reaction was performed in potassium phosphate buffer with pH 6.0. At this pH, the racemase
activity also remained at a high level. The two reactions were all carried out at around 37 ◦C, where the
activities of the two enzymes both reached the optimum (Figures 4b and 5b). For the metal ions, in the
first step, none were added into the reaction solution. After the end of the racemization reaction,
10 mM of Fe2+ was added to improve the catalytic rate during the lysine decarboxylation process.
A supplement of 0.1 mM PLP was also added during the decarboxylation reaction step.
2.5. D-Lysine Production at Different Substrate Concentrations
In this study, L-lysine concentrations ranging from 680 to 1710 mmol/L in the bioconversion
mixture were investigated. As illustrated in Figure 6, D-lysine productivity improved with the
increasing L-lysine concentration. When the initial L-lysine concentration was 680 mmol/L (Figure 6a),
the production rate of D-lysine was 9.6 mmol/L/min, whereas the D-lysine production rate increased
to 22.6 mmol /L/min at an L-lysine concentration of 1710 mmol/L (Figure 6d). After bioconversion
for 0.5 h, all D-lysine production from different concentrations of L-lysine had nearly reached the
equilibrium. After about 1 h, cell extracts of E. coli ATS3 were added into the reaction mixture. It was
observed that the L-lysine decarboxylation process could be completed within 0.5 h. The L-lysine
degradation rate was increased with increasing concentration of the resting L-lysine. Our results
indicated that an initial concentration of L-lysine ranging from 680 to 1710 mmol/L appeared to
have no influence on either the racemization or decarboxylation processes. As shown in Table 1,
a moderate improvement in D-lysine yield was observed with an increase in L-lysine concentration. At a
concentration of 680 mmol/L L-lysine, the D-lysine titer was only 287.2 mmol/L, and the molar yield
was 46.9%. When the initial L-lysine concentration was increased to 1710 mmol/L, 750.7mmol/L of
D-lysine was produced with a final yield of 48.8%. Meanwhile, 783.4 mmol/L cadaverine was obtained,
and the total conversion yield of L-lysine was 99.7%. With the two-enzyme cascade bioconversion
process we established, the enantiomeric excess of D-lysine was always higher than 99.0%.
Table 1. The production of D-lysine from different concentration of L-lysine.
L-Lysine (mM) D-Lysine (mM) Cadaverine (mM) D-Lysine Yield Enantiomeric Excess
680 287.2 323.5 46.9% 99.5%
1030 446.0 479 48.1% 99.5%
1370 601.0 628.5 48.8% 99.4%
1710 750.7 783.4 48.8% 99.3%
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Figure 6. The production of D-lysine from different concentration of L-lysine. The intial L-lysine was
680 mmol/L (a); 1030 mmol/L (b); 1370 mmol/L (c); and 1710 mmol/L (d), respectively.
3. Discussion
D-Amino acids have been proved to be naturally present in many bacteria, plants, and
animals [19–21], which exhibited widespread applications in industry, such as pharmaceutics, food,
and cosmetics [5]. For example, D-amino acids can be used to synthetize the peptides which are
very potent in the inhibition of HIV [22]. Thus, an efficient process for the large-scale production of
D-amino acids is highly desirable. As one of the important D-amino acids, the widespread application
of D-lysine in industry has also been reported [2,3]. In our study, we established a two-step process for
D-lysine production from L-lysine by the microbial racemization and asymmetric degradation with
lysine racemase and decarboxylase.
In our work, L-lysine was used as the starting material and racemized to generate DL-lysine
under the biocatalysis of amino acid racemases. Currently, a variety of amino acid racemases, such as
those for alanine, glutamate, serine, aspartate, and arginine, have been discovered in bacteria, archaea,
and eukaryotes [23–25]. However, only a handful of amino acid racemases that are active with lysine
have been isolated. In our study, the racemases from strain P. mirabilis (LYR) and L. paracasei (AAR)
were expressed in E. coli. The LYR protein was highly soluble in E. coli, and the whole-cell BL21-LYR
showed higher lysine racemization activity with an approximate D-lysine yield of 48%. The biochemical
characterization study revealed that the racemase activity of the whole-cell BL21-LYR was most active
at 37 ◦C and pH 7.0, while the characterization of purified enzyme LYR in the previous study revealed
that the optimal pH was between 8.0 and 9.0, and the optimum temperature was 50 ◦C [8]. The high
temperature and pH might affect the survival of the whole cells. Therefore, the activity of whole cell
showed a difference with the purified enzyme. Meanwhile, it was found that the addition of metal
ions did not enhance the activity of BL21-LYR, indicating that the racemization activity of LYR was
independent of metal ions, which was in accordance with the conclusion from the previous studies on
the purified enzyme LYR [8].
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After the racemization reaction, the microbial asymmetric degradation of L-lysine in the DL-lysine
mixture solution was performed to generate the enantiopure D-lysine. L-Lysine decarboxylase is
one of the PLP fold type I enzymes, which selectively catalyze the decarboxylation of L-lysine to
generate cadaverine [15,18]. The engineered E. coli ATS3 used in our previous study was constructed
by overexpressing endogenous cadA gene encoding lysine decarboxylase [15,18]. Meanwhile, the
ribose 5-phosphate-dependent pathway genes pdxS and pdxT from Bacillus subtilis were introduced
into the engineered E. coli for de novo PLP biosynthesis [15]. As shown in Figure 3, the crude enzyme
of ATS3 exhibited the highest L-lysine decarboxylation activities, and was identified as the best
biocatalyst. We also determined that the lysine decarboxylase we used in this study was specific
for L-lysine (Figure S1). Furthermore, the characterization of lysine decarboxylase revealed that
decarboxylation activity was dependent on Fe2+ ion and PLP additive. Bagni et al. also reported that
lysine decarboxylase needs Fe2+ as a cofactor [26]. However, the activation mechanism of Fe2+ on
decarboxylase was still unclear. For the PLP-dependent decarboxylation, it referred to the transfer of
the proton during the elimination of the CO2 [27]. Fe2+ has been reported to be a good metal as redox
center, which might be associated with its role in the activation of lysine decarboxylase [28].
According to the characteristics of lysine racemase and lysine decarboxylase, a two-step process
for efficient D-lysine production from L-lysine was established through a two-enzyme cascade system.
When L-lysine at different concentrations was used as the starting material, D-lysine with enantiomeric
excess ≥ 99% could always be synthesized efficiently. For example, after 1 h of racemization reaction
and 0.5 h of decarboxylation reaction, 750.7 mmol/L D-lysine could be obtained from 1710 mmol/L
L-lysine with a yield of 48.8%. Meanwhile, with the increase of L-lysine, the production rate of D-lysine
was increased, which suggested that no substrate inhibition on the activity of whole-cell BL21-LYR
was observed when the initial L-lysine concentration ranges from 680 to 1710 mmol/L. The synthesis
of cadaverine was also desirable for D-lysine separation due to their large difference in the polarity.
In conclusion, the two-enzyme cascade for D-lysine production described in our work shows promise
for the large-scale synthesis of D-amino acids.
4. Materials and Methods
4.1. Chemicals and Enzymes
Isopropyl-β-D-1-thiogalactopyranoside (IPTG), L-lysine (>98%), and D-lysine (>98%), were
purchased from Sigma Aldrich (St. Louis, MO, USA). The restriction enzymes, T4 DNA ligase and
agarose gel DNA purification kit were supplied by TaKaRa Biotechnology (Otsu, Japan).
4.2. Bacterial Strains and Growth Conditions
The Escherichia coli Tans1-T1 was purchased from TransGen (Beijing, China) and used for gene
cloning. The E. coli BL21 (DE3; TransGen) and pET-28a vector (Novagen, San Diego, CA, USA) were
employed as a host for gene expression. The engineered strain E. coli AST3 with lysine decarboxylase
(EC 4.1.1.18) activity was preserved in our laboratory [15]. The E. coli strains were routinely cultured
in modified Luria–Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract and 10 g/L sodium
chloride) containing 50 mg/mL kanamycin (Kan).
4.3. Construction of Plasmids
The lysine racemase (LYR, EC 5.1.1.5) from strain P. mirabilis BCRC10725 and the amino acid
racemase (AAR, EC 5.1.1.10) from strain L. paracasei ATCC 334 were reported to be capable of
racemizing lysine [8,16]. The two genes were codon-optimized for E. coli expression system [29],
and synthesized by Genewiz Company (Jiangsu, China). The two gene fragments were cloned
into NcoI/XhoI sites of plasmid pET-28a to generate the plasmid pET-28a-LYR and pET-28a-AAR,
respectively (Figure 2a). The two recombinant plasmids were then transformed into E. coli BL21
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(DE3) competent cell to obtain the recombinant strain BL21/pET-28a-LYR, and BL21/pET-28a-AAR.
E. coli BL21 (DE3) harboring empty plasmid pET-28a was used as the control.
4.4. Expression of Recombinant Proteins in E. coli BL21(DE3)
The recombinant strain BL21/pET-28a-LYR, and BL21/pET-28a-AAR were inoculated from
a freshly transformed single colony to 10 mL of LB medium. After cultivation for 8 h at 37 ◦C,
the recombinant strain BL21/pET-28a-LYR and BL21/pET-28a-AAR were then seeded into 100 mL of
LB medium with 50 mg/L kanamycin at an inoculation volume of 1%. Cell densities were monitored
by measuring the optical density at 600 nm (OD600). Upon reaching OD600 of 0.6~0.8, cells were
induced by IPTG addition at 1.0 mM. After incubation for 12 h at 30 ◦C, cells were harvested by
centrifugation (6000× g, 5 min, 4 ◦C), and resuspended in 200 mM potassium phosphate buffer (pH 6.0).
The recombinant strain AST3 was then seeded into 100 mL of culture medium [15] with 100 mg/L
ampicillin and 34 mg/L chloramphenicol at an inoculation volume of 2%. After incubation for 12 h
at 37 ◦C, cells were harvested by centrifugation (6000× g, 5 min, 4 ◦C), and resuspended in 200 mM
potassium phosphate buffer (pH 6.0). To prepare the crude enzyme, the cell paste was sonicated for
15 min (2 s worktime with 2 s interval). Cell extracts were then centrifuged for 15 min at 10,000× g to
remove cell debris. The supernatant was analyzed using sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) analysis (12% acrylamide).
4.5. Racemase and Decarboxylase Activity Characterization
In the present study, one unit of racemase activity was defined as the amount of dry cell weight
(DCW) that produced 1 μM of amino acid enantiomer from its corresponding enantiomer per minute.
The impact factors associated with racemase activity were investigated in a reaction solution containing
resting cells (OD600 = 5), 820 mmol/L L-lysine, and 200 mM sodium phosphate buffer (pH = 7.0) in a
total volume of 10 mL. The optimal pH for racemase activity was confirmed in the 200 mM sodium
phosphate buffer pH 4.0–8.0. The effect of temperature on racemase activity was determined by
measuring the enzyme activity between 20 and 45 ◦C. To determine the metal ions preference of
racemase, the effects of K+, Fe2+, Fe3+, Mg2+, Mn2+, Cu2+, Zn2+, Ca2+, Co2+, and Ni2+ additives
were investigated.
The lysine decarboxylase assay was carried out in a 50 mL centrifuge tube with 5 mL reaction
broth containing 270 mmol/L L-lysine, 200 mmol/L sodium phosphate buffer (pH = 7.0), 1.0 mmol/L
PLP, and 0.2 g/L crude enzyme. One unit of lysine decarboxylase activity was defined as the amount of
enzyme that transformed 1 μM of L-lysine to cadaverine per minute. For pH optimization, the reaction
was performed in 200 mmol/L sodium phosphate buffer (pH 4.0–8.0). To optimize temperature, the
decarboxylase activity was measured in the condition with temperatures varying between 20 and
45 ◦C. To determine the effect of metal ions on enzyme activity, we measured decarboxylase activity in
the reaction broth containing K+, Fe2+, Fe3+, Mg2+, Mn2+, Cu2+, Zn2+, Ca2+, Co2+, and Ni2+. The PLP
content in the reaction mixture was also optimized.
4.6. The Microbial Production of Enantiopure D-Lysine and Cadaverine
In this study, L-lysine was first biologically racemized to give DL-lysine under the biocatalysis of
lysine racemase. The recombinant strain BL21/pET-28a-LYR was resuspended into 20 mL of reaction
mixture containing 550 mmol/L, 680 mmol/L, 1030 mmol/L, 1370 mmol/L, or 1710 mmol/L L-lysine
and 200 mmol/L sodium phosphate buffer (pH 6.0) with an OD600 of 5. The whole-cell biocatalyst
was carried out in a 50 mL flask at 37 ◦C. Samples were taken at the specific intervals to measure the
concentration of L-lysine and D-lysine.
When the reaction reached the equilibrium, the BL21/pET-28a-LYR cells were removed by
centrifugation. The supernatant was maintained at 80 ◦C for 10 min. Then the whole cell (5.0 of OD600)
or crude enzyme (0.2 g/L) of the strain ATS3 expressing L-lysine decarboxylase was added into the
supernatant to selectively catabolize L-lysine to generate cadaverine and CO2. The reaction mixture
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also contained 200 mmol/L sodium phosphate buffer (pH 6.0), 10 mmol/L Fe2+, and 0.1 mmol/L PLP.
To identify the best biocatalyst for the enantiopure D-lysine production, the activity of resting whole
cells, permeabilized cells, and crude enzyme was comparatively investigated under the condition of
550 mmol/L L-lysine.
4.7. Analysis Methods
The D-lysine and L-lysine in the reaction mixture were analyzed via a high-performance liquid
chromatography (HPLC) system (Agilent 1290 series; Agilent, Palo Alto, CA, USA) equipped with a
UV–vis detector (wavelength = 254 nm) and a chirex chiral column (Chirex 3126 (D)-penicillamine
150 mm × 4.6 mm with a pre-column 30 mm × 4.6 mm, 5 μm, Waters, Milford, MA, USA). The column
was maintained at 25 ◦C. One millimolar CuSO4 5 H2O dissolved into water/isopropanol (95:5, v/v)
with the flow rate of 0.8 mL/min was used as the mobile phase.
The cadaverine concentrations were determined by reverse-phase high performance liquid
chromatography (HPLC) using an Agilent 1290 Infinity System equipped with a fluorescence detector
(FLD, G1321B, Agilent, Palo Alto, CA, USA). The cadaverine concentration was determined by
precolumn dansyl chloride derivatization following a previously described procedure [16].
5. Conclusions
In the current work, we have developed a two-step microbial process for high-level conversion of
L-lysine to D-lysine through a lysine racemase and decarboxylase cascade system. The recombinant
strain BL21-LYR, used as the biocatalyst of a racemization reaction to generate DL-lysine,
was constructed by expressing lysine racemase from the strain P. mirabilis (LYR). Subsequently, lysine
decarboxylase was employed for the asymmetric degradation of L-lysine to generate cadaverine.
To produce D-lysine with high enantiomeric excess, the decarboxylation activities of resting whole
cells, permeabilized cells, and crude enzyme were compared, and the crude enzyme was identified
as the best biocatalyst. After characterization of the lysine racemase and decarboxylase, the two-step
reaction was performed under optimal condition, and 750.7 mmol/L D-lysine could be obtained from
1710 mmol/L L-lysine. The enantiomeric excess of D-lysine was higher than 99%.
Supplementary Materials: The following are available online at www.mdpi.com/2073-4344/6/11/168/s1,
Figure S1: Determining the substrate specificity of the lysine decarboxylase.
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